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ABSTRACT 
RUTHENIUM-CATALYZED DEHYDROGENATIVE AND DEHYDRATIVE 
C-H COUPLING REACTIONS OF ARENES WITH ALCOHOLS  
AND CARBONYL COMPOUNDS 
 
 
Hanbin Lee, B.Sc., M.Sc. 
Marquette University, 2017 
Despite their outstanding achievements, the requirement of preformed functional 
groups and wasteful byproduct formation are inherent disadvantages associated with the 
transition metal catalyzed cross-coupling methods. Inspired by the needs for green and 
sustainable chemistry, transition metal catalyzed dehydrogenative and dehydrative 
coupling methods have been recognized as environmentally sustainable and atom 
economical synthetic routes for the new C-C bond formation. The catalytic activation of 
C-H and C-O bonds allows the formation of coupling products from ubiquitous 
hydrocarbon substrates by releasing hydrogen or water byproduct. However, these novel 
protocols require relatively harsh conditions due to their low reactivity of C-H and C-O 
bonds, and difficulty in controlling regioselectivity. The development of new catalytic C-
H bond activation methods is highly desirable for the selective C-C formation reactions. 
The cationic ruthenium-hydride complex was found to be a highly effective catalyst 
for the dehydrogenative and dehydrative C-H coupling reactions of simple arenes with 
alcohols and carbonyl compounds. The dehydrogenative coupling reaction of phenols with 
aldehydes formed the 2-acylphenols without using any metal oxidant or forming wasteful 
byproducts. The mechanistic studies suggested that the aldehyde substrate was served as 
both the coupling partner and hydrogen acceptor. The coupling method was successfully 
extended to the synthesis of 2H-chromene derivatives by using α,β-unsaturated aldehydes. 
The cationic ruthenium-hydride complex was found to exhibit uniquely high activity for 
the coupling reaction of phenols with ketones to form synthetically useful 2-vinylphenols. 
The coupling of phenols with linear ketones led to a highly (Z)-selective formation of 
trisubstituted olefins. We also developed the catalytic synthesis of biologically important 
indole and quinoline derivatives from the coupling reaction of arylamines with diols. A 
broad range of substrates was demonstrated to afford the regioselective N-heteroannulated 
products. The deuterium labeling study and control experiments were performed to discern 
the mechanistic pathway. 
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CHAPTER 1 
Introduction 
Hydrocarbons are ubiquitous constituents present in organic and petroleum 
products. It is very important to develop efficient processes for the transformation of 
inexpensive hydrocarbons to more valuable products such as pharmaceuticals, natural 
products, and polymers. Since carbon-hydrogen (C-H) and carbon-carbon (C-C) bonds are 
the most fundamental linkage for these substances, the development of catalytic methods 
for efficient and selective C-H bond activation and C-C bond formation reactions remains 
one of the most critical challenges in organic chemistry.  
To overcome shortcomings of classical C-C coupling methods such as Grignard 
and Friedel-Crafts reactions, transition metal catalyzed cross-coupling reactions have 
emerged as highly effective methods for C-C bond formation. Since Heck’s pioneering 
work on the palladium-catalyzed cross coupling of aryl halides and olefins in late 1960s, 
extensive research has been directed to the development of transition metal catalyzed cross-
coupling reactions.1 Many types of transition metal catalyzed C-C coupling methods 
(Kumada, Suzuki−Miyaura, Negishi, Stille, and Hiyama) have led to indispensable tools 
for chemical synthesis.2 However, in spite of outstanding achievements on these catalytic 
C-C bond formation methods, these processes commonly require prefunctionalized starting 
materials and a stoichiometric amount of base.3 The requirement of preformed functional 
groups is an inherent disadvantage because the substrate availability is often limited or 
multiple functionalization steps are needed to synthesize these starting materials. Moreover, 
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the formation of stoichiometric amount of undesirable salt byproduct is inevitable from the 
use of base (Scheme 1.1). 
 
Scheme 1.1 Transition metal catalyzed cross-coupling reactions 
In this regards, the development of catalytic methods which can lead to the direct 
formation of C-C bonds through the selective cleavage of unreactive C-H bonds would be 
highly desirable. Thus, the transition metal catalyzed C-H activation methods have 
attracted much interest in synthetic chemistry.4 In particular, dehydrogenative and 
dehydrative C-C cross-coupling methods via C-H activation have been found to be highly 
atom economical ways that do not form any harmful byproducts. This chapter will mainly 
discuss the recent developments on the synthetic and mechanistic aspects of transition 
metal mediated C-C bond formation methods via C-H bond activation. 
1.1 Catalytic Dehydrogenative Cross-Coupling Methods via C-H Activation 
Considerable efforts have been devoted to the development of catalytic C-C bond 
formation methods via unfunctionalized C-H bond activation, which are inspired by the 
needs for green and sustainable chemistry.5 The cross-dehydrogenative-coupling (CDC) of 
two C-H bonds is not only advantageous in terms of eliminating byproduct formation but 
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also from the viewpoint of reducing the reaction steps. Both starting hydrocarbon substrates 
do not need to be prefunctionalized, which reduces costly chemical steps and the wasteful 
byproducts (Scheme 1.2). 
 
Scheme 1.2 Transition metal catalyzed oxidative cross-coupling reactions via C-H 
activation 
Although CDC method can be a powerful tool for the selective formation of new 
C-C bonds, certain obstacles still remain to be resolved. First, the generation of C-C bonds 
with loss of hydrogen gas might not be thermodynamically favored under normal reaction 
conditions. Thus, the reaction may require an external driving force such as a hydrogen 
acceptor and/or elevated temperature. Second, the selective activation of two different C-
H bonds is required on the starting materials. In case of benzene derivatives, the difference 
in reactivity between the C-H bonds is generally less ascertained. The use of directing 
groups is commonly employed to improve both regioselectivity and reactivity, because the 
C-H bond near the directing group would promote the access to metal catalysts.6 Despite 
such challenges, various oxidative C-C bond formation methods have been achieved by 
using CDC strategy including alkenylations7, arylations, alkylations8, and acylation 
reactions. 
1.1.1 Dehydrogenative Heck-Type Cross-Coupling Reactions 
Olefins are fundamental building blocks for a variety of important reactions in 
organic synthesis. In a pioneering study, Fujiwara reported a Mizoroki-Heck-type reaction 
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of Pd-catalyzed oxidative cross-coupling between aryl C-H bonds and olefins to generate 
arylalkenes.9 The proposed mechanism as shown in Scheme 1.3 involves arene-C-H bond 
activation and transmetalation by Pd(II) complex 1 to generate arylpalladium intermediate 
2, which undergoes carbopalladation of olefin (3) to form new C-C bond of akylpalladium 
complex 4. The β-H elimination yields styrenyl product 5 and Pd(II)-hydride species 6. 
The subsequent reductive elimination gives Pd(0) species 7, and reoxidation of Pd(0) to 
Pd(II) 1 completes the catalytic cycle.10 There are two major problems for this reaction. 
First, the reaction requires a large excess of arene substrate. Second, poor regioselectivity 
was observed for monosubstituted benzene substrates. 
 
Scheme 1.3 Oxidative Heck-type alkenylation via C-H activation 
To address this regioselectivity problem, de Vries and van Leeuwen adopted 
chelate assisted regioselective oxidative cross-coupling between anilides (8) and olefins (9) 
under mild conditions (eq 1.1).11  
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The Pd(II) catalyst was found to be most effective for the coupling reaction, 
whereas other metal complexes such as Ru3(CO)12, [RuCl2(p-cymene)]2, PtCl2, and 
Ni(OAc)2 showed no activity. The reaction was found to exhibit a large electronic 
dependence as measured from the competitive experiments of a series of para-substituted 
anilides (ρ+ =  2.2). A large deuterium isotope effect was measured on the ortho-C-H bond 
of anilides, indicating the C-H activation is the slow step (kH/kD = 3). The authors proposed 
a mechanism involving the electrophilic cyclopalladation of anilides 8 as the rate-limitng 
step to generate palladacycle 11. Then, carbopalladation of olefin 9 generates ortho-
akylpalladium complex 12, which undergoes β-H elimination to yield the ortho-
alkenylation product 10. Stoichiometric amount of benzoquinone (BQ) was found to be the 
optimal oxidant. p-Toluenesulfonic acid (TsOH) also showed beneficial effect for 
improving the product yields. 
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Scheme 1.4 Proposed mechanism of the Pd-catalyzed oxidative ortho-alkenylation of 
anilides 
 
In 2001, Milstein and co-workers reported the oxidative olefination of arenes 
catalyzed by ruthenium complexes (eq 1.2).12 A number of ruthenium complexes such as 
RuCl3·3H2O, [Ru(CO)3Cl2]2, [(η6-C6H6)RuCl2]2, Ru(NO)Cl3·5H2O, and 
Ru(CF3COCH2COCF3)3 showed similar catalytic activity. The authors found that O2 can 
be directly used as the oxidant, but olefins can also serve as the oxidant in the absence of 
O2 to yield a 1:1 ratio of alkenylation and the alkylation products. The Hammett type of 
competitive experiment indicated that electron-donating substituents on the arene react 
faster than electron-deficient arenes (ρ+ = -1.16). The authors proposed a possible 
mechanism as shown in Scheme 1.5. First, C-H activation of 13 forms an arylruthenium 
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intermediate 16. The insertion of olefin 14 into metal-aryl bond forms alkylruthenium 
complex 17, which undergoes β-H elimination to yield the product 15 and ruthenium-
hydride species 18. Regeneration of electrophilic ruthenium species 19 by oxidation with 
O2 completes the catalytic cycle. The product yield increases under CO atmosphere (6.1 
atm) by stabilizing the electrophilic ruthenium species. In support of this, ruthenium-
carbonyl peaks (2054 and 1983 cm-1) are observed by IR spectroscopy in the reaction 
mixture. 
 
Scheme 1.5 Proposed mechanism for Ru-catalyzed oxidative arene-alkene olefination 
The selective activation of sp3-C-H bonds of simple alkanes has proven to be much 
more challenging because it is both kinetically and thermodynamically less favored than 
sp2-C-H bonds. However, sp3-C-H bonds with neighboring α-heteroatom could be 
selectively activated by late transition metal complexes.13  
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Previously, our research group developed a highly regioselective dehydrogenative 
coupling reaction between cyclic amines and alkenes by using the Ru-H catalyst 
(PCy3)2(CO)RuHCl (23) (eq 1.3).
14 The reaction occurred without any additives, and H2 is 
the only byproduct consumed by excess alkene starting material. A normal deuterium 
isotope effect was observed from the coupling reaction of C4H8N-H and C4H8N-D (kH/kD 
= 1.9), whereas no significant carbon isotope effect was measured. The authors were able 
to isolate an anionic ruthenium-amido complex as a sodium salt. The X-ray 
crystallographic analysis (Figure 1.1) supports that the isolated complex is an active species 
for the reaction. The proposed mechanism starts with coordination of 20 to ruthenium 
complex 23, followed by α-C-H activation and olefin insertion to form the alkylruthenium 
intermediate 24 (Scheme 1.6). The subsequent β-H elimination liberates an equivalent of 
alkane, which was detected by NMR in the reaction mixture. Another α-C-H activation of 
cyclic imine forms α-ruthenated imine complex 25. Insertion of second olefin 21 followed 
by reductive elimination gives the product 22 with the regenerated Ru catalyst. 
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Figure 1.1 ORTEP diagram of anionic Ru-amido-hydride complex 
 
Scheme 1.6 Proposed mechanism for Ru-catalyzed oxidative α-alkenylation of cyclic 
amines 
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In 2010, our group also reported a chelate-assisted oxidative coupling reaction of 
arylamides and unactivated alkenes by using the well-defined cationic ruthenium-hydride 
complex [(C6H6)(CO)(PCy3)RuH]
+BF4
- (26) (eq 1.4).15 Compared to other oxidative Heck-
type C-H alkenylations, the coupling reaction is environmentally beneficial because it does 
not employ any hazardous external metal oxidants or additives.  
 
The reaction between C6D5CONEt2 and cyclopentene showed an extensive ortho-
H/D exchange pattern (55% D) on both products at 50 % conversion. A rapid and reversible 
ortho-C-H bond activation of the amide substrate was also observed (eq 1.5). The carbon 
isotope effect revealed a pronounced 13C ratio on the ortho-carbon 
(13C(recovered)/13C(virgin) = 1.023), when recovered amide at 80% conversion and virgin 
sample are compared. These results suggest that C-C bond formation step is the rate-
limiting step. 
 
 A stable Ru-H complex 31 was isolated from the reaction of cyclopentene and 
naphthylamide-coordinated complex 32, which is prepared from the reaction of 
tetranuclear ruthenium complex [RuH(CO)(PCy3)]4(O)(OH)2, N,N-dimethyl-2-
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naphthamide, and HBF4·OEt2 (eq 1.6).
16 The cationic ruthenium complex 31 showed the 
same activity as the catalyst 26 for the coupling reaction between naphthylamide and 
cyclopentene. 
 
The proposed mechanism involves an initial arene exchange from 26 to form 
arylamide-coordianted cationic ruthenium-hydride species 33. The subsequent chelate-
directed ortho-C-H activation and dehydrogenation steps generate the ortho-metalated 
species 34. The vinyl C-H activation of alkenes, followed by aryl-to-vinyl reductive 
elimination steps produce cationic ruthenium hydride complex 35. Liberation of the 
product 29 and coordination of another arylamide completes the catalytic cycle. 
 
Scheme 1.7 Proposed mechanism of oxidative cross-coupling reaction of benzamide and 
cyclopentane  
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1.1.2 Catalytic Dehydrogenative Biaryl C-C Bond Formation Reactions 
Biaryls are common structural motifs in pharmaceutical products, liquid crystals, 
and chiral ligands. Although the synthesis of biaryls has its roots in the pioneering work of 
Ullmann and Goldberg over a century ago,17 the development of broadly applicable Pd-
catalyzed aryl-aryl bond formation methods (Kumada, Suzuki, Negishi, Stille, Hiyama) 
still require aryl halides and appropriate organometallic reagents. Recently, direct C-H 
oxidative coupling of two unfunctionalized arenes has emerged as a promising synthetic 
strategy for the formation of biaryl products.18 
 
In 2006, Lu and co-workers published oxidative cross-coupling of naphthalene with 
various arenes (eq 1.7).19 The biaryl formation reaction was achieved with a palladium(II) 
catalyst, K2S2O8, and CF3COOH (TFA), which is the same catalytic system used for the 
carboxylation of arenes.20 The authors found that the ratio between homo-coupling and 
unsymmetrical biaryl products from the reaction of benzene and anisole can be controlled 
by changing the relative concentration of TFA (eq 1.8).  
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 A stoichiometric amount of K2S2O8 was used as the terminal oxidant. Various 
unsymmetrical biaryls were produced from the oxidative cross-coupling of naphthalene 
and benzene derivatives at room temperature. However, a large excess of arene substrates 
(5-100 equivalents) was required in order to avoid the homo-coupling products. 
 
Scheme 1.8 Proposed mechanism of Pd-catalyzed oxidative cross-coupling of naphthalene 
with arenes 
 The authors proposed a plausible mechanism as shown in Scheme 1.8. The initial 
C-H activation occurs with a highly concentrated arene 37 to give arylpalladium complex 
41, then the preferential attack of the electron-rich arene 40 takes place in the mixture. A 
lower amount of TFA leads to the less electrophilicity of Pd(II) complexes. 
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Fagnou and co-workers reported a palladium catalyzed C3-arylation of N-
acetylindoles with simple arenes by using Cu(OAc)2 as the oxidant (eq 1.9).
21 Optimal 
catalytic reactivity was discovered with palladium trifluoroacetate [Pd(TFA)2] complex, 3-
nitropyridine, cesium pivalate, and pivalic acid as the solvent. Addition of pyridine 
presumably acts to stabilize the palladium(0), thereby preventing the formation of 
palladium black precipitates before reoxidation. The authors believed that a complete 
inversion of catalyst selectivity occurred in a single catalytic cycle by using two different 
arenes as starting materials, because no homo-coupling products are detected in the crude 
reaction mixture. They hypothesized that two potential arene palladation pathways could 
be involved in the mechanism for the formation of unsymmetrical biaryl products (Scheme 
1.9). 
 
Scheme 1.9. Two possible metalation pathways. (a) The electrophilic aromatic metalation 
pathway, and (b) concerted proton transfer metallation pathway 
Fagnou group also showed that changing the oxidant from Cu(OAc)2 to AgOAc 
results in regioselective C2 arylation of indoles (eq 1.9).22 Although the rationale of the 
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C2/C3 regioselectivity has not been settled, they explained that the formation of mixed Pd-
Cu clusters may promote pronounced C3 selectivity. 
 
 More recently, Dong and co-workers reported O-carbamate directed ortho-
selective oxidative arylation by using palladium catalyst.23 Sodium persulfate (Na2S2O8) 
was found to be an optimal oxidant, whereas Cu(OAc)2 and AgOAc were ineffective. The 
authors observed that either products 44 and 45 can be selectively produced by controlling 
the relative concentration of the oxidant (eq 1.10). Also, ortho- or meta-substituted O-
phenylcarbamates readily underwent to form the monoarylation products. The addition of 
TFA was found to be critical for achieving highly efficient oxidative cross-coupling 
reactions. The authors proposed that TFA enhances the electrophilic metalation of the 
palladium catalyst center toward arene substrates.24  
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Scheme 1.10 Proposed mechanism for Pd-catalyzed oxidative ortho-arylation 
 The authors proposed a possible mechanism is proposed as shown in Scheme 1.10. 
Carbamate-assisted cyclopalladation of 42 forms the arylpalladium 46. The subsequent C-
H bond activation of electron-deficient arene 43 by electrophilic metalation, followed by 
reductive elimination to yield the product 44 (or 45 for the second cycle) and Pd(0) 47. The 
reoxidation of Pd(0) 47 with Na2S2O8 forms active Pd(II) species 48. In order to support 
the first C-H bond activation by cyclopallation,25 Pd complex 49 was prepared by treatment 
of m-tolyl dimethylcarbamate with Pd(OAc)2 in the presence of TFA (eq 1.11). The Pd 
complex 49 was characterized by NMR spectrocscopy and X-ray crystallography (Figure 
1.2). The treatment of obtained dimeric Pd complex 49 with benzene produced ortho-
phenylated O-phenylcarbamate in excellent yield. The molecular structure of 49 suggests 
the formation of palladacycle intermediate 46. 
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Figure 1.2 ORTEP plot of dimeric Pd complex 49 
 
Scheme 1.11 Cyclo-dehydrogenative arylation of 1,2,3-triazoles 
Heterocyclic products have been synthesized by applying intramolecular 
dehydrogenative C-C bond formation protocol. Ackermann and co-workers reported 
intramolecular arylation of 1,2,3-triazoles via two different sp2 C-H bond activation by 
using Pd(OAc)2 catalyst (Scheme 1.11).
26 The heteroannulated triazoles could be formed 
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by intramolecular C-C bond formation with 6:1 toluene/pivalic acid solvent system in air, 
but there was no distinct advantage on using moleculer oxygen as the oxidant. The addition 
of the stoichiometric amount of Cu(OAc)2 was found to be the most optimal among a 
variety of screened terminal oxidants. The authors were able to expand the scope of this 
method to synthesize π-conjugated heteroannulated phenanthrenes. 
Recently, Xu and co-workers reported Pd(OAc)2 catalyzed intramolecular 
heterocyclization of 4-aniline substituted coumarins, quinolinones, and pyrones (Scheme 
1.12).27 A wide range of indole-fused polyheterocycles such as indolo[3,2-c]coumarins, 
indolo[3,2-c]quinolinones, and indolo[3,2-c]pyrones can be produced by atom economical 
dehydrogenative C-C bond connection. The authors devised base-free reaction conditions 
by changing catalyst loading and the oxidant. Since replacing AgOAc (method B) with air 
(method A) is environmentally beneficial, method A was employed for the 
heterocyclization of 4-arylamino coumarines with a longer reaction time (> 24 h). These 
methods readily afforded biologically valuble polyheterocycle compounds in good to 
excellent yields while avoiding prefunctionalization or N-protection of substrates.   
 
Scheme 1.12 Dehydrogenative polyheterocyclization 4-aniline substituted coumarins, 
quinolinones, and pyrones 
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1.1.3 Catalytic Oxidative Coupling of Aldehydes via C-H Bond Activation 
 Transition metal catalyzed direct carbonylation via C-H bond activation is an 
attractive synthetic method in organic chemistry. In a pioneering study, Murai and co-
workers developed Ru3(CO)12 catalyzed acylation of imidazoles with CO and olefins.
28 In 
2013, Beller and co-workers reported [RuCl2(cod)]n catalyzed C-C coupling of 2-
phenylpyridine with CO and aryl halides to form benzophenones.29 In both cases, the 
authors applied high pressure of CO gas (20-40 atm) to proceed their reactions. Recently, 
the acylation of arenes via direct aldehydic C-H bond activation has been developed, but 
most of the applications are limited to aromatic aldehydes.30 For example, Cheng and co-
workers reported palladium-catalyzed ortho-selective C-H acylation of arenes with 
aldehydes (eq 1.12).31 The reaction was carried out with 10 mol % of Pd(OAc)2 as the 
catalyst, 1:2 mol ratio of 2-phenylpyridine derivatives and aryl aldehydes in dry xylene at 
120 °C using air as the optimal oxidant. The authors found a high degree of functional 
group tolerance on both starting meterials. The electronic effect was not observed on 2-
arylpyridines for both electron-donating and electron-withdrawing substituents. However, 
the reaction efficiency was sensitive to the electronic nature on aryl aldehyde substituents. 
Electron-withdrawing groups on the phenyl ring of benzaldehyde gave higher yields than 
benzaldehydes with electron-donating groups. 
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 The proposed mechanism involves a chelate-directed C-H activation of 2-
phenylpyridine to form a cyclopalladated complex 54. To support this initial step, the 
authors were able to isolate and characterize the palladacycle complex 54, which showed 
the same catalytic activity as Pd(OAc)2 catalyst 53. Insertion of C=O bond of aldehyde into 
C-Pd bond gives palladium complex 55, and the consequent β-H elimination forms the 
product 52 and Pd(0) species 56. The Pd(0) species is reoxidized by air to regenerate the 
Pd(II) catalyst 53. 
 
Scheme 1.13 Proposed mechanism for Pd-catalyzed oxidative ortho-acylation of 2-
phenylpyridines with aryl aldehydes 
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Scheme 1.14 Pd-catalyzed cross-coupling of aryl ketone O-methyl oximes with aldehydes 
In 2010, Yu and co-workers reported Pd-catalyzed ortho-acylation of aryl-
substituted oximes with aldehydes (Scheme 1.14).32 The reaction was carried out with 5 
mol % of Pd(OAc)2, 0.5 equivalent of acetic acid (HOAc), and 2 equivalents of tert-butyl 
hydroperoxide (TBHP) in toluene at 100 °C for 2 h. The oxime was found to be an effective 
directing group for the ortho-acylation reaction. Moreover, the treatment of ortho-acylated 
product 57 with HCl/dioxane provided oxime deprotected 1,4-diketone product 58 (eq 
1.13).  
 
tert-Butyl hydroperoxide (TBHP) was found to be an optimal oxidant. The authors 
proposed a radical pathway involving hydrogen abstraction from the aldehyde, because 
dramatic decrease in reaction yields was observed in the presence of a radical scavenger 
such as ascorbic acid. Also, the reaction did not produce the product in the absence of 
TBHP. 
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Scheme 1.15 Proposed mechanism for Pd-catalyzed ortho-acylation of aryl oxime with 
aldehydes 
A proposed mechanism involving radical pathway is shown in Scheme 1.15. The 
reaction is initiated by chelate-assisted ortho-selecetive cyclopalladation on the substrate 
59 by Pd(OAc)2 catalyst. The palladacycle intermediate 60 reacts with acyl radical 61 to 
produce putative Pd(III) or Pd(IV) complex 62. The acyl radical is generated in situ by 
hydrogen abstraction of aldehyde be using TBHP. The Pd complex intermediate 62 
undergoes reductive elimination to form the active catalyst 53. 
 
Recently, Li and co-workers demonstrated Cu-catalyzed intramolecuar oxidative 
acylation of formyl-N-arylformamides (63) to produce indoline-2,3-diones (64) using O2 
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as the terminal oxidant (eq 1.14).33 A 10 mol % of CuCl2 with 1 atm of O2 offered the 
optimal reaction condition at 100 °C for 4 h. Substrates with a variety of functional 
substituents on aromatic ring were tolerated under the reaction conditions. The electron 
density of the substituents at the para position was found to affect the reaction. The desired 
products were obtained when the electron-donating or weak electron-withdrawing group is 
attached to the aromatic ring. 
 
Scheme 1.16 Proposed mechanism for Cu-catalyzed intramolecular acylation of formyl-
N-arylformamides 
The authors proposed a possible mechanism as shown in Scheme 1.16. First, C-H 
bond activation of aldehyde generates copper(II) complex intermediate 65 by releasing 
HCl. Subsequent arene C-H activation produces Cu(III) intermediate 66. The intermediate 
then undergoes reductive elimination to yield heterocyclic product 64 and Cu(I) species 67. 
The formation of intermediate 65 and 66 was supported by the detection of C=O peak from 
FTIR spectroscopy. Based on the kinetic isotope effect study (kH/kD (monodeuterated 
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aldehyde) = 2.4), the authors suggested that the aldehyde C-H bond activation is the rate-
liming step. 
1.2 Catalytic Dehydrative Cross-Coupling Reactions via C-H and C-O Bond 
Activation 
 From the viewpoint of green and sustainable chemistry, atom economical C-C bond 
formation methods have emerged as an attractive strategy in terms of minimizing reagents 
and corresponding waste products. Transition metal catalyzed cross-dehydrogenative 
coupling (CDC) method has become one of the most active area in research, which renders 
the formation of C-C bond from two different C-H bond activations, with H2 as the only 
byproduct. Despite the significant advances in eco-friendly chemistry, many oxidative C-
C formation methods still require stoichiometric oxidants or hydrogen acceptors. One of 
the ideal scenarios would be to employ catalytic cross-dehydrative coupling via C-H and 
C-OH bond activations. The attractive features of this method are the direct use of 
inexpensive and broadly available alcohols as coupling partner, and water is the only 
byproduct (Scheme 1.17). Although the transition metal catalyzed cross-dehydratve 
coupling reaction has been recognized as environmentally and economically impeccable 
strategy in recent years, this novel protocol has been rarely explored in synthetic 
chemistry.34  
 
Scheme 1.17 Transition metal catalyzed cross-dehydrative coupling reactions 
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1.2.1 Catalytic Dehydrative Reaction of Allylic Alcohols 
The palladium catalyzed allylation of carbon nucleophiles with allylic compounds 
(Tsuji-Trost reaction) is an important synthetic method in organic chemistry.35 However, 
very few articles have been reported on using allylic alcohols in Tsuji-Trost reaction 
because the alcohol hydroxy group has very poor leaving ability.36 Ozawa and co-workers 
reported allylation of anilines with allyl alcohols by using the π-allyl palladium complexes 
bearing diphosphinidenecyclobutene ligands (DPCB-Y).37 Mechanistic studies revealed 
that the C-O bond cleavage is the rate-determining step in these reactions. Li and co-
workers have developed a palladium catalyzed direct dehydrative coupling of terminal 
alkynes with allylic alcohols.38 A series of 1,4-enyne derivatives could be obtained from 
the reaction of (triisopropylsilyl)acetylene with Morita-Baylis-Hillman (MBH) alcohols in 
the presence of Pd(PPh3)4, N,P-ligand L1, and Ti(OiPr)4 (Scheme 1.18a). For the reaction 
between cinnamyl alcohol and arylacetylenes, catalytic amount of diisopropylethylamine 
(DIPEA) was employed to activate the alkynyl C-H bond (Scheme 1.18b). The authors 
proposed a plausible mechanism for this reaction as shown in Scheme 1.19. The initial 
activation of allylic alcohol by Ti(OiPr)4 generates allylic titanate 67, which reacts with 
Pd(0)/L1 species to give π-allylpalladium intermediate 68. The subsequent deprotonation 
of terminal alkyne by assistant of L1 and base forms an intermediate 69 and water. The 
reductive elimination of 69 furnishes the 1,4-enyne product and regenerates the palladium 
catalyst for the next catalytic cycle. 
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Scheme 1.18 Pd-catalyzed dehydrative coupling of allyl alcohols with alkynes 
 
Scheme 1.19 Proposed mechanism for the dehydrative coupling of terminal alkynes with 
allylic alcohols 
Reek and co-workers reported palladium catalyzed dehydrative cross-coupling 
reaction between allylic alcohols and styrenes without using any stoichiometric additives.39 
The cationic palladium(II) complex 70 was identified as an effective catalyst to form π-
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allyl palladium species (Figure 1.3), while other neutral palladium(II) or palladium(0) 
complexes failed to show any activities. The treatment of cinnamyl alcohol with styrene 
derivatives in the presence of 3 mol % Pd complex 70 in dioxane at 120 °C formed the 
corresponding linear 1,4-diene products (Scheme 1.20a). In case of the coupling reaction 
between methyl substituted aliphatic allyl alcohols and styrene derivatives, two 
regioisomers were formed depending on the allyl alcohol substrates (Scheme 1.20b). The 
authors explained that these two products were generated by the isomerization of π-allyl 
palladium intermediate involving β-hydride elimination. 
 
Figure 1.3 Cationic palladium(II) complex 70 
 
Scheme 1.20 Pd-catalyzed dehydrative coupling of allyl alcohols with styrenes 
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Although the Pd-catalyzed C-O activation of allyl alcohol via formation of π-
allylpalladium species has been shown to be an efficient method, the catalytic cross-
dehydrative C-H allylation reactions can also be achieved by different transition metals 
such as cobalt and ruthenium. In these cases, the C-O activation occurs through β-hydroxy 
elimination rather than the formation of π-allylmetal species. 
 
Scheme 1.21 Co-cataylzed dehydrative C-H ortho-allylation of arenes 
Very recently, Yoshino and Matsunaga reported cobalt catalyzed C-H allylation of 
6-arylpurins and aryl amides with allyl alcohols.40 The reaction of purinyl arenes or 
benzamides with allyl alcohols catalyzed by Cp*Co(CO)I2, silver salt and base afforded 
ortho-allylated arenes in good yields at a moderate temperature (Scheme 1.21). During the 
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solvent screening, the authors found that fluorinated alcohols, 2,2,2-trifluoroethanol (TFE) 
and 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), are the most effective solvents for this 
catalytic system. A broad range of benzamides and N9-substituted purinyl derivatives 
(including fully acetylated 6-phenylpurine riboside) afforded the allylation product for this 
method.  
 
Scheme 1.22 Proposed mechanism for the dehydrative C-H allylation of 6-arylpurines 
A plausible mechanism for the allylation of 6-arylpurine 71 is shown in Scheme 
1.22. The active cationic cobalt species would be generated from Cp*Co(CO)I2, AgOTf, 
and AgOAc. Coodination of 71 followed by acetate-assisted sp2-C-H activation gives 5-
membered metallacycle complex 73. Subsequent alkene insertion of allyl alcohol forms 7-
membered metallacycle intermediate 74. At this stage, β-hydroxy elimination is favored 
over the competing β-hydride elimination to release the desired allylation product 72 with 
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cationic cobalt hydroxo complex. The authors also observed a trace amount of aldehyde 
byproduct 75, which was resulted from β-hydride elimination process. 
Kapur and co-workers reported ruthenium catalyzed dehydrative C-H allylation of 
indoles with allyl alcohols.41 Coupling reaction of N-pyridinyl indoles with allyl alcohols 
in the presence of [RuCl2(p-cymene)]2, Cu(OAc)2, and AgSbF6 afforded C2-arylated 
indoles. In this protocol, pyridine served as a directing group for the regioselective C-H 
activation of indoles. The authors also demonstrated the removal of the pyridinyl directing 
group of the coupling products by simple reaction with MeOTf followed by base solution 
treatment. The proposed mechanism similarly follows Yoshino and Matsunaga’s cobalt 
catalyzed allylation process.40 Pyridine directed C-H activation of indole generates C2-
metallated indole intermediate. Alkene insertion of allyl alcohol followed by β-hydroxy 
elimination gives the product. 
 
Scheme 1.23 Ru-catalyzed dehydrative C-H allylation of indoles 
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1.2.2 Catalytic Dehydrative Coupling Reaction of Aliphatic Alcohols 
Catalytic dehydrative C-C coupling reactions involving C-O bond cleavage of 
unactivated aliphatic alcohols are very difficult to achieve because it is thermodynamically 
less favorable than alkoxylation or dehydrogenation of alcohols (C-O bond dissociation 
energy = 85 to 91 kcal∙mol-1).42 Recently, a number of ruthenium complexes have been 
successfully employed for the selective activation of challenging sp3 C-O bond activation 
of alcohols. 
In 2011, our group reported ruthenium catalyzed dehydrative C-H alkylation of 
alkenes with alcohols.43 The coupling reaction employed 0.5 mol % cationic Ru-H complex 
[(C6H6)(PCy3)(CO)RuH]
+BF4
- (26) at 75-110 °C without using any additives. The catalytic 
method tolerated a broad range of alcohol and alkene (including cycloalkenes, indene, N-
methylindole, 2,3-dihydrobenzofuran, and styrene derivatives) substrates with high 
product yields. The catalytic method was successfully applied to several biologically active 
alkenes to demonstrate high regioselectivity and functional group tolerance. 
 
Scheme 1.24 Ru-catalyzed dehydratve alkylation of alkenes with alcohols 
The preliminary mechanistic studies were inconsistent with the Friedel-Crafts-type 
electrophilic substitution reactions. For example, an opposite trend in reactivity of alcohols 
(1° > 2° > 3°) was observed from the initial rate comparison study of the alkylation reaction 
of primary, secondary, and tertiary alcohols. A plausible mechanism is proposed in Scheme 
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1.25. A cationic Ru-alkenyl species 76 is generated by the initial alkene insertion, vinylic 
C-H activation, and alkane elimination sequence. Coordination of an alcohol to the 
ruthenium center followed by oxidative addition of the C-O bond would give cationic 
Ru(IV)-alkenyl-alkyl species, which liberates the alkene alkylation product to form the 
coupling product and forms Ru-hydroxo intermediate 77 by reductive elimination. Another 
vinylic C-H activation and subsequent water elimination regenerates the Ru-alkenyl 
species 76. 
 
Scheme 1.25 A plausible mechanism for the dehydrative C-H alkylation of alkenes 
The well-defined cationic ruthenium hydride complex 
[(C6H6)(PCy3)(CO)RuH]
+BF4
- complex (26) has been found to exhibit exceptional 
catalytic activity for C-O bond activation of alcohols. Our group also developed the 
ruthenium catalyzed dehydrative C-H alkylation and alkenylation of phenols with alcohols 
without using any expensive or toxic metal oxides.44 The initial reaction of 3-
methoxyphenol with cyclohexanol in the presence of 1 mol % 26 and a catalytic amount 
(10 mol %) of cyclopentene in toluene at 100 °C resulted in the formation of highly 
regioselective ortho-cyclohexylphenol product along with a trace mount of ortho-
cyclohexenylphenol product. Notably, synthetically more useful ortho-alkenylated phenols 
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can also be obtained as the major product in this catalytic protocol by simply adding excess 
(3.0 equivalents) amount of cyclopentene. A series of benzofuran derivatives was formed 
when 1,2-diol was used as the coupling partner (Scheme 1.26b). The catalytic method was 
successfully extended to bioactive phenol and alcohol substrates such as cholesterol, 
estrone, coumarine derivatives to produce the corresponding ortho-alkylated phenol or 
benzofuran compounds in good to excellent yields (67-91 %). 
 
Scheme 1.26 Ru-catalyzed dehydrative synthesis of ortho-alkylated phenols and 
benzofurans 
The possible mechanistic pathway of the dehydrative ortho-alkylation of phenols 
involves the initial formation of cationic ortho-ruthenated phenol species by ortho-C-H 
activation of phenol. Subsequent C-O bond oxidative addition of alcohol followed by 
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reductive elimination of product to form the Ru-hydroxo species, which then reacts another 
phenol and releases water. The deuterium labeling experiment, Hammett plot, and kinetic 
isotope effect studies were conducted, and these results supported the proposed mechanism. 
1.2.3 Dehydrative Arene C-H Coupling Reactions 
 
Scheme 1.27 Ru/L2-catalyzed dehydrative biarylation of arenes with phenols 
In 2008, Ackermann and co-workers have developed the ruthenium catalyzed 
cross-dehydrative biarylation reactions by using inexpensive phenols as the starting 
materials.45 As shown in Scheme 1.27, chelate-assisted C-H arylation of ortho-oxazolyl 
and pyrazolyl arenes with a variety of substituted phenols was achieved in the presence of 
[RuCl2(p-cymene)]2, ligand L2, K2CO3, and 4-toluenesulfonyl chloride (p-TsCl). In this 
study, the air-stable ligand precursor, heteroatom-substituted secondary phosphine oxide 
(HASPO, L2), was shown to be more efficient than simple tertiary phosphine ligands. To 
explain high catalytic efficacy of HASPO, the authors proposed base-assisted 
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cyclometalation-deprotonation model in the C-H bond activation transition state (scheme 
1.28a).5(f) The catalytic system was successful with a wide range of phenol substrates 
bearing ether, ester, alkyl, and fluorides.  
 
Scheme 1.28 Proposed transition states for the ortho-arene arylations 
 
Scheme 1.29 Ru-catalyzed dehydrative biarylation of arenes with phenols 
Ackermann’s group later modified this dehydrative ortho-arene arylation by 
employing the well-defined Ru(O2CMes)2(p-cymene) catalyst without using any external 
ligands (Scheme 1.29).46 They have found that ruthenium(II) carboxylates are powerful 
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catalysts for the direct C-H arylation reaction,5(f),47 which could successfully replace the in 
situ generated ruthenium complexes derived from HASPO ligand (Scheme 1.28b). Notably, 
this catalytic system could also be performed in water at a lower reaction temperature.  
 In conclusion, transition metal-catalyzed dehydrogenative and dehydrative 
coupling reactions have received considerable interest in recent years. A number of 
catalytic methods have greatly advanced synthetic strategies for the economically and 
environmentally sustainable formation of the C-C coupling products. Although the direct 
activation of C-H and C-O bond allows a broad range of available substrates without 
preforming reactive functional groups, these methods often require relatively harsh 
conditions and a stoichiometric amount of additives. Thus, the development of efficient 
catalytic methods with high regioselectivity remains a long term challenge to subjugate. In 
this context, our research group have developed a number of dehydrogenative and 
dehydrative C-H coupling reaction by using well-defined cationic ruthenium-hydride 
catalyst 26. The recent synthetic and mechanistic studies of dehydrogenative and 
dehydrative coupling reactions will be presented in the following chapters. 
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CHAPTER 2 
Ruthenium Catalyzed Dehydrogenative ortho-Acylation of Phenols with Aldehydes 
via C-H Activation 
2.1 Backgrounds 
2.1.1 Traditional Acylation Methods 
 
Aryl ketones are common structural motifs present in biologically active 
compounds and pharmaceutical agents. Traditionally, Friedel-Crafts acylation method has 
been commonly used for installing acyl groups to aromatic rings by using strong Lewis 
acid catalysts (AlCl3, FeCl3).
48 The general reaction conditions of the Friedel-Crafts 
acylation facilitates the coupling of arene with acyl chloride in the presence of Lewis acid 
to give an acylated arene product along with a hydrochloric acid byproduct (eq 2.1). The 
reaction mechanism involves the initial formation of the acyl cation by the Lewis acid-
mediated halide dissociation. The acyl cation can be stabilized by its acylium ion resonance 
structure, thus other acylium sources such as acid anhydrides can also be used for this 
reaction. The nucleophilic attack of π-electrons on the benzene to the electrophilic acyl 
cation forms the cyclohexadienyl cation intermediate by breaking aromaticity. The 
subsequent dehydrogenation by tetrachloroaluminate provides acylated product and HCl. 
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Scheme 2.1 Reaction mechanism of the Friedel-Crafts acylation 
Hoesch and Houben have reported the formation of 2-acylphenols from the reaction 
of phenols with nitriles by using ZnCl2 catalyst and HCl (Scheme 2.2).
49 This is similar to 
Friedel-Crafts acylation reaction, and the ketimine can be isolated as an intermediate 
product via nucleophilic attack on the nitrile electrophile by π-electrons of phenols. The 
ketimine is subsequently hydrolyzed by aqueous workup to afford 2-acylphenols.  
 
Scheme 2.2 The reaction pathway of the Houben-Hoesch reaction 
 Despite of its convenient process to produce acylated arenes, these Friedel-Crafts 
type of coupling methods possess a number of drawbacks and limitations. The reaction is 
problematic in controlling product regioselectivity and often results in multiple addition of 
electrophiles. Also, the reaction works only with benzene or activated arenes for the 
formation of dearomatized intermediate. Furthermore, employing toxic acyl halide or 
nitrile starting materials yields the corresponding wasteful byproducts.  
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2.1.2 Transition Metal-Catalyzed Acylation Methods  
Much research has been devoted to the development of transition metal catalyzed 
carbonyl functionalization of arenes via C-H bond activation. In particular, Pd-catalyzed 
arene carbonylation methods have greatly advanced synthetic potency for forming acyl-
substituted arene compounds.50 Recently, Newman and Houk reported Suzuki-Miyaura 
coupling of aryl esters with arylboronic acids (eq 2.2).51 The NHC-based Pd catalyst 
enabled the formation of acylated products via C(aryl)-O activation. However, these 
catalytic methods typically require prefunctionalized starting materials, which lead to the 
formation of wasteful byproducts.  
 
From the viewpoint of step efficient and environmentally compatible synthesis, 
catalytic C-H oxidative coupling reaction of unactivated arenes with aldehydes is a 
promising method for the synthesis of aryl ketones. Li and co-workers reported Cu-
catalyzed intramolecular arene-to-aldehyde coupling reaction to from indoline-2,3-
diones.33 Cheng31 and Yu32 reported intermolecular C-H oxidative arene-aldehyde 
coupling reactions. These coupling methods are facilitated by directing groups for the 
regioselective C-H activation of arenes. In 2012, Wang and co-workers reported Cu-
catalyzed ortho-acylation of a simple directing group phenol with aldehydes,52 but the 
scope of aldehyde substrates is limited to aromatic aldehydes.  
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2.2 Results and Discussion 
Recently, our research group developed the synthesis of a well-defined cationic 
ruthenium-hydride complex [(ɳ6-C6H6)(PCy3)(CO)RuH]+BF4- (26). The complex 26 was 
found to be a highly effective catalyst precursor for a number of dehydrogenative and 
dehydrative C-C bond formation reactions. The cationic ruthenium-hydride complex was 
synthesized in three steps from ruthenium-hydride complex (PCy3)2(CO)RuHCl (23) as 
described in Scheme 2.3.15,53 Treatment of 23 with KOH in 2-propanol at 90 ºC formed the 
dinuclear Ru complex 78, which was isolated in 85% yield after recrystallization in hexane. 
The tetranuclear Ru complex {[(PCy3)(CO)RuH]4(μ-O)(μ-OH)2} (79) was obtained in 
80% yield as brown-red solid from the reaction of 78 with wet acetone at 100 ºC. 
Subsequent treatment of 79 with one equivalent of HBF4·OEt2 in benzene at room 
temperature cleanly afforded the cationic ruthenium-hydride complex 26, which was 
isolated as an ivory solid in 90% yield. 
The molecular structure of the cationic ruthenium-hydride complex was elucidated 
by NMR spectroscopy and X-ray crystallography (Figure 2.1). In 1H NMR, the metal-
hydride signal was observed at δ -10.39 (d, JPH = 25.9 Hz) in CD2Cl2, and a single 
phosphine signal was detected by 31P NMR at δ 72.9 ppm. The X-ray crystallography 
showed a three legged piano-stool geometry, which is capped by a ɳ6-benzene moiety. 
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Scheme 2.3 Synthesis of cationic ruthenium-hydride complex 26 
 
Figure 2.1 Molecular geometry of cationic ruthenium-hydride complex 26 
We found that the cationic ruthenium-hydride complex 26 is a highly effective 
catalyst for a number of dehydrogenative and dehydrative coupling reactions involving C-
H and C-O bond activation. By using the cationic ruthenium-hydride complex 26, we 
achieved the chelate-assisted oxidative coupling reaction of arylamides and with 
unactivated alkenes,15 the coupling reaction of α,β-unsaturated carbonyl compounds with 
alkenes,54 the coupling reaction of aryl ketones with cyclic alkenes,53 selective catalytic 
alkylation of alkenes with alcohols,43 and the C-H alkylation and alkenylation of phenols 
with alcohols44 (Scheme 2.4). 
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Scheme 2.4 Dehydrogenative and dehydrative coupling reactions mediated by Ru catalyst 
We next explored its catalytic activity for the dehydrogenative coupling reaction of 
phenols and aldehydes. Initially, we found that [(ɳ6-C6H6)(PCy3)(CO)RuH]+BF4- (26) 
catalyzes the reaction of 3-methoxyphenol with benzaldehyde in the presence of catalytic 
amount (10 mol %) of cyclopentene in chlorobenzene at 120 ºC to form a 1:1 mixture of 
2-benzyl-3-methoxyphenol (80a) and 2-hydroxy-4-methoxybenzophenone (81a), but with 
only ca. 20 % of the combined yield (eq 2.3).  
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 The ortho-alkylated phenol 80a was formed apparently from the elimination of an 
equivalent of water molecule. Two catalytic ortho-phenol C-H activation pathways can be 
proposed to explain the formation of the alkylated product 80a. Our group has 
demonstrated a broad scope of the dehydrative alkylation of phenols with alcohols as 
indicated above (Scheme 2.4).44 One possible path involves the reduction of benzaldehyde 
to benzyl alcohol, followed by the dehydrative benzylation of phenol with newly generated 
alcohol. Second, we recently observed the hydrogenolysis of ketones or aldehydes by using 
cationic ruthenium-hydride complex 26 and phenol ligands with H2.
55 The reaction is more 
environmentally friendly than the conventional Clemmensen reduction or Wolff-Kishner 
reduction methods. For this deoxygenation method, a catalytic amount of phenol was found 
to be an effective additive to promote the reaction. Similarly, the hydrogenolysis of ketone 
to alkane pathway might be feasible for the acylated product 81a in the catalytic system. 
However, the hydrogen source was unclear in this case because both pathways require the 
same equivalent of H2 to lose a water molecule. We performed the following experiments 
in order to discern the formation of 80a (eq 2.4 and 2.5).  
 
 The treatment of benzaldehyde (0.5 mmol) with an excess amount of cyclopentene 
(5 equiv) in the presence of cationic ruthenium-hydride complex 26 (5 mol%) did not form 
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benzyl alcohol (eq 2.4). Also, the treatment of the acylated product 81a (0.5 mmol) did not 
produce its deoxygenated product 80a under the same reaction condition (eq 2.5). These 
results indicate that cyclopentene is not the hydrogen source. We believe that two products 
80a and 81a were formed simultaneously in this case because a 1:1 ratio between two 
products was observed, and that the alkylation product 80a was resulted from the coupling 
with the alcohol formed from the hydrogenation of aldehyde. 
The ortho-acylated phenol product 81a was obtained (11 % GC-MS yield) (eq. 2.3) 
from the dehydrogenative direct C-H acylation of aldehydes. Rather than consuming acyl 
halide and generating a stoichiometric amount of wastes, this catalytic method directly 
combines simple phenols and aldehydes to form the acylated product. Due to its synthetic 
importance for the oxidative C-C formation reactions via double C-H activation of two 
starting materials, we devoted much efforts to optimize the reactivity and selectivity pattern 
of acylated phenol product 81a. First, the amount of cyclopentene was increased up to 10 
equivalents from 3 equivalents, but there was no significant improvement on either 
reactivity or selectivity. Also, other alkenes such as cyclohexene, 1,4-cyclohexadiene, and 
3,3-methyl-1-butene were found to be ineffective.  
 
Instead, high selectivity for the ortho-acylation product was observed from the 
addition of an inorganic base K2CO3 (eq 2.6). With the addition of catalytic amount of 
K2CO3 (30 mol%), only the acylated product 81a was obtained in a moderate yield (39 % 
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GC-MS yield). Although K2CO3 has a poor solubility in chlorobenzene, the addition of 
water did not improve the efficiency of the reaction. Since the catalytic dehydrogenative 
C-H acylation reaction of phenols with aliphatic aldehydes has not been reported, we 
further investigated the reaction scope of phenols with aliphatic aldehydes. 
2.3 Optimization Studies 
2.3.1 Additive Effect 
The additive effect was found to be critical for increasing the reactivity and 
selectivity of the catalytic C-H acylation reaction. A variety of inorganic bases was 
screened for the reaction of 3-methoxyphenol (0.5 mmol) and benzaldehyde (1.0 mmol) in 
the presence of the cationic ruthenium-hydride complex 26 in chlorobenzene at 110 ºC for 
12 h (Table 2.1). The product yield was determined by GC-MS. 
We found that inorganic bases K2CO3, Cs2CO3, and KOH exhibit similar effect in 
promoting the selective formation of ortho-acylated phenol product 81a, whereas other 
inorganic bases and triethylamine were ineffective. We have chosen K2CO3 as an 
appropriate additive over KOH due to a slightly increased yield. Also, K2CO3 was chosen 
rather than Cs2CO3 for this catalytic reaction due to its cost. The relative additive 
concentration effect was surveyed by changing the amount of base in the reaction mixture 
(entries 1, 10-12). About 30 mol % of K2CO3 was found to be optimal, as no significant 
increase in yield was observed when the additive loading was increased above 30 mol % 
(entry 12). Significantly less than a stochiomeric amount of base needed for the reaction 
suggests that the base takes role of activating the ruthenium catalyst. 
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Table 2.1 Additive effect on the reaction of 3-methoxyphenol and benzaldehydea 
 
entry additive loading (mol%) 81ab (%) 
1 K2CO3 30 39 
2 Cs2CO3 30 38 
3 Na2CO3 30 < 3 
4 KHCO3 30 0 
5 NaHCO3 30 0 
6 NaOMe 30 0 
7 NaOAc 30 0 
8 KOH 30 33 
9 NEt3 30 0 
10 K2CO3 10 16 
11 K2CO3 20 31 
12 K2CO3 50 38 
a Reaction conditions: 3-methoxyphenol (0.5 mmol), benzaldehyde (1.0 mmol), 
26 (5 mol %), additive (10-50 mol %), chlorobenzene (2 mL), 110 °C, 12 h. b The 
product yield of 81a was determined by GC-MS using hexamethylbenzene as an 
internal standard. 
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2.3.2 Solvent and Temperature Effects 
Table 2.2 Solvent and temperature effects for the reaction of 3-methoxyphenol and 
benzaldehydea 
 
entry solvent temperature (⁰C) 81ab (%) 
1 toluene 110 29 
2 chlorobenzene 110 39 
3 1,4-dioxane 110 0 
4 water 110 0 
5 chlorobenzene 90 12 
6 chlorobenzene 100 28 
7 chlorobenzene 125 43 
a Reaction conditions: 3-methoxyphenol (0.5 mmol), benzaldehyde (1.0 mmol), 26 
(5 mol %), K2CO3 (30 mol %), solvent (2 mL), 90-125 °C, 12 h. 
b The product yield 
of 81a was determined by GC-MS using hexamethylbenzene as an internal standard. 
 
The choice of solvent was surveyed as shown in Table 2.2. The use of 
chlorobenzene gave the best yield among the screened solvents (entries 1-4). Dioxane and 
water did not form any products, presumably because oxygen-containing solvent could 
coordinate to the Ru center to inhibit the coordination of benzaldehyde. The effect of 
temperature was investigated by running reactions at different temperatures using 
chlorobenzene as the solvent (entries 2, 5-7). The reaction of 3-methoxyphenol with 
benzaldehyde effectively occurred at above 100 ⁰C, and 110 ⁰C was found to be the most 
optimal temperature for the coupling reaction. 
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2.3.3 Catalyst Survey 
Table 2.3 Catalyst and additive survey for the reaction of 3-methoxyphenol and 
benzaldehydea 
 
entry 
catalyst 
additiveb yield 81a 
(%)c 
   1 26 --- trace 
   2 26 K2CO3 34 
   3  26 PPh3   0 
   4 26 K2CO3, PPh3 47 
   5 RuCl3·3H2O K2CO3   0 
   6 RuCl3·3H2O K2CO3, PPh3 21 
   7 [RuH(CO)(PCy3)]4(O)(OH)2 K2CO3, PPh3 40 
   8 RuCl2(PPh3)3 K2CO3 28 
   9 [(p-cymene)RuCl2]2 K2CO3   0 
  10 Ru3(CO)12 K2CO3   0 
  11 --- K2CO3   0 
  12 --- PPh3   0 
a Reaction conditions: 3-methoxyphenol (0.5 mmol), benzaldehyde (1.0 mmol), 
additive (20-30 mol %), chlorobenzene (2 mL), catalyst (5 mol % Ru), 110 °C, 12 h. b 
Amount of additives: PPh3 (20 mol %), K2CO3 (30 mol %). c The product yield of 81a 
was determined by 1H NMR using hexamethylbenzene as an internal standard. 
 
Initially, we used the reaction of 3-methoxyphenol (0.5 mmol) with benzaldehyde 
(1.0 mmol) to screen the activity of ruthenium catalysts (Table 2.3). The product yields 
were analyzed by GC-MS at 110 ºC after 12 h. The cationic ruthenium-hydride complex 
26 exhibits the best catalytic activity for the C-C coupling reaction with additives. In the 
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absence of any additives, the cationic Ru complex 26 gave only a trace amount of product 
(entry 1). The inorganic base K2CO3 was found to be critical for obtaining acylated phenol 
product 81a selectively. The data for the other ruthenium complexes without K2CO3 are 
not included in the table due to the absence of any catalytic activity for this transformation. 
Moreover, we subsequently observed that the addition of 20 mol % of PPh3 further 
promoted the reactivity of the catalytic system (entries 4, 6). No product was formed either 
K2CO3 or PPh3 were used in the absence of ruthenium complexes (entries 11, 12). On the 
basis of these screening of ruthenium catalysts and additives, the cationic ruthenium 
complex 26, K2CO3, and PPh3 were found to be the most effective catalytic system for the 
dehydrogenative acylation of phenols with aldehydes (entry 4). 
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2.4 Reaction Scope 
2.4.1 Dehydrogenative ortho-Acylation of Phenols with Aldehydes 
Table 2.4 Dehydrogenative acylation of phenols with aldehydesa 
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Table 2.4 Dehydrogenative acylation of phenols with aldehydesa (continued) 
 
a Reaction conditions: phenol (0.5 mmol), aldehyde (1.0 mmol), 26 (5 mol %), PPh3 (20 
mol %), K2CO3 (30 mol %), chlorobenzene (2 mL), 110 °C. b Isolated yields. 
We found that the cationic ruthenium-hydride complex 26 is a highly effective 
catalyst for the direct dehydrogenative coupling of phenols and aldehydes to afford ortho-
acylated phenol products. As mentioned in the previous section, the addition of catalytic 
amount of K2CO3 (30 mol %) and PPh3 (20 mol %) was found to be critical for the selective 
formation of ortho-acylated phenols over the ortho-alkylated phenol products. We 
explored the reaction scope with various phenols and aldehydes by using the optimized 
conditions (Table 2.4). The electron-rich 3-methoxyphenol, 3,5-dimethoxyphenol, and 1- 
and 2-naphthol were found to be suitable substrates for the ortho-acylation reactions. 
However, relatively electron-deficient phenols such as a phenol or 3-chlorophenol gave 
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undesired benzyl benzoates as the major product resulted from Tishchenko-type reaction 
of benzaldehydes (eq 2.7).56 
 
 We first examined the substituent effect of aromatic aldehydes such as ortho- and 
para-substituted benzaldehydes. These benzaldehydes readily reacted with 3-
methoxyphenol to produce 2-hydroxy-4-methoxybenzophenone products 81a-81d. 
Among para-substituted benzaldehydes, 4-fluorobenzaldehyde showed higher product 
yield than simple benzaldehyde and 4-methylbenzaldehyde (entries 1-3). The results 
indicate that the benzaldehydes with electron-withdrawing group promote the coupling 
reaction. We observed that the reaction of 3-methoxyphenol and electron-rich 4-
methoxybenzaldehyde gave less than 10% yield as analyzed by GC-MS. Notably, sterically 
hindered 3,5-dimethoxyphenol was found to be a better substrate than 3-methoxyphenol in 
forming the ortho-acylphenol products. A similar substituent dependence trend was also 
observed from the reactions of 3,5-dimethoxyphenol with para-substituted benzaldehydes 
(entries 10-14). The coupling of phenols with linear or branched aliphatic aldehydes also 
gave the corresponding ortho-acylphenol products (entries 5-9, 15-18). 
 Aliphatic aldehydes are generally not suitable for the catalytic C-C coupling 
reactions because they can be easily converted to homo-aldol products. We have not found 
any reports on the catalytic dehydrogenative ortho-acylation of phenols with aliphatic 
aldehydes. We successfully demonstrated that the reaction of phenols with aliphatic 
aldehydes proceeds to form ortho-acylated phenols without forming aldol byproducts. 
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Among the screened aliphatic aldehydes, 2-phenylpropionaldehyde as a coupling partner 
showed the highest product yields. Steric environment on the α-carbon adjacent to 
aldehyde group was found to be less important because no significant difference in 
reactivity was observed between linear and branched aldehydes by comparing the product 
yields. Both 1-naphthol and 2-naphthol also readily reacted with aliphatic and aryl-
substituted aldehydes to give 2-acylated (81s-81x) and 1-acylated (81y-81z) products 
respectively (entries 19-26). Although the crude mixture typically contained a negligible 
amount of alkylation product along with unidentified oligomeric side products (5-10 % 
combined), analytically pure ortho-acylphenol products were isolated by silica gel column 
chromatography.  
2.4.2 Formation of Flavene Derivatives for the Dehydrative Coupling of Phenols 
with α,β-Unsaturated Aldehydes 
Flavonoids are a large family of polyphenolic compounds with a wide range of its 
biological activities such as antioxidant, cancer prevention, and antibacterial agents.57 
Flavonoids can be classified as flavanones, flavenes, flavones, and anthocyanidins 
according to their chemical structures (Figure 2.2). 
 
Figure 2.2 Common structures of flavonoids 
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Table 2.5 Formation of flavene derivatives from the dehydrative coupling reaction of 
phenols with α,β-unsaturated aldehydesa 
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Table 2.5 Formation of flavene derivatives from the dehydrative coupling reaction of 
phenols with α,β-unsaturated aldehydesa (continued) 
 
a Reaction conditions: phenol (0.5 mmol), aldehyde (1.0 mmol), 26 (5 mol %), PPh3 (20 
mol %), chlorobenzene (2 mL), 110 °C. b Isolated yields. 
 To extend the synthetic utility of the catalytic method, we explored the coupling 
reaction of phenol substrates with α,β-unsaturated aldehydes (Table 2.5). We initially 
investigated the cationic ruthenium-hydride complex 26 catalyzed coupling reaction of 3-
methoxyphenol with trans-2-hexenal, which gave a mixture of heterocyclic annulated 
compounds 2,3-dihydrochromone 82a and 2H-chromene 83a (eq 2.8). In the course of 
additive screening, we have found that the same reaction in the presence of 20 mol % of 
PPh3 formed only the 2H-chromene-type product 83a selectively (entry 1). Since 2H-
Chromene is known to be a core structure of naturally occurring flavene compounds, we 
next aimed to expand the substrate scope of the formation of flavene derivatives. The 
reaction was carried out with 0.5 mmol of phenols, 1.0 mmol of α,β-unsaturated aldehydes, 
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5 mol% of cationic ruthenium-hydride complex 26, and 20 mol % of PPh3 in the absence 
of base additive. The addition of K2CO3 reliably produced the acylated phenols. For 
example, the coupling reaction of 3,5-dimethoxyphenol with α-methylcinnamaldehyde in 
the presence of 26, PPh3, and K2CO3 gave the ortho-acylphenol product 81aa in 82 % yield 
without forming any byproduct (eq 2.9). 
 
 
 The coupling reaction of 3-methoxyphenol with α-substituted cinnamaldehydes 
smoothly occurred to give the 3-substituted flavene derivatives (entries 2-4).  The reaction 
of 3-methoxyphenol with β-phenylcinnamaldehyde resulted in selective formation 2,2-
diphenyl-2H-chromene compound 83e, which indicates that the intramolecular 
heterocyclization of phenol and alkene was not inhibited by sterically demanding phenyl 
groups (entry 5). The coupling with 1-cyclohexene-1-carboaldehyde also gave polycyclic 
2H-chromene product 83f (entry 6). Higher product yields were obtained from the reaction 
of 3,5-dimethoxyphenol substrate with disubstituted enals (entries 7-13). Other electron-
rich phenol derivatives, including 1-naphthol and 9-phenanthrol, afforded the 
corresponding polycyclic enol ether products 83n-83t (entries 14-20). The formation of 
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flavene derivatives 83 can be rationalized by ortho-C-H acylation followed by conjugate 
addition and dehydrative annulation, and water is the only byproduct in this reaction. 
 The structure of 2-acylphenols 81 and 2H-chromenes 83 was completely 
established by NMR analysis. In the acylated phenol products, characteristic phenolic OH 
signal was shown at δ 12-14 ppm in 1H NMR, due to the hydrogen bond with adjacent 
carbonyl group. We also confirmed the molecular structure of the products 81v and 83t by 
X-ray crystallography (Figure 2.3 and 2.4). 
 
Figure 2.3 Molecular structure of 81v 
 
Figure 2.4 Molecular structure of 83t 
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2.4.3 Dehydrogenative ortho-Acylation of Estrone with Aldehydes 
 We further demonstrated the synthetic utility of ortho-acylation by using bioactive 
phenol substrates with aliphatic- and aryl-substituted aldehydes (Scheme 2.5). The 
treatment of estrone with 4-chlorobenzaldehyde and cyclohexanecarboxaldehyde in the 
presence of 26, PPh3, and K2CO3 at 150 °C gave 1:2 coupling products 84a and 84b, 
respectively. In this case, both arene C-H acylation and aldol condensation-type couplings 
occurred on the estrone substrate. Our efforts on the formation of C-H acylated 1:1 
coupling product was unsuccessful. Instead, a small amount of aldol condensation-type 
coupling product were detected as the byproduct, which indicates that the aldol formation 
is faster than the C-H acylation for these substrates. The molecular structure of 84a and 
84b were established by NMR spectroscopy, and (E)-enone configuration was confirmed 
by X-ray crystallography (84b) (Figure 2.5). 
 
Scheme 2.5 Oxidative C-H acylation and aldol condensation of estrone with aldehydes 
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Figure 2.5 Molecular structure of 84b 
2.5 Mechanistic Studies 
2.5.1 Deuterium Labeling Study 
 
We conducted the deuterium labeling experiment to obtain mechanistic insights on 
the acylation reaction. To probe the possible hydrogen-deuterium exchange pattern, we 
performed the reaction of 3,5-dimethoxyphenol (0.5 mmol) with PhCDO (> 95 % D, 1.0 
mmol) in the presence of 26 (5 mol %), PPh3 (20 mol %), and K2CO3 (30 mol %) in 
chlorobenzene (2 mL) at 110 °C for 12 h (eq 2.10). After the reaction (86 % conversion by 
GC-MS), analytically pure product 81j and unreacted phenol substrate were isolated by a 
simple column chromatography on silica gel. The deuterium content of these was 
determined by NMR and GC-MS spectroscopic methods. The 1H, and 2H NMR showed 
that 83% deuterium was incorporated to the α-CH2 of benzyl alcohol byproduct while no 
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H/D exchange was observed on the either recovered phenol or acylphenol product (Figure 
2.6). This result suggests that the aldehyde coupling partner also serves as an internal 
oxidant via hydrogenation to the corresponding alcohol. Thus, the oxidative C-H acylation 
reaction could be achieved in the absence of any external oxidants. 
 
 
Figure 2.6 1H and 2H NMR spectra of benzyl alcohol byproduct isolated from the reaction 
of 3,5-dimethoxyphenol with benzaldehyde--d1 
2.5.2 Deuterium Isotope Effect Study 
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To discern the rate-determining step of the catalytic reaction, we measured the 
deuterium isotope effect of aldehyde by comparing the initial reaction rate of 3,5-
dimethoxyphenol with PhCHO and PhCDO at 110 °C (eq 2.11). The kobs value of for each 
substrate was obtained as kobs = 1.80 × 10
-3 min-1 (PhCHO) and kobs = 5.43 × 10
-4 min-1 
(PhCDO) from the pseudo-first order plot of the formation of 81j, which led a normal 
deuterium isotope effect of kH/kD = 3.3 ± 0.3 (Figure 2.7). A relatively high kH/kD value 
indicates that the cleavage of aldehydic C-H bond is the rate-determining step of the 
coupling reaction. 
 
Figure 2.7 Deuterium isotope effect study for the reaction of 3,5-dimethoxyphenol with 
benzaldehyde and benzaldehyde-α-d1 
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2.5.3 Hammett Study 
 
 To probe the electronic influence on the aldehyde substrate, a Hammett plot is 
constructed from the reaction of 3,5-dimethoxyphenol with a series of para-substituted 
benzaldehydes p-X-C6H4CHO (X = Me, H, F, Cl, CF3) (eq 2.12). A positive ρ value of 
+0.69 ± 0.05 was obtained from a linear correlation of the relative rate vs. Hammett σp 
constant (Figure 2.8). This result indicates that the negative charge is built-up in the 
transition state, which is stabilized by electron-withdrawing inductive effect on the 
aldehyde. Thus, the aldehyde C-H activation can be promoted by electron withdrawing 
substituents in forming Ru-acyl species. Similar Hammett ρ values have been observed in 
the catalytic coupling reactions of benzaldehydes and related arenes.58  
 
Figure 2.8 Hammett plot from the reaction of 3,5-dimethoxyphenol with p-X-C6H4CHO 
(X = Me, H, F, Cl, CF3) 
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2.5.4 Proposed Mechanism 
Although detail of the reaction mechanism remains unclear at the present time, we 
present a mechanistic hypothesis for the formation of ortho-acylated phenols on the basis 
of mechanistic experimental results. A plausible mechanism is compiled as shown in 
Scheme 2.6. 
 
Scheme 2.6 Proposed mechanism for the dehydrogenative ortho-acylation of phenols with 
aldehydes 
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Initially, the cationic ruthenium hydride complex 26 would be transformed to an 
active neutral Ru-arene species 85 via a base-assisted deprotonation and the benzene ligand 
exchange with the phenol substrate. In support of this notion, we previously reported a 
facile arene exchange reaction of 26 at room temperature.15,55 The C-H activation of the 
first equivalent of aldehyde generates Ru-acyl intermediate 86. Both Hammett study and 
the normal kinetic isotope effect (kH/kD 3.3 ± 0.3) indicate that the aldehyde C-H activation 
is the rate-limiting step. The subsequent carbonyl insertion of the second aldehyde into Ru-
H bond forms alkoxy Ru-acyl species 87. The alkoxy-assisted ortho-C-H activation of 
phenol substrate and the liberation of benzyl alcohol would give the ortho-metallated 
phenol species 88, which is followed by reductive elimination of the coupling product 73 
and the regeneration of 85. The electron-rich phenols were found to be suitable for the 
ortho-C-H activation because we observed the formation of Tishchenko-type byproduct 
89 with relative electron-deficient phenol substrates. We rationalized the formation of 89 
from the reductive coupling of Ru-acyl with alkoxy via the intermediate 87. 
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2.6 Conclusions 
We have successfully developed an ortho-selective C-H acylation method for 
simple phenol substrates. The cationic Ru-H catalyst exhibits a uniquely high catalytic 
activity for the dehydrogenative coupling reaction of phenols with aldehydes without using 
any external oxidants. Deuterium labeling study showed that the aldehyde substrate served 
as both the coupling partner and hydrogen acceptor. The reaction tolerates electron 
withdrawing and donating group substituted aryl aldehydes as well as aliphatic aldehydes 
without forming aldol byproducts. The coupling method can be extended to the step-
efficient synthesis of bioactive flavene derivatives by using α,β-unsaturated aldehydes. A 
portion of this work was published in European Journal of Organic Chemistry 2015, 2015, 
1899-1904. DOI: 10.1002/ejoc.201403518 
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CHAPTER 3 
Synthesis of Alkenylated Phenols from Ruthenium-Catalyzed Dehydrative C-H 
Coupling of Phenols with Ketones 
3.1 Backgrounds 
3.1.1 Synthetic Application of 2-Vinylphenols 
2-Vinylphenol compounds comprise versatile synthetic intermediates in forming 
various pharmaceutically active compounds (Table 3.1).59-70 A number of catalytic 
reactions including asymmetric hydrogenation,59 dehydrogenative intramolecular 
cyclization,60 hydroalkoxylation,61 and hydroacylation62 have been explored for using 2-
vinylphenol as the starting material. Iwasawa reported Pd-catalyzed direct synthesis of 
coumarin derivatives under atmospheric pressure of CO2.
63 Recently, a number of coupling 
reactions have been shown to provide biologically active heterocycles through 
cycloaddition of alkynes with 2-vinylphenols.65-69 Yao reported Pd-catalyzed asymmetric 
cascade annulation between 2-alkynylbenzaldehydes and 2-vinylphenols, which led to the 
formation of naturally occurring tetrahydronaphthalene derivatives.65 Analogous alkyne 
coupling reactions have been successfully developed for the formation of structurally 
diverse oxygen-containing heterocycles, such as tetrahydrocyclobuta[b]benzofuran,66 
benzoxepin,67 spirocyclic enons,68 and 3,4-dihydro-2H-2,4-methanochromans.69 Besides, 
Cheng’s group reported Co-catalyzed synthesis of alkene-substituted 2H-chromenes from 
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2-vinylphenols with allenes.70 The authors proposed a reaction mechanism via a vinylic C-
H activation and [5+1] annulation with the allene acting as a one-carbon source. 
Table 3.1 Synthetic applications of 2-vinylphenols 
 
3.1.2 Traditional Carbonyl Olefination Methods 
Traditionally, 2-vinylphenol starting materials have been prepared by using 
carbonyl olefination methods from 2-acylphenols compounds.59-70 The Wittig reaction has 
been used as the standard tool for the synthesis of olefin natural products.71 The reaction 
of carbonyl compounds with a phosphonium ylide produced alkene products with 
concomitant formation of phosphine oxide byproduct. The reaction mechanism involves 
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the formation of oxaphosphetane intermediate 90 by nucleophilic addition of ylide to the 
carbonyl carbon (Scheme 3.1). The subsequent decomposition of the intermediate led to 
the formation of alkene and phosphine oxide by breaking C-P and C-O bonds. The 
stereoselectivity of the olefin products is influenced by many factors including the type of 
phosphorus and carbonyl starting materials, solvent, and reaction conditions. In general, 
(Z)-selectivity (typically ~9:1) can be expected when nonstabilized ylide reacts to 
aldehydes because TSZ is believed to be kinetically favored over TSE. Much effort has 
been devoted to controlling the stereoselectivity of alkene products.72  
 
 
Scheme 3.1 Mechanism for the Wittig olefination reaction 
The Peterson olefination has been found to be a highly effective method for the 
stereoselective formation of alkenes from the reaction of α-silylcarbanions with carbonyl 
compounds (Scheme 3.2).73 The nucleophilic addition of a silylcarbanion to a carbonyl 
substrate generates a set of diasteromers of β-hydroxysilane intermediate 91, where the 
diastereoselectivity can be modulated by the choice of starting materials and reaction 
conditions. The β-hydroxysilane intermediate can be isolated or can be prepared in 
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different pathways including reduction of α-silyl ketones and nucleophilic opening of silyl 
epoxides. Decomposition of β-hydroxysilane 91 leads to the olefin and silanol products 
under acidic or basic conditions. Notably, the acid and base treatments of β-hydroxysilane 
proceed different eliminations to give the opposite stereoselectivity for alkenes (Scheme 
3.2b). 
 
Scheme 3.2 The reaction pathways for the Peterson olefination 
 
Scheme 3.3 The olefnation of carbonyl compounds by using the Tebbe’s reagent 
The Tebbe’s reagent also allows efficient synthesis of olefins from various types of 
carbonyl compounds including aldehydes, ketones, esters, and amides (Scheme 3.3).74 The 
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treatment of the Tebbe’s reagent with a mild Lewis base generates the active titanium 
carbene 92 with Al2Cl2(CH3)4. The in situ formed titanium carbene 92 reacts with carbonyl 
compounds to yield the olefin product and Cp2TiO. Even though these methods have been 
widely used for the alkene synthesis, these methods commonly employ stoichiometric 
amount of reagents, thus the formation of copious amount of wasteful byproducts remains 
as an inherent drawback. 
3.2 Catalytic Reactions for the Formation of 2-Vinylphenols 
A number of catalytic methods have been developed for the formation of bioactive 
compounds using 2-vinylphenols as the starting material.59-70 However, in most cases, 2-
vinylphenols are still prepared from the traditional stoichiometric carbonyl olefination 
methods. To solve the problems associated with the wasteful byproducts, the development 
of environmentally sustainable green catalytic methods for the synthesis of 2-vinylphenols 
has attracted considerable attentions in synthetic and catalysis communities. 
 
Scheme 3.4 Rh-catalyzed coupling reaction of N-phenoxyacetamides with N-
tosylhydrazones 
In recent years, considerable efforts have been devoted to the development of new 
catalytic approaches involving arene-C-H activation for the formation of 2-vinylphenols. 
Wang and co-workers reported Rh-catalyzed C-H ortho-alkenylation of N-
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phenoxyacetamides with N-tosylhydrazones (Scheme 3.4).75 The coupling reaction of N-
phenoxyacetamides with N-tosylhydrazones in the presence of a rhodium catalyst, LiOtBu, 
and NaOAc afforded ortho-alkenylated phenol derivatives. In this protocol, the authors 
proposed that the ortho-alkenylated phenoxyacetamide intermediate would be transformed 
into ortho-alkenylated phenol product via a Rh-mediated N-O bond activation, and the 
subsequent protonation by acetic acid. The authored showed that the catalytic method could 
be extended for the coupling reaction of N-phenoxyacetamides with diazoesters. Similarly, 
Cheng and co-workers reported Rh-catalyzed 2-vinylphenol synthesis via Stille-type C-H 
vinylation of N-phenoxyacetamides with vinylstannanes.76 Despite the recent advances in 
forming 2-vinylphenols, these catalytic coupling methods still require a stoichiometric 
amount of base and prefunctionalized starting materials. Therefore, additional synthetic 
steps are needed for the preparation of active functional groups which would eventually be 
transformed into the corresponding wasteful byproducts. 
 
 
 Catalytic olefination of simple ketones has been rarely achieved in part due to their 
tendency for undergoing kinetically more favorable hydrogenation or aldol-type 
condensation reactions. Our research group previously discovered intermolecular 
dehydrative coupling reaction of arylketones with alkenes by using the ruthenium-hydride 
catalyst 26. The coupling reaction of acetophenone with 1-hexene in the presence of in situ 
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formed cationic ruthenium-hydride complex gave a 2:3 mixture of the indene derivative 93 
and the ortho-C-H insertion product 94 (eq 3.1).77 Similarly, the coupling reaction of 
acetophenone with cyclopentene in the presence of 5 mol % 26 and HBF4∙OEt2 produced 
nearly 1:1 ratio of double bond isomers of the olefination products 95 and 96 (eq 3.2).53 
The common features of these reactions are the carbonyl insertion after the requisite C-H 
activation, and subsequent dehydration of alkoxy-Ru species in forming the alkene 
products. 
 
 Our group also reported dehydrative C-H alkylation and alkenylation of phenols 
with alcohols (Scheme 1.26).44 The treatment of 3-methoxyphenol with cycloalkanol in the 
presence of 26 and excess cyclopentene (3 equiv) yielded ortho-cycloalkenylphenol 
products 97a-97c and water (eq 3.3). Inspired by these environmentally friendly 
dehydrative alkenylation methods, we explored the analogous coupling reaction of phenols 
with simple ketones. We initially discovered that the treatment of 3,5-dimethoxyphenol 
with cyclohexanone in the presence of cationic ruthenium-hydride complex 26 in 1,2-
dichloroethane led to the formation of ortho-alkenylated phenol product 98a (eq 3.4). 
 
The salient features of the catalytic method are that synthetically valuable 2-
vinylphenols are formed from readily available phenol and ketone substrates. In particular, 
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the reaction does not require any stoichiometric amount of additives or activating reagents, 
and water is the only byproduct. To the best of our knowledge, the catalytic synthesis of 2-
vinylphenols from the coupling reaction of phenols with ketones has not been achieved 
before. 
3.3 Optimization Studies 
3.3.1 Solvent Screening  
Table 3.2 Solvent screening for the coupling reaction of 3,5-dimethoxyphenol with 
cyclohexanonea 
 
entry solvent yieldb (%) 
1 1,2-dichloroethane 92 
2 chlorobenzene 72 
3 toluene 90 
4 benzene 87 
5 n-hexane 55 
6 1,4-dioxane 24 
7 tert-amyl alcohol < 3 
a Reaction conditions: 26 (3 mol %), phenol (0.5 mmol), cyclohexanone (1.5 mmol), 
solvent (2 mL), 125 °C, 16 h. b The product yield of 98a was determined by 1H NMR using 
methylsulfonylmethane as an internal standard. 
We first screened a number of different solvents to attain optimized reaction 
conditions for the coupling reaction of phenols with ketones (Table 3.2). The reaction 
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progress of 3,5-dimethoxyphenol (0.5 mmol) with cyclohexanone (1.5 mmol) in the 
presence of ruthenium-hydride catalyst 26 (3 mol %) in different solvents was analyzed by 
GC-MS and 1H NMR using methylsulfonylmethane as an internal standard. The use of 1,2-
dichloroethane showed the highest product yield (entry 1), while other non-polar aprotic 
solvents were found to be acceptable solvents for this coupling method (entries 1-5). A 
poor solubility of the catalyst and phenol substrate in n-hexane resulted a relatively low 
activity among the selected non-polar solvents (entry 5). 1,4-Dioxane was not a suitable 
solvent, which might inhibit the coordination of ketone to the ruthenium center (entry 6). 
The use of a polar protic solvent, tert-amyl alcohol yielded a trace amount of product (entry 
7). 
3.3.2 Catalyst Screening 
We next surveyed the activity of commonly available ruthenium catalysts for the 
reaction of 3,5-dimethoxyphenol with cyclohexanone in 1,2-dichloroethane (Table 3.3). 
Among the screened ruthenium catalysts, cationic ruthenium-hydride complex 26 
exhibited the highest activity in forming the coupling product 98a (entry 1). The 
tetranuclear ruthenium-hydride complex 79 also showed a moderate activity while other 
ruthenium complexes did not proceed the reaction efficiently. The in situ generated cationic 
ruthenium-hydride 26 from the treatment of 79 with HBF4∙OEt2 gave the undesired 2H-
chromene derivative 99 as the major product (entry 3) (eq 3.5), Wu and co-workers 
reported similar acid-catalyzed synthesis of chromenes from ketones and phenols.78 The 
acid-catalyzed 2H-chromene formation was also observed when only HBF4∙OEt2 was 
employed as the catalyst (entry 12). Additive effects of phosphine ligands (PPh3, PCy3) 
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and base (K2CO3) were also investigated, but none of the tested additives was found to be 
effective in improving the product yields. 
Table 3.3 Catalyst screening for the coupling reaction of 3,5-dimethoxyphenol with 
cyclohexanonea 
 
entry catalyst yieldb (%) 
1 [(C6H6)(PCy3)(CO)RuH]BF4 (26) 91 
2 [(PCy3)(CO)RuH]4(μ-O)(μ-OH)2 (79) 52 
3 79 / HBF4∙OEt2 < 3 
4 [RuCl2(p-cymene)]2 14 
5 [Ru(COD)Cl2]n < 3 
6 [(PCy3)(CH3CN)(CO)RuH]BF4 < 3 
7 RuCl2(PPh3)3 11 
8 RuHCl(CO)(PCy3)2 < 3 
9 RuH2(CO)(PPh3)3 18 
10 RuCl3∙3H2O 6 
11 Ru3(CO)12 15 
12 HBF4∙OEt2 < 3 
a Reaction conditions: catalyst (3 mol % Ru equivalents), phenol (0.5 mmol), 
cyclohexanone (1.5 mmol), 1,2-dichloroethane (2 mL), 125 °C, 16 h. b The product yield 
of 98a was determined by 1H NMR using methylsulfonylmethane as an internal standard. 
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3.4 Reaction Scope and Applications 
3.4.1 Scope of Dehydrative C-H Alkenylation of Phenols with Ketones 
The substrate scope of the phenol ortho-alkenylation reaction was explored by using the 
optimized conditions (Table 3.4). The electron-releasing group substituted phenols and 1-
naphthol were found to be suitable substrates for the coupling reaction. Phenols with 
electron-withdrawing group including simple phenol, 3-fluorophenol, 3-chlorophenol, and 
3-nitrophenol did not form the desired coupling product with ketones. The coupling 
reaction of catechol with phenols gave the undesired 1,3-benzodioxole derivatives in 
excellent yields (< 90 %) (eq 3.6), wherein several synthetic approaches have already been 
reported.79  
 
 The coupling reaction of 3,5-dimethoxyphenol with cycloalkanones cleanly formed 
cycloalkenylated phenol products 98a-98c (entries 1-3). The coupling reaction of 3,5-
dimethoxyphenol with 2-Indanone and 2-tetralone led to the formation of 
benzocycloalkenylated phenol products 98d and 98f, respectively (entries 4, 5). 3-
Methoxyphenol and 1-naphthol also reacted with cycloalkanones to form 2-vinylphenol 
products (entries 6-8). 
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Table 3.4 Dehydrative C-H alkenylation of phenols with ketonesa 
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Table 3.4 Dehydrative C-H alkenylation of phenols with ketonesa (continued) 
 
a Reaction conditions: phenol (0.5 mmol), ketone (1.0 mmol), 26 (3 mol %), 1,2-
dichloroethane (2 mL), 125 °C. b Isolated yields. c 1.5 mmol ketone substrate used. 
In a similar fashion, we next examined the substrate scope of linear ketones. 
Acetophenone and 4’-chloroacetophenone readily reacted with 3,5-dimethoxphenol to give 
2-vinylphenol products 98i and 98j, respectively (entries 9, 10). The coupling reaction of 
3,5-dimethoxyphenol with a series of 2-substituted acetophenones afforded trisubstituted 
alkene products 98k-98m (entries 11-13). To our surprise, the stereochemistry of the 
trisubstituted alkene products was determined to be (Z)-alkenes by nuclear Overhauser 
effect spectroscopy (NOESY) analysis. To support this, we were able to obtain the X-ray 
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crystal structure for 98k (Figure 3.1). The X-ray structure of 98k showed a (Z)-
configuration, where the phenolic group is rotated out of conjugation (dihedral angle 69.8º).  
 
Figure 3.1 Molecular structure of 98k 
Propiophenones with both electron-withdrawing and -donating group also afforded 
trisubstituted (Z)-alkenes exclusively from the coupling reaction with 3,5-
dimethoxyphenols (entries 14-17). For these benzoyl-type substrates, a highly (Z)-selective 
formation of ortho-alkenylated phenol products were observed. However, the 
stereoselectivity of the coupling products from alkyl substituted ketone substrates were 
found to depend on the substituents. The treatment of 3,5-dimethoxyphenol with 4-phenyl-
2-butanone gave a 4:1 mixture of Z/E-stereoisomers 98s, while the reaction with 2-
butanone gave less selective 1.4:1 mixture of 98u (entries 19 and 21). These results suggest 
that the stereoselectivity of the coupling product would be influenced by steric 
environments around the carbonyl group of the ketone substrate. 3,4,5-Trimethoxyphenol 
also reacted with propiophenone to form (Z)-alkenylphenol product 98v (entry 22). In case 
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of 3-methoxy-5-methylphenol, two regioisomers 98w and 98x were obtained from the 
reaction with propiophenone (entry 23). The analogous treatment of 1-naphthol with 
propiophenones led to the (Z)-selective formation of 2-alkenylated-1-naphthol products 
(entries 24, 25).  
3.4.2 Synthetic Applications for the Catalytic Method for the Coupling of Phenols 
with Ketones 
Table 3.5 Dehydrative coupling of 3,5-dimethoxyphenol with biologically active ketonesa 
 
a Reaction conditions: 3,5-dimethoxyphenol (0.5 mmol), ketone (1.0 mmol), 26 (3 mol %), 
1,2-dichloroethane (2 mL). Isolated yields in parenthesis. 
To further illustrate synthetic versatility of the catalytic coupling method, we next 
surveyed the coupling reaction of biologically active ketone substrates with 3,5-
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dimethoxyphenol (Table 3.5). The dehydrative coupling reaction of 3,5-dimethoxyphenol 
with 4-hydroxycoumarin yielded 4-arylated coumarin product 98aa. The reaction of 3,5-
dimethoxyphenol with (+)-nootkatone led to the alkenylated coupling product 98ab, and 
the structure of 98ab was completely established by two-dimensional NMR spectroscopy 
(HMQC and HMBC). An anti-inflammatory drug nabumetone also readily reacted with 
3,5-dimethoxyphenol to afford a 5:1 mixture of alkenylated phenol products 98ac. 
Analogous treatment of 3,5-dimethoxyphenol with (+)-4-cholesten-3-one and 
adrenosterone gave the corresponding coupling products 98ad and 98ae, respectively. 
In an effort to extend the substrate scope, we next explored the coupling reaction 
with α,β-unsaturated ketones. The treatment of 3,5-methoxyphenol with 4-phenyl-3-buten-
2-one led to the formation of 4H-chromene product 100, which is likely resulted from the 
Michael addition followed by dehydrative annulation.80 In case of 2-cyclohexenone as a 
coupling partner, a bicyclic hemiketal compound 101 was obtained, and the molecular 
structure of 101 was also confirmed by X-ray crystallography (Figure 3.2). Bicyclic ketone 
2-norbornanone also smoothly reacted with 3,5-dimethoxyphenol to give 
dihydrobenzofuran product 102. The coupling reaction of 3,5-dimethoxyphenol with 2,5-
hexanedione yielded bicyclic ketal compound 103 under the standard conditions. The 
analytically pure coupling products 98-103 were isolated by simple column 
chromatography, and their molecular structure was completely established by NMR 
spectroscopy. 
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Figure 3.2 Molecular structure of 101 
3.5 Mechanistic Studies 
3.5.1 Deuterium Labeling Study 
 
 We conducted the deuterium labeling experiment to probe the possible H/D 
exchange pattern on the coupling product. The treatment of 3,5-dimethoxyphenol (0.5 
mmol) with 2,2,6,6-deuterated cyclohexanone (93% D, 1.5 mmol) in the presence of 26 (3 
mol %) in 1,2-dichloroethane (2 mL) was heated at 125 °C for 16 h (eq 3.8). The 
analytically pure product 98a-d was isolated by silica gel column chromatography, and was 
analyzed by 1H and 2H NMR spectroscopic methods. The 1H and 2H NMR spectra of 
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isolated 2-cyclohexenylphenol showed a selective H/D exchange on ortho (44% D) and 
para (50% D) positions on phenol as well as C2 (72% D) and C6 (78% D) of cyclohexenyl 
group (Figure 3.3). The observed H/D exchange pattern suggests that both reversible C-H 
activation on phenol and tautomerization of ketone are mediated by the Ru catalyst during 
the course of the coupling product formation. 
 
Figure 3.3 1H and 2H NMR spectra of the product 98a-d isolated from the reaction of 3,5-
methoxyphenol with cyclohexanone-2,2,6,6-d4 
3.5.2 Deuterium Isotope Effect Study 
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To discern the rate-determining step of the catalytic reaction, we performed the 
deuterium isotope effect on the α-C-H bond of cyclohexanone by comparing the initial 
reaction rate of 3,5-dimethoxyphenol with cyclohexanone and 2,2,6,6-deuterated 
cyclohexanone (93% D) at 125 °C in separate reaction tubes (eq 3.8). The kobs value of for 
each substrate was obtained as kobs = 1.86 × 10
-3 min-1 (cyclohexanone) and kobs = 1.75 × 
10-3 min-1 (cyclohexanone-d4) from the pseudo-first order plot of the formation of 98a, 
which led a normal kinetic isotope effect of kH/kD = 1.07 ± 0.05 (Figure 3.4). The 
experimentally determined kinetic isotope effect value indicates that there is no significant 
initial reaction rate difference between two reactions in forming alkenylated product. 
These results indicate that the cleavage of α-C-H bond of ketone substrate is not likely the 
rate-determining step of the coupling reaction. 
 
Figure 3.4 The pseudo-first order plots for the reaction of 3,5-dimethoxyphenol with 
cyclohexanone and cyclohexanone-2,2,6,6-d4 
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3.5.3 Proposed mechanism 
 
Scheme 3.5 Mechanistic rationale for the C-H alkenylation of phenols 
Although details for the C-H alkenylation of phenols still remains unclear at this 
stage, a plausible reaction mechanism is compiled in Scheme 3.5. We propose that the 
ortho-ruthenated phenol species 104 is initially generated from the dehydrogenative ortho-
C-H activation of the phenol substrate by cationic ruthenium-hydride catalyst 26. The 
observed H/D exchange pattern suggested that the rapid and reversible C-H activation 
occurs adjacent to the phenol directing groups. The ketone substrate would coordinate to 
the electrophilic ruthenium center, and the subsequent carbonyl insertion into the Ru-
phenyl bond generates 6-membered ruthenacyclic intermediate 105. The syn-elimination 
of 105 would form the ruthenium-hydroxo species and liberate the ortho-alkenylated 
86 
 
phenol product. Dehydrative C-H activation of another phenol substrate would regenerate 
ortho-metalated Ru species 104 for the next catalytic cycle. 
The (Z)-selective formation of the alkene products 98 can be rationalized by the 
geometrically preferred formation of the intermediate 105Z over 105E due to the steric 
hindrance between R group and ruthenium center (Scheme 3.6). We observed that the (Z)-
selectivity of the products increases with respect to the steric bulkiness of R group on the 
ketone substrate (Table 3.3, entries 15-18). 
 
Scheme 3.6 Mechanistic rationale for the (Z)-selective formation of 2-alkynylphenols 
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3.6 Conclusions 
We have successfully developed a highly regio- and stereoselective dehydrative 
ortho-alkenylation method of phenols with ketones. The well-defined ruthenium-hydride 
catalyst 26 exhibits high activity and a broad substrate scope in promoting the coupling 
reaction to give (Z)-selective olefinated products. The catalytic method employs readily 
available phenols and ketone substrates to produce synthetically useful 2-vinylphenols 
without using any additives or activating reagents. The mechanistic rationale has been 
presented for the (Z)-selective formation of coupling product. Efforts to investigate the 
detailed mechanistic pathway are currently underway. 
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CHAPTER 4 
Catalytic Synthesis of Substituted Indoles and Quinolines from the Dehydrative C-
H Coupling of Arylamines with 1,2- and 1,3-Diols 
4.1 Introduction 
 Indole and quinoline derivatives are common structural motifs present in many 
bioactive natural products and pharmaceutical compounds. The synthesis of these 
biologically important nitrogen-containing heterocyclic compounds has been studied with 
a large number of different synthetic methods over the decades.81,82 Since, Fischer 
pioneered the synthesis of indole products from arylhydrazines with ketones/aldehydes 
under acidic conditions (eq 4.1), various modifications on the classical Fischer indole 
synthesis have been applied including transition metal-based catalytic methods.83  
 
 
 Larock’s indole synthesis is another effective heteroannulation protocol which 
mediates the coupling of ortho-haloaniline with alkynes by using palladium catalysis (eq 
4.2).84 However, these catalytic methods generally require prefunctionalized starting 
materials such as hydrazines and ortho-haloanilines. Also, the consumption or substitution 
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of these reactive functional group leads to the inevitable formation of corresponding 
byproducts.  
 Recently, a number of oxidative catalytic C-H coupling methods have been 
developed as viable synthetic methods for indole and related nitrogen heterocyclic 
compounds. These catalytic methods alleviate inherent problems associated with the 
classical methods such as requiring prefuctionalized substrates and wasteful byproduct 
formation.85,86 Very recently, the analogous C-H coupling reactions have been achieved by 
using earth-abundant Co and Ni catalysts.87 Notably, a number of oxidative C-H cross-
coupling methods have been successfully used to promote the intramolecular annulation of 
N-arylimines and enamines.88 Yoshikai and co-workers reported Pd-catalyzed aerobic 
oxidative cyclization N-arylimines (eq 4.3).89 This process allowed an atom-economical 
assembly of indole derivatives from readily available anilines and ketones. 
 
 From both environmental and economic points of view, catalytic C-H annulation 
of simple anilines with diols would be an attractive method to afford N-heterocyclic 
compounds because such method would generate water as the only byproduct. The 
pioneering work on this protocol was first reported by Watanabe with RuCl3∙nH2O/PBu3 
system.90 Shim later demonstrated RuCl3∙nH2O/SnCl2∙2H2O system for indole and 
quinoline synthesis from anilines with ethylene glycols or trialkanolammonium salts.91 
Using the IrCl3/BINAP catalyst system, Ishii achieved a highily regioselective coupling of 
naphthylamines with 1,2- and 1,3-diols to give indole and quinoline products.92 Recently, 
Madsen described 2,3-disubtituted indole and quinoline synthesis from anilines with diols 
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in the presence of RuCl3 catalyst.
93 However, the synthetic utility of these C-H dehydrative 
coupling methods has been limited because of the requirement of an excess amount of 
arylamine substrate, difficulty in controlling regioselectivity as well as the lack of 
functional group tolerance, and relatively harsh reaction conditions (> 170 °C). 
4.2 Results and Discussion 
 From both environmental and economical points of view, alcohols are highly 
attractive substrates because they can be readily obtained from natural sources. However, 
they have been rarely employed for the catalytic C-H coupling reactions because C-O bond 
cleavage of alcohol is energetically less favored than alkoxylation or dehydrogenation 
reactions. Our research group recently has shown that the cationic ruthenium-hydride 
complex 26 is a highly active catalyst for the C-O bond activation reactions, as 
demonstrated in the C-H alkylation of alkenes with alcohols (Scheme 1.24)43 and C-H 
alkylation and alkenylation of phenols with alcohols (Scheme 1.26).44 More recently, we 
also reported unsymmetrical etherification of two different alcohols (Scheme 4.1a)94 and 
reductive coupling of aldehydes and ketones with alcohols in aqueous solution (Scheme 
4.1b).95 A common feature of these catalytic methods involves the formation of ruthenium-
hydroxo species as the key intermediate for the C-O bond activation. Late metal-hydroxo 
and -phenoxo complexes have been found to mediate a number of C-O cleavage 
reactions.96  
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Scheme 4.1 Ruthenium-hydride catalyzed syntheses of unsymmetrical ethers 
 Glycols and polyols are organic compounds containing more than two hydroxyl 
groups, which can be easily obtained from the oxidation of alkenes or the dehydration of 
natural carbohydrates. In the catalytic dehydrative C-O bond activation reactions, they can 
also be used as the substrates having multiple activation sites. Our group has been able to 
devise the coupling reaction of phenols with vicinal 1,2-diols to form benzofuran 
derivatives (eq 4.4).44  
 
 The success in the heterocyclic annulation of phenols led us to explore the synthesis 
of nitrogen-containing heterocyclic compounds. Our studies began with the exploration of 
coupling reactions of arylamines with 1,2-diols. Initially, we have chosen the coupling 
reaction of 1-naphthylamine with 1,2-cyclooctanediol to produce indole product under the 
previously reported conditions. The reaction was performed in the presence of the 
ruthenium catalyst 26 (3 mol %) and cyclopentene (3 equiv.) in chlorobenzene at 120 °C. 
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However, under these conditions, the desired indole 106r was obtained only 10 % isolated 
yield along with α-ketoamine 107r as the major product (35 %) (eq 4.5). The undesired α-
ketoamine was formed apparently from the dehydrative N-alkylation of 1-naphthol with 
the dehydrogenation of alcohol, which was favored over the dehydrative C-H annulation. 
In an effort to improve the catalytic efficacy, we were pleased to find that the coupling 
reaction in the presence of the catalytic amount of HBF4∙OEt2 (7 mol %) additive in 1,4-
dioxane afforded 62 % of the polycyclic indole 106r as the major product and 15 % of 
byproduct 107r (eq 4.6). These results indicate that the addition of HBF4∙OEt2 promotes 
the activity of the Ru catalyst 26 for the both ortho-C-H activation of arylamine and C-O 
bond activation of alcohols. Our previous study showed that the 26/HBF4∙OEt2 system 
effectively catalyzed the coupling reaction of anilines with ethylenes to produce N-
ethylanilines and 2-methylquinolines (eq 4.7).97  
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 Our catalytic method efficiently forms the indole derivatives from the coupling 
reaction of readily available anilines with 1,2-diols. The catalytic method does not require 
any stoichiometric amount of base and does not generate any toxic byproducts. For these 
reasons, we have decided to further investigate both synthetic utility and the mechanism of 
the catalytic method.  
4.3 Catalyst Screening and Optimization Studies 
To attain the optimized conditions, we next screened both Ru catalysts and additives for 
the coupling reaction of aniline with 1-phenyl-1,2-ethanediol (Table 4.1). The treatment of 
aniline (0.5 mmol) with 1-phenyl-1,2-ethandiol (0.75 mol) in the presence of a ruthenium 
catalyst (3 mol %) and cyclopentene (1.5 mmol) dioxane was heated at 110 °C for 14 h. 
The conversion of the indole product 106c was analyzed by both GC-MS and NMR 
methods. We found that the addition of catalytic amount of HBF4·OEt2 has led to the 
dramatic improvement of the product yield. The cationic Ru-H complex, either in isolated 
form of the complex 26 or in situ generated from a tetranuclear Ru complex 79 exhibited 
uniquely high catalytic activity with HBF4∙OEt2 (entries 3, 8). No reaction occurred when 
only HBF4∙OEt2 was employed without Ru complex (entry 22). Among the screened 
ruthenium complexes and additives, tetranuclear ruthenium hydride complex 
{[(PCy3)(CO)RuH]4(μ4-O)(μ3-OH)(μ2-OH)} (79) with HBF4∙OEt2 was found to be the 
most effective catalyst for the selective formation of 2-phenylindole product 106a (entry 
3), and 1,4-dioxane was found to be the most suitable solvent for the coupling reaction 
(entries 3-6). 
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Table 4.1 Catalyst and additive screening for the coupling reaction of aniline with 1-
phenyl-1,2-ethanediola 
 
entry catalyst additive solvent 
yield 
(%)b 
1 [RuH(CO)(PCy3)]4(O)(OH)2 (79) --- 1,4-dioxane    0 
2 [RuH(CO)(PCy3)]4(O)(OH)2 (79) NH4PF6 1,4-dioxane  18 
3 [RuH(CO)(PCy3)]4(O)(OH)2 (79) HBF4·Et2O 1,4-dioxane  96 
4 [RuH(CO)(PCy3)]4(O)(OH)2 (79) HBF4·Et2O chlorobenzene  46 
5 [RuH(CO)(PCy3)]4(O)(OH)2 (79) HBF4·Et2O toluene  42 
6 [RuH(CO)(PCy3)]4(O)(OH)2 (79) HBF4·Et2O dichloroethane  17 
7 [RuH(C6H6)(CO)(PCy3)]+BF4- --- 1,4-dioxane  19 
8 [RuH(C6H6)(CO)(PCy3)]+BF4- HBF4·Et2O 1,4-dioxane  83 
9 [RuH(CO)(CH3CN)2(PCy3)2]+BF4- --- 1,4-dioxane    0 
10 RuHCl(CO)(PCy3)2 --- 1,4-dioxane    0  
11 RuHCl(CO)(PCy3)2 HBF4·Et2O 1,4-dioxane  23 
12 RuCl2(PPh3)3 --- 1,4-dioxane < 3  
13 RuCl2(PPh3)3 HBF4·Et2O 1,4-dioxane  42 
14 RuCl3·3H2O --- 1,4-dioxane    0 
15 [Ru(COD)Cl2]2 HBF4·Et2O 1,4-dioxane < 3 
16 [RuCl2(p-cymene)]2 --- 1,4-dioxane    0 
17 [RuCl2(p-cymene)]2 HBF4·Et2O 1,4-dioxane    0 
18 Ru3(CO)12 --- 1,4-dioxane    0 
19 Ru3(CO)12 NH4PF6 1,4-dioxane    0 
20 RuH2(CO)(PPh3)3 --- 1,4-dioxane    0  
21 PCy3 HBF4·Et2O 1,4-dioxane    0 
22 --- HBF4·Et2O 1,4-dioxane    0 
 a Reaction conditions: catalyst (3 mol % Ru equivalents), additive (7 mol %), aniline (0.5 
mmol), 1-phenyl-1,2-ethanediol (0.75 mmol), cyclopentene (1.5 mmol), 1,4-dioxane (2 
mL), 110 °C, 14 h. b The product yield of 106a was determined by 1H NMR using 
hexamethylbenzene as an internal standard. 
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4.4 Reaction Scope and Applications 
4.4.1 Scope of Dehydrative C-H Coupling Reaction of Arylamines with 1,2-Diols 
Table 4.2 Dehydrative coupling of arylamines with 1,2-diolsa 
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Table 4.2 Dehydrative coupling of arylamines with 1,2-diolsa (continued) 
 
a Reaction conditions: amine (1.0 mmol), 1,2-diol (1.5 mmol), 79 (0.75 mol %), HBF4∙OEt2 
(7 mol %), cyclopentene (3.0 mmol), 1,4-dioxane (3 mL), 14-16 h. b Isolated yields. c 1H 
NMR yield. 
 With these optimized reaction conditions in hand, we explored the substrate scope 
of the coupling reaction of anilines with 1,2-diol substrates (Table 4.2). Both aliphatic and 
aryl-substituted primary-secondary diols readily reacted with aniline to give regioselective 
2-substituted indole products 106a-106c (entries 1-3). A secondary diol 2,3-butanediol 
afforded 2,3-disubstituted indole product 106d (entry 4), but with a lower yield than 
primary-secondary diols. 1,2-Cyclohexenediol also successfully gave the coupling product 
106e, and no difference in reactivity was observed between cis- and trans-cyclohexanediol. 
For the coupling of 3-methoxyanilines, 6-methoxyindoles 106f-106j were obtained 
regioselectively along with a negligible amount of 4-methoxyindole products by forming 
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a new C-C bond at para to the methoxy group. A series of 1,2-cycloalkanediols effectively 
proceeded to form tricyclic indoles 106h-106j (entries 8-10). The coupling of electron-rich 
3,4,5-trimethoxyaniline with 1,2-diols also gave the indole products 106k and 106l (entries 
11, 12). We found that a range of polycyclic indole derivatives can be obtained from the 
coupling reaction of 1-naphthylamine with 1,2-diols (entries 13-18). Both primary-
secondary and secondary-secondary 1,2-diols afforded the corresponding 2-substituted and 
2,3-disubstituted 1H-benzo[g]indoles 106m-106p in moderate to good yields (entries 13-
16). The coupling reaction of 1-naphthylamine with 1,2-indandiol and 1,2-cyclooctanediol 
gave polycyclic indole products 106q and 106r, respectively (entries 17, 18). Among the 
tested 1,2-diols, 1-phenyl-1,2-ethanediol was found to be the most efficient diol substrate 
to give 2-substituted indoles for this coupling reaction. The catalytic method achieves the 
regioselective synthesis of indole derivatives from the direct coupling between arylamines 
and 1,2-diols without forming any harmful byproducts. 
 We next surveyed the scope of substituted anilines with 1-phenyl-1,2-diols (Table 
4.3). Mono- and disubstituted anilines readily reacted with the diol substrate to form the 2-
phenylindole products in good to excellent yields. Both electron-withdrawing and -
donating groups were found to be compatible, but we observed the relatively electron-
deficient 3-substituted aniline (106u) generally gave lower yield than the ones with 
electron-releasing group (106g, 106s, 106t). The reaction also tolerates sterically 
demanding ortho-substituted anilines (106v, 106w) and 4-aminoindan (106z) in the 
formation of corresponding indole products. The coupling reaction of 3,4-
(methylenedioxy)aniline with diol afforded the heterocyclic indole product 106aa in 80 % 
yield. 
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Table 4.3 Dehydrative coupling of anilines with 1-phenyl-1,2-ethanediola 
 
a Reaction conditions: aniline (1.0 mmol), 1-phenyl-1,2-ethanediol (1.5 mmol), 79 (0.75 
mol %), HBF4∙OEt2 (7 mol %), cyclopentene (3.0 mmol), 1,4-dioxane (3 mL), 14-16 h. 
Isolated yields in parenthesis. b Combined yield of two regioisomers. 
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4.4.2 Scope of Dehydrative C-H Coupling Reaction of Arylamines with 1,3-Diols 
Table 4.4 Dehydrative coupling of arylamines with 1,3-diolsa 
 
a Reaction conditions: amine (1.0 mmol), 1,3-diol (1.5 mmol), 79 (0.75 mol %), HBF4∙OEt2 
(7 mol %), cyclopentene (3.0 mmol), 1,4-dioxane (3 mL), 130-150 °C, 14 h. Isolated yields 
in parenthesis. 
 
100 
 
 We have been able to extend the synthetic utility to the C-H annulation of anilines 
with 1,3-diols to produce quinoline derivatives (Table 4.4). The coupling reaction of 
anilines with 1,3-diols readily afforded quinoline product 108 by using the same catalytic 
system. However, these reactions required higher temperature (130-150 °C) for the optimal 
conversion and selectivity in forming the quinoline products. In most cases, significant 
amount of N-alkylated aniline 109 was obtained as the byproduct. We reasoned that the 
byproduct 109 was formed by the dehydrative hydrogenolysis of the other hydroxyl group 
over the requisite ortho-C-H coupling and annulation process. Anilines bearing electron-
withdrawing and -donating group readily reacted with 1,3-propanediols to give the 
substituted quinoline derivatives (108a-108d) with N-alkylated anilines (109a-109d). In 
contrast to the anilines with electron-donating group, electron-deficient 3- and 4-
chloroanilines gave N-alkylated anilines as the major product. Electron-donating group di-
substituted anilines smoothly reacted with 2-phenyl-1,3-propanediols to form quinolines 
as the major product (108e-108g). We found that the coupling reaction of 3,5-
dimethoxyaniline with 2-substituted 1,3-propanediol gave quinoline product 108h and 108i 
selectively among the screened reactions, as only a trace amount of N-alkylated aniline 
byproduct was detected from the GC-MS analysis of the crude mixture. However, the 
coupling of 3,5-dimethoxyaniline with secondary 1,3-diol 2,4-pentanediol led to nearly 1:1 
mixture of the quinoline product 108j and N-alkylated aniline 109j. The analogous 
treatment of 1-naphthylamine with 1,3-diols formed the corresponding polycyclic 
quinoline derivatives 108k-108n. Both quinoline and N-alkylaniline products 108 and 109 
were readily separated by silica gel column chromatography and were analyzed by 1H and 
13C NMR spectroscopy. 
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4.4.3 Ru-Catalyzed C-C Bond Activation Reactions of 1,3-Diols 
 
 To examine the coupling reaction of arylamines with 2,2-disubstituted-1,3-diols by 
using 26, we initially tested the coupling of 3-methoxyphenol with 2,2-dimethyl-1,3-
propanediol in chlorobenzene at 130 °C (eq 4.8). To our surprise, the C-C cleavage product 
N-isobutylaniline 110a was obtained along with tetrahydroquinoline derivative 111. This 
unexpected formation of 110a was apparently resulted from the dehydrative N-alkylation 
and the cleavage of C-C bond adjacent to the hydroxyl group. To the best of our knowledge, 
catalytic methods for the selective activation of unstrained sp3-sp3 C–C bond are very rare 
and difficult, because the C–C bond activation of unstrained saturated hydrocarbons is both 
kinetically and thermodynamically less favored than that of the C–H bonds.98 
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Table 4.5 Ruthenium catalyzed C-C bond activation reaction of 1,3-diolsa 
 
a Reaction conditions: amine (0.5 mmol), 1,3-diol (1.0 mmol), 26 (5 mol %), chlorobenzene 
(2 mL), 130 °C. b Cs2CO3 (20 mol %) was added. 
 We next explored several other coupling reactions to investigate the pattern of this 
C-C bond activation method (Table 3.5). The coupling of 3-methoxyaniline with 1,3-
butanediol yielded a mixture of the products N-ethylaniline 110b, N-butylaniline 112, and 
quinoline 113 (entry 2). Again, the coupling product 110b was formed from the 
regioselective C-C bond cleavage next to the secondary alcohol. The formation of 
quinoline product 113 can be explained from the competitive dehydrative ortho-C-H 
alkylation and annulation of two equivalents 1,3-diols. We also observed a similar C-C 
cleavage pattern from the coupling reaction of 3-methoxybenzylamine with 2,2-dimethyl-
1,3-propanediol. In this case, a 2:1 mixture of N-isobutylbenzylamine 110c and tetrahydro-
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1,3-oxazine 114 was formed (entry 3). The exact reaction pathways is still not clear at this 
stage, but we presumed that the byproduct formaldehyde, might have coupled with 
benzylamine and diol in forming tetrahydro-1,3-oxazine 114. The product selectivity 
control is generally difficult in this coupling reaction, often gave a complex mixture of 
N,N-disubstituted products at a higher temperature. Interestingly, the addition of catalytic 
amount of base completely switched the product formation of the C-C bond cleavage 
reaction. The coupling reaction of anilines with 2,2-dimethyl-1,3-propanediol in the 
presence of 26 (5 mol %) and Cs2CO3 (20 mol %) in chlorobenzene at 130 °C led to the 
selective formation of N-methylanilines 110d-110f (entries 4-6).  
4.4.4 Ru-Catalyzed ortho-C-H Alkylation of Arylamines with 1,4-Diols 
 During the course of extending this methodology to 1,4-diol substrates, we 
observed an interesting product formation. The reaction of 1-naphthylamine with 2,5-
hexanediol in the presence of 26 (5 mol %), cyclopentene (3 equivalents) in chlorobenzene 
at 110 °C afforded a 1:1 diasteromeric mixture of ortho-alkylated arylamine products 115a 
along with pyrrole 116a (Scheme 4.2). Each diastereomer of 115a was cleanly separated 
by column chromatography and analyzed by both GC-MS and NMR spectroscopy. For the 
formation of 115a, we suspected that a 2,5-dimethyltetrahydrofuran intermediate might 
have been formed initially via intramolecular dehydration, which subsequently reacted 
with 1-naphthylamine to give the ortho-alkylated product. To discern this hypothesis, we 
next performed the coupling of 1-naphthylamine with 2,5-dimethyltetrahydrofuran under 
the same reaction conditions, and the resulting product mixture was similar to the reaction 
between 1-naphtylamine and 2,5-diol (Scheme 4.2).  
104 
 
 
Scheme 4.2 The coupling reaction of 1-naphthylamine with 1,4-diols 
 The coupling method can accommodate a variety of electron-rich anilines such as 
3-methoxyaniline, 3-isopropylaniline, 3-phenoxyaniline, and 4-ethylaniline. However, the 
scope of 1,4-diol substrates is limited to 2,5-hexanediol or 1,4-pentanediol thus far. The 
coupling reaction with 1,4-diphenyl-1,4-butanediol gave only intramolecular cyclization 
product 2,5-diphenyltetrahydrofuran with the recovered aniline starting material, while 
other primary-primary diols 1,4-butanediol and 1,5-pentanediol gave only corresponding 
N-heterocycles under the catalytic system. 
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4.5 Mechanistic Study for the Ru Catalyzed Coupling of Aniline with 1,2-Diols 
4.5.1 Deuterium Labeling Study 
 
 To probe the possible H/D exchange pattern on the coupling product, we examined 
the reaction of a deuterium-labeled aniline with a 1,2-diol. A mixture of deuterium-labeled 
aniline-2,3,4,5,6-d5 (0.5 mmol) with 1-phenyl-1,2-ethanediol (0.75 mmol) in the presence 
of 79 (0.75 mol %), HBF4∙OEt2 (7 mol %), cyclopentene (3 equivalents) in 1,4-dioxane 
was heated at 110 °C for 14 hours (eq 4.9). The isolated 2-phenylindole product 106a-d 
showed a selective deuterium incorporation to both ortho (42% D) and para (54% D) arene 
positions as measured by 1H and 2H NMR analysis. The observed extensive H/D exchange 
pattern suggests a rapid and reversible ortho- and para-C-H bond activations by the Ru 
catalyst. Our group previously observed a similar H/D exchange pattern on the para-arene 
position from the coupling reaction of arylamines with terminal alkynes from using the 
same Ru catalytic system.99  
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Figure 4.1 1H and 2H NMR spectra of the product 106a-d isolated from the reaction of 
aniline-2,3,4,5,6-d5 with 1-phenyl-1,2-ethanediol 
4.5.2 Control Experiments 
 We conducted a series of control experiments to distinguish the possible 
mechanistic pathways. Since the deuterium labeling study showed the selective H/D 
exchange on ortho- and para-positions of the aniline substrate, this result indicates the 
aniline substrate possesses two different potential sites for the C-H activation. However, 
para-alkylated aniline had not been detected under the catalytic conditions, which led us 
to hypothesize that the coupling reaction might be proceeded by the initial generation of 
C-N bond with the subsequent intramolecular ortho-C-H activation. 
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 To test this hypothesis, we first employed an aliphatic alcohol under the similar 
reaction conditions. The coupling reaction of aniline with n-butanol selectively formed N-
butylaniline in 70 % yield (eq 4.10). In this case, N-alkylation product was formed 
preferentially over the ortho-alkylated aniline product. This result is in sharp contrast to 
the previously reported coupling reaction of phenol with alcohols, where the ortho-
alkylation product was exclusively formed.44 In a separate experiment, the coupling 
reaction of N,N-dimethylaniline with 4-methoxybenzyl alcohol afforded both ortho- and 
para-alkylated N,N-dimethylanilines (eq 4.11). These experimental results support a 
reaction sequence involving the initial C-N bond followed by intramolecular ortho-C-H 
annulation. 
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 We discovered that the reaction of 3-methoxyaniline with benzoin provides 
corresponding indole product 106ab in 82 % yield under the standard conditions. For this 
reaction, no difference in product yield was made even in the absence of hydrogen acceptor 
(cyclopentene) (eq 4.12). To explain the observed regioselectivity of the indole product, 
we hypothesized that the 1,2-diol substrate could undergo dehydrogenation to form a α-
hydroxyketone intermediate prior to the dehydrative C-N bond formation. In support of 
this initial formation of α-hydroxyketone and the regioselectivity of the indole product, 2-
hydroxyacetophenone was cleanly formed when 1-phenyl-1,2-ethanediol was treated with 
79 and cyclopentene (24 % conversion in 3 hours) (eq 4.13). The similar chemoselective 
oxidation of the secondary alcohols over the primary alcohols was reported by using 
transition metal catalysts.100   
4.5.3 Proposed Mechanism 
 On the basis of these results, we present a possible mechanism for the dehydrative 
coupling reaction of aniline with 1,2-diol (Scheme 4.3). We propose that the 
dehydrogenation of diol would initially generate α-hydroxyketone, which could react with 
aniline to give α-hydroxyimine 111 by releasing water. We believe that the chemoselective 
oxidation of the secondary alcohol at this stage is the key step for the regioselective 
formation of the 2-substituted indole products. The subsequent chelate-assisted ortho-C-H 
activation would form ortho-ruthenated imine species 118, in a similar fashion to the 
dehydrative C-H insertion reaction of phenols.44 The intramolecular C-O bond activation 
of alcohol followed by reductive elimination would liberate the indole product 106 and 
generate cationic Ru-hydroxo species 119. In support of this proposal, we recently showed 
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that Ru-hydroxo complexes are a key intermediate species in ketone hydrogenolysis 
reaction.55 In addition, the formation of N-alkylated product 108 can be explained by a 
competitive hydrogenolysis pathway especially in case of for the coupling of an electron-
deficient aniline with 1,3-diols. 
 
 
Scheme 4.3 Plausible mechanistic pathway for the dehydrative coupling of aniline with 
1,2-diol 
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4.6 Conclusions 
 We have successfully developed an effective catalytic protocol for the coupling of 
inexpensive and readily available arylamines and diols substrates to produce biologically 
important indole and quinoline derivatives. A wide range of substrates has been 
demonstrated to form the regioselective N-heteroannulated products without forming any 
toxic byproducts. The tetrameric Ru-hydride 79 with HBF4∙OEt2 was found to be an 
effective catalyst precursor, which exhibits uniquely high catalytic activity for the 
dehydrative coupling reaction of arylamines with diols. We have performed the deuterium 
labeling study and control experiments, which support our proposed mechanism for the 
regioselective formation of indoles. A part of this work was published in Organometallcs 
2016, 35, 1973-1977. DOI: 10.1021/acs.organomet.6b00273 
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CHAPTER 5 
Experimental Section 
5.1 General Information 
All operations were carried out in a nitrogen-filled glove box or by using standard 
high vacuum and Schlenk techniques unless otherwise noted. Solvents were freshly 
distilled over appropriate drying reagents. Benzene, toluene, and n-hexane were distilled 
from purple solutions of sodium and benzophenone, and dichloromethane was dried over 
calcium hydride prior to use. All organic substrates were received from commercial sources 
and were used without further purification. Column chromatography was performed on 
Dynamic Absorbents silica gel 60A (32-63 μm particle size), and thin layer 
chromatography was performed on Agela glass back TLC plates pre-coated with silica gel 
MF254. The 1H, 2H, 13C, 19F and 31P NMR spectra were recorded on a Varian 300 or 400 
MHz FT-NMR spectrometer, and the data are reported in parts per million (ppm) relative 
to TMS, with the residual solvent peak as an internal reference. Multiplicities are reported 
as: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad; coupling 
constant(s) in Hz. Mass spectra were recorded from Agilent 6850 GC-MS spectrometer 
with a HP-5 (5% phenylmethylpolysiloxane) column (30 m, 0.32 mm, 0.25 μm). High 
resolution mass spectra (HRMS) were obtained at the Mass Spectrometry/ICP Lab, 
Department of Chemistry and Biochemistry, University of Wisconsin Milwaukee, 
Milwaukee, WI and the Center of Mass Spectrometry, Washington University, St. Louis, 
MO. Elemental analyses were performed at the Midwest Microlab, Indianapolis, IN. 
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5.2 Synthesis of Ruthenium Catalysts 
5.2.1 Synthesis of [(PCy3)2(CO)RuH]4(µ4-O)(µ3-OH)(µ2-OH) (79) 
The tetranuclear Ru-hydride complex 79 was synthesized in two steps from the 5-
coordinated Ru-hydride complex (PCy3)2(CO)RuHCl (23) (Scheme 2.3). In a glovebox, a 
25 mL Schlenk tube equipped with a magnetic stirring bar and Teflon stopcock was 
charged with (PCy3)2(CO)RuHCl (2) (726 mg, 1.0 mmol), KOH (6.5 mmol), and 2-
propanol (5 mL). The reaction tube was brought out of the box and was stirred in an oil 
bath at 90 °C for 8 h. The solvent was removed under high vacuum, and the residue was 
washed with 2-propanol and benzene to obtain the dinulear Ru complex 78.  
In the glove box, the obtained Ru complex 78 (500 mg, 0.46 mmol) and acetone (5 
mL) were added to a 25 mL Schlenk tube equipped with a magnetic stirring bar and Teflon 
stopcock. The reaction tube was brought out of the glovebox and stirred in an oil bath at 
100 °C for 4 h. After the tube was cooled to room temperature, the resulting red solid was 
filtered, washed with cold acetone (5 mL, 3 times), and recrystallized in dichloromethane 
to obtain product 79 in 90 % yield. Spectroscopic data for 78: 1H NMR (300 MHz, CD2Cl2) 
δ 2.25-1.15 (m, PCy3), -2.50 and -2.60 (s, µ-OH), -14.56 (d, JPH = 19.2 Hz, Ru-H), -15.02 
(d, JPH = 18.0 Hz, Ru-H), -15.28 (d, JPH = 34.8 Hz, Ru-H), -18.64 (dt, JPH = 13.2, 4.8 Hz, 
Ru-H-Ru); 31P{1H} NMR (CDCl3, 121.6 MHz) δ 82.13 (s, PCy3), 79.01 (d, JPP = 14.0 Hz 
(PCy3)), 71.96 (s, (PCy3)), 68.89 (d, JPP = 14.0 Hz, (PCy3)); IR (CH2Cl2) νOH = 2926, 2849 
cm-1, νCO = 1925, 1912, 1894, 1868 cm-1. Anal. Calcd for 79 C76H138O7P4-Ru4: C 53.95; H 
8.22. Found: C 55.03; H 8.14. 
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5.2.2 Synthesis of [(η6-C6H6)(PCy3)(CO)RuH]+BF4- (26) 
The cationic Ru-hydride 26 was synthesized from the tetranuclear Ru-H complex 
79 (Scheme 2.3). Under N2 atmosphere (glove box), the complex 79 (400 mg, 0.24 mmol) 
was dissolved in benzene (15 mL) in a 25 mL Schlenk tube equipped with a Teflon screw-
cap stopcock and a magnetic stirring. Then HBF4·OEt2 (128 μL, 0.96 mmol) was added to 
the tube via syringe under N2 stream. The color of the solution was changed from brown-
red to pale yellow immediately. After stirring for 1 h at room temperature, the solvent was 
removed under vacuum, and the residue was crashed by adding hexanes (20 mL). Filtering 
the resulting solid through a fritted funnel and recrystallization from CH2Cl2/hexanes 
yielded the product as a pale yellow powder (524 mg, 95% yield). Single crystals of 26 
suitable for X-ray crystallography were obtained from a slow evaporation of benzene and 
hexanes solution. Spectroscopic data for 26: 1H NMR (CD2Cl2, 400 MHz) δ 6.53 (s, C6H6), 
2.0-1.2 (m, PCy3), -10.39 (d, JPH = 25.9 Hz, Ru-H); 
13C{1H} NMR (CD2Cl2, 100 MHz), δ 
196.4 (d, JCP = 19.3 Hz, CO), 100.0 (C6H6), 38.4, 38.2, 30.2, 29.9, 27.4, 27.3 and 26.2 
(PCy3); 
31P{1H} NMR (CD2Cl2, 162 MHz) δ 72.9 (PCy3); IR (KBr) νCO = 1991 cm-1; 
Anal. Calcd for 26 C25H40BF4OPRu: C, 52.18; H, 7.01. Found: C, 51.73; H, 6.91. 
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5.3 Experimental Procedures and Data for the Chapter 2 
5.3.1 General Procedures for the Coupling Reaction of Phenol with Aldehydes 
General Procedure for the C-H Acylation of Phenol with Aldehyde. In a glove 
box, a phenol (0.5 mmol), an aldehyde (1.0 mmol), K2CO3 (30 mol %), PPh3 (20 mol %) 
and complex 26 (14 mg, 5 mol %) were dissolved in chlorobenzene (2 mL) in a 25 mL 
Schlenk tube equipped with a Teflon stopcock and a magnetic stirring bar. The tube was 
brought out of the glove box, and was stirred in an oil bath set at 70-110 °C for 8-16 h. The 
reaction tube was taken out of the oil bath, and was cooled to room temperature. After the 
tube was open to air, the solution was filtered through a short silica gel column by eluting 
with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. Analytically pure product 
was isolated by a simple column chromatography on silica gel (280-400 mesh, 
hexanes/EtOAc). The product was completely characterized by NMR and GC-MS 
spectroscopic methods.  
General Procedure for the C-H Acylation of Phenol with α,β-Unsaturated 
Aldehyde. In a glove box, a phenol (0.5 mmol), an α,β-unsaturated aldehyde (1.0 mmol), 
K2CO3 (30 mol %), PPh3 (20 mol %) and complex 26 (14 mg, 5 mol %) were dissolved in 
chlorobenzene (2 mL) in a 25 mL Schlenk tube equipped with a Teflon stopcock and a 
magnetic stirring bar. The tube was brought out of the glove box, and was stirred in an oil 
bath set at 110-130 °C for 12-24 h. The reaction tube was taken out of the oil bath, and was 
cooled to room temperature. After the tube was open to air, the solution was filtered 
through a short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate was 
analyzed by GC-MS. Analytically pure product was isolated by a simple column 
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chromatography on silica gel (280-400 mesh, hexanes/EtOAc). The product was 
completely characterized by NMR and GC-MS spectroscopic methods. 
5.3.2 General Procedures for the Mechanistic Studies 
Deuterium Labeling Study. In a glove box, 3,5-dimethoxyphenol (0.77 g, 5.0 
mmol), benzaldehyde--d1 (>95 % D, 1.0 mmol), K2CO3 (30 mol %), PPh3 (20 mol %) 
and complex 26 (5 mol %) were dissolved in chlorobenzene (2 mL) in a 25 mL Schlenk 
tubes equipped with a Teflon screw cap stopcock. The tube were brought out of the box, 
and immersed in an oil bath preset at 110 °C for 12 h. The reaction tube was taken out of 
the oil bath, and was cooled to room temperature. After the tube was open to air, the 
solution was filtered through a short silica gel column by eluting with CH2Cl2 (10 mL), 
and the filtrate was analyzed by GC-MS. Analytically pure products and unreacted phenol 
substrate were isolated by a simple column chromatography on silica gel (280-400 mesh, 
hexanes/EtOAc = 100:1 to 1:1), then were completely characterized by 1H, 2H NMR and 
GC-MS spectroscopic methods. 
Deuterium Isotope Effect Study. In a glove box, 3,5-methoxyphenol (0.5 mmol), 
benzaldehyde--d1 (1.0 mmol), K2CO3 (30 mol %), PPh3 (20 mol %) and complex 26 were 
dissolved in chlorobenzene (2 mL) in five separate 25 mL Schlenk tubes equipped with a 
Teflon screw cap stopcock. The tubes were brought out of the box, and immersed in an oil 
bath preset at 110 °C. The reaction rate was measured by monitoring the appearance of the 
product signals on 1H NMR, which were normalized against the internal standard 
hexamethylbenzene in 20 min intervals for 100 min of the reaction time. The experiment 
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was repeated by using benzaldehyde. The kobs was determined from a first-order plot of -
ln[(3,5-methoxyphenol)t/(3,5-methoxyphenol)0] vs time. 
Hammett Study. In a glove box, 3,5-dimethoxyphenol (0.5 mmol), p-X-C6H4CHO 
(1.0 mmol), K2CO3 (30 mol %), PPh3 (20 mol %) and complex 26 were dissolved in 
chlorobenzene (2.0 mL) in five separate 25 mL Schlenk tubes equipped with a Teflon 
screw cap stopcock. The tubes were brought out of the box, and immersed in an oil bath 
preset at 110 °C. The reaction rate was measured by monitoring the appearance of the 
product signals on 1H NMR, which were normalized against the internal standard 
hexamethylbenzene peak in 20 min intervals for 100 min of the reaction time. The kobs was 
determined from a first-order plot of -ln[(3,5-dimethoxyphenol)t/(3,5-dimethoxyphenol)0] 
vs time. The Hammett plot of log(kX/kH) vs σp is shown in Figure 2.9. 
5.3.3 X-Ray Crystallographic Determination of 81v, 83t, and 84b 
For 81v: Colorless single crystals of 81v were grown in CH2Cl2 at room 
temperature. A suitable crystal with the dimension of 0.28  0.14  0.11 mm3 was selected 
and mounted on an Oxford SuperNova diffractometer equipped with dual microfocus 
Cu/Mo X-ray sources, X-ray mirror optics, and Atlas CCD area detector. A total of 15224 
reflection data were collected by using MoKα (λ = 0.71073) radiation while the crystal 
sample was cooled at 100.05 K during the data collection. Using Olex2, the molecular 
structure was solved with the ShelXS structure solution program by using Direct Methods, 
and the data was refined with the XL refinement package using Least Squares minimization. 
The molecular structure of 81v is shown in Figure 2.4. 
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For 83t: Colorless single crystals of 83t were grown in CH2Cl2 at room temperature. 
A suitable crystal with the dimension of 0.42  0.35  0.18 mm3 was selected and mounted 
on an Oxford SuperNova diffractometer equipped with dual microfocus Cu/Mo X-ray 
sources, X-ray mirror optics, and Atlas CCD area detector. A total of 18380 reflection data 
were collected by using CuKα (λ = 1.54184) radiation while the crystal sample was cooled 
at 100.00 K during the data collection. Using Olex2, the molecular structure was solved 
with the ShelXS structure solution program by using Direct Methods, and the data was 
refined with the XL refinement package using Least Squares minimization. The molecular 
structure of 83t is shown in Figure 2.5. 
 For 84b: Colorless single crystals of 84b were grown in CH2Cl2/Hexane at room 
temperature. A suitable crystal with the dimension of 0.18  0.14  0.02 mm3 was selected 
and mounted on an Oxford SuperNova diffractometer equipped with dual microfocus 
Cu/Mo X-ray sources, X-ray mirror optics, and Atlas CCD area detector. A total of 11892 
reflection data were collected by using CuKα (λ = 1.54184) radiation while the crystal 
sample was cooled at 99.8 K during the data collection. Using Olex2, the molecular 
structure was solved with the ShelXS structure solution program by using Direct Methods, 
and the data was refined with the XL refinement package using Least Squares minimization. 
The molecular structure of 84b is shown in Figure 2.6. 
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5.3.4 Characterization Data of the Products 
Data for 81a: 1H NMR (400 MHz, CDCl3) δ 12.70 (s, 1H), 7.65-
7.62 (m, 2H), 7.59-7.54 (m, 1H), 7.52-7.47 (m, 3H), 7.50 (d, J = 
9.0, 1H), 6.52 (d, J = 2.5 Hz, 1H), 6.41 (dd, J = 9.0, 2.5 Hz, 1H), 
3.86 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 200.0, 166.3, 166.2, 138.2, 135.2, 
131.4, 128.8, 128.3, 113.1, 107.4, 101.0, 55.6 ppm; GC-MS m/z = 228 (M+); Anal. Calcd 
for C14H12O3: C, 73.67; H, 5.30. Found: C, 73.56; H, 5.25. 
Data for 81b: 1H NMR (400 MHz, CDCl3) δ 12.73 (s, 1H), 7.55 
(d, J = 8.1 Hz, 2H), 7.53 (d, J = 8.9 Hz, 1H), 7.29 (d, J = 8.1 
Hz, 2H), 6.52 (d, J = 2.5 Hz, 1H), 6.41 (dd, J = 8.9, 2.5 Hz, 1H), 
3.86 (s, 3H), 2.44 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.8, 166.2, 166.0, 
142.1, 135.5, 135.2, 129.1, 128.9, 113.2, 107.2, 101.0, 55.6, 21.5 ppm; GC-MS m/z = 242 
(M+); Anal. Calcd for C15H14O3: C, 74.36; H, 5.82. Found: C, 74.29; H, 5.94. 
Data for 81c: 1H NMR (400 MHz, CDCl3) δ 12.58 (s, 1H), 
7.69-7.64 (m, 2H), 7.47 (d, J = 9.0 Hz, 1H), 7.20-7.14 (m, 2H), 
6.52 (d, J = 2.5 Hz, 1H), 6.42 (dd, J = 9.0, 2.5 Hz, 1H), 3.86 (s, 
3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 198.4, 166.3, 166.2, 164.7 (d, JCF = 252.7 
Hz), 134.9, 134.4 (d, JCF = 3.4 Hz), 131.4 (d, JCF = 9.0 Hz), 115.5 (d, JCF = 21.7 Hz), 112.9, 
107.5, 101.1, 55.6 ppm; Anal. Calcd for C14H11FO3: C, 68.29; H, 4.50. Found: C, 68.23; 
H, 4.47. 
Data for 81d: 1H NMR (400 MHz, CDCl3) δ 12.45 (s, 1H), 7.64 
(dd, J = 7.9, 1.2 Hz, 1H), 7.41 (td, J = 7.4, 1.2 Hz, 1H), 7.34 (td, 
J = 7.9, 1.8 Hz, 1H), 7.30 (dd, J = 7.4, 1.8 Hz, 1H), 7.10 (d, J = 
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9.0 Hz, 1H), 6.50 (d, J = 2.5 Hz, 1H), 6.36 (dd, J = 9.0, 2.5 Hz, 1H), 3.84 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 199.0, 166.8, 166.1, 139.5, 135.1, 133.0, 131.0, 128.4, 
127.2, 119.1, 113.2, 108.0, 100.8, 55.6 ppm; GC-MS m/z = 306 (M+); +); Anal. Calcd for 
C14H11BrO3: C, 54.75; H, 3.61. Found: C, 54.68; H, 3.70. 
Data for 81e: 1H NMR (400 MHz, CDCl3) δ 12.83 (s, 1H), 7.64 (d, 
J = 10.5 Hz, 1H), 6.42 (dd, J = 10.5, 2.5 Hz, 1H), 6.40 (d, J = 2.5 Hz, 
1H), 3.81 (s, 3H), 2.93 (q, J = 7.3 Hz, 2H), 1.21 (t, J = 7.3 Hz, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 205.3, 165.7, 165.1, 131.3, 113.2, 107.4, 100.8, 
55.4, 31.0, 8.4 ppm; GC-MS m/z = 180 (M+); Anal. Calcd for C10H12O3: C, 66.65; H, 6.71. 
Found: C, 66.57; H, 6.68. 
Data for 81f: 1H NMR (400 MHz, CDCl3) δ 12.91 (s, 1H), 7.66 
(d, J = 9.2 Hz, 1H), 6.44 (dd, J = 9.2, 2.5 Hz, 1H), 6.42 (d, J = 2.5 
Hz, 1H), 3.84 (s, 3H), 2.88 (t, J = 7.4 Hz, 2H), 1.76 (sextet, J = 
7.4 Hz, 2H), 1.01 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 205.0, 
165.9, 165.4, 131.6, 113.5, 107.5, 100.9, 55.5, 39.8, 18.2, 13.9 ppm; GC-MS m/z = 194 
(M+); Anal. Calcd for C11H14O3: C, 68.02; H, 7.27. Found: C, 67.81; H, 7.19. 
Data for 81g: 1H NMR (400 MHz, CDCl3) δ 12.99 (s, 1H), 7.63 
(d, J = 9.3 Hz, 1H), 6.41 (dd, J = 9.3, 2.5 Hz, 1H), 6.40 (d, J = 2.5 
Hz, 1H), 3.81 (s, 3H), 2.74 (d, J = 6.9 Hz, 2H), 2.25 (m, 1H), 0.99 
(d, J = 6.7 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 204.8, 165.8, 165.5, 131.7, 
113.7, 107.4, 100.8, 55.5, 46.7, 25.8, 22.7 ppm; GC-MS m/z = 208 (M+); Anal. Calcd for 
C12H16O3: C, 69.21; H, 7.74. Found: C, 69.08; H, 7.59. 
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Data for 81h: 1H NMR (400 MHz, CDCl3) δ 13.10 (s, 1H), 7.68 
(d, J = 8.4 Hz, 1H), 6.44 (dd, J = 8.4, 2.4 Hz, 1H), 6.42 (d, J = 2.4 
Hz, 1H), 3.83 (s, 3H), 3.19 (tt, J = 11.6, 2.9 Hz, 1H), 1.90-1.17 
(m, 10H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 208.3, 166.0, 165.8, 131.3, 112.3, 
107.5, 101.1, 55.5, 45.0, 29.6, 25.8, 25.8 ppm; GC-MS m/z = 234 (M+); Anal. Calcd for 
C14H18O3: C, 71.77; H, 7.74. Found: C, 71.53; H, 7.58. 
Data for 81i: 1H NMR (400 MHz, CDCl3) δ 12.99 (s, 1H), 7.72 
(d, J = 9.0 Hz, 1H), 7.35-7.21 (m, 5H), 6.42 (d, J = 2.5 Hz, 1H), 
6.37 (dd, J = 9.0, 2.5 Hz, 1H), 4.66 (q, J = 6.9 Hz, 1H), 3.78 (s, 
3H), 1.56 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 204.6, 166.1, 166.1, 
141.5, 132.0, 129.0, 127.5, 127.1, 107.6, 101.0, 101.0, 55.5, 46.9, 19.2 ppm; GC-MS m/z 
= 256 (M+); Anal. Calcd for C16H16O3: C, 74.98; H, 6.29. Found: C, 74.82; H, 6.16. 
Data for 81j: 1H NMR (400 MHz, CDCl3) δ 12.27 (s, 1H), 7.54-
7.51 (m, 2H), 7.48-7.44 (m, 1H), 7.41-7.36 (m, 2H), 6.17 (d, J = 
2.3 Hz, 1H), 5.92 (d, J = 2.3 Hz, 1H), 3.85 (s, 3H), 3.45 (s, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 199.1, 166.4, 166.0, 161.9, 141.7, 130.8, 127.8, 
127.5, 105.6, 93.6, 91.3, 55.6, 55.1 ppm; GC-MS m/z = 258 (M+); Anal. Calcd for C15H14O4: 
C, 69.76; H, 5.46. Found: C, 69.44; H, 5.44. 
Data for 81k: 1H NMR (400 MHz, CDCl3) δ 12.11 (s, 1H), 7.46 
(d, J = 8.1 Hz, 2H), 7.18 (m, J = 8.1 Hz, 2H), 6.16 (d, J = 2.3 
Hz, 1H), 5.94 (d, J = 2.3 Hz, 1H), 3.85 (s, 3H), 3.48 (s, 3H), 
2.40 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 198.7, 166.1, 165.6, 161.8, 141.6, 
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138.7, 128.3, 128.2, 105.7, 93.6, 91.3, 55.6, 55.1, 21.6 ppm; GC-MS m/z = 272 (M+); Anal. 
Calcd for C16H16O4: C, 70.58; H, 5.92. Found: C, 70.57; H, 5.95. 
Data for 81l: 1H NMR (400 MHz, CDCl3) δ 12.09 (s, 1H), 
7.58-7.53 (m, 2H), 7.09-7.03 (m, 2H), 6.16 (d, J = 2.3 Hz, 1H), 
5.93 (d, J = 2.3 Hz, 1H), 3.85 (s, 3H), 3.48 (s, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 197.4, 166.4, 165.8, 164.4 (d, JCF = 251.8 Hz), 161.7, 137.7 (d, 
JCF = 3.5 Hz), 130.4 (d, JCF = 9.0 Hz), 114.5 (d, JCF = 21.9 Hz), 105.4, 93.7, 91.3, 55.7, 
55.1 ppm; GC-MS m/z = 276 (M+); Anal. Calcd for C15H13FO4: C, 65.21; H, 4.74. Found: 
C, 62.17; H, 4.76. 
Data for 81m: 1H NMR (400 MHz, CDCl3) δ 12.17 (s, 1H), 
7.47 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.4 Hz, 2H), 6.16 (d, J = 
2.3 Hz, 1H), 5.92 (d, J = 2.3 Hz, 1H), 3.85 (s, 3H), 3.48 (s, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 197.6, 166.6, 166.0, 161.7, 140.0, 136.9, 129.3, 
127.8, 105.3, 93.7, 91.3, 55.6, 55.1 ppm; GC-MS m/z = 292 (M+); Anal. Calcd for 
C15H13ClO4: C, 61.55; H, 4.48. Found: C, 61.20; H, 4.34. 
Data for 81n: 1H NMR (400 MHz, CDCl3) δ 12.41 (s, 1H), 
7.65 (d, J = 8.1 Hz, 2H), 7.58 (d, J = 8.1 Hz, 2H), 6.16 (d, J 
= 2.3 Hz, 1H), 5.91 (d, J = 2.3 Hz, 1H), 3.85 (s, 3H), 3.42 (s, 
3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 197.8, 167.1, 166.6, 161.9, 145.3 (q, JCF = 
1.2 Hz), 131.9 (q, JCF = 32.4 Hz), 127.6, 124.5 (q, JCF = 3.8 Hz), 123.8 (q, JCF = 272.6 Hz), 
105.2, 93.7, 91.3, 55.7, 55.0 ppm; GC-MS m/z = 326 (M+); Anal. Calcd for C16H13F3O4: 
C, 58.90; H, 4.02. Found: C, 58.81; H, 3.94. 
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Data for 81o: 1H NMR (400 MHz, CDCl3) δ 14.10 (s, 1H), 6.04 (d, 
J = 2.3 Hz, 1H), 5.90 (d, J = 2.3 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 
3.00 (q, J = 7.2 Hz, 2H), 1.13 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 206.3, 167.4, 165.7, 162.7, 105.6, 93.5, 90.6, 55.4, 55.4, 37.3, 8.5 
ppm; GC-MS m/z = 210 (M+); Anal. Calcd for C11H14O4: C, 62.85; H, 6.71. Found: C, 
62.45; H, 6.66. 
Data for 81p: 1H NMR (400 MHz, CDCl3) δ 14.15 (s, 1H), 6.04 
(d, J = 2.4 Hz, 1H), 5.89 (d, J = 2.4 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 
3H), 2.83 (d, J = 6.7 Hz, 2H), 2.18 (nonet, J = 6.7 Hz, 1H), 0.95 
(d, J = 6.7 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 205.5, 167.7, 165.7, 162.5, 
105.8, 93.6, 90.7, 55.4, 55.4, 53.0, 25.2, 22.8 ppm; GC-MS m/z = 238 (M+); Anal. Calcd 
for C13H18O4: C, 65.53; H, 7.61. Found: C, 65.59; H, 7.62. 
Data for 81q: 1H NMR (400 MHz, CDCl3) δ 14.14 (s, 1H), 6.04 
(d, J = 2.4 Hz, 1H), 5.90 (d, J = 2.4 Hz, 1H), 3.84 (s, 3H), 3.79 (s, 
3H), 3.43 (tt, J = 11.0, 2.9 Hz, 1H), 1.89-1.78 (m, 4H), 1.73-1.67 
(m, 1H), 1.45-1.19 (m, 5H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 209.2, 167.9, 165.6, 
162.3, 105.1, 93.7, 90.8, 55.6, 55.4, 50.0, 29.4, 26.2, 26.1 ppm; GC-MS m/z = 264 (M+); 
Anal. Calcd for C15H20O4: C, 68.16; H, 7.63. Found: C, 67.86; H, 7.46. 
Data for 81r: 1H NMR (400 MHz, CDCl3) δ 14.07 (s, 1H), 
7.32-7.24 (m, 4H), 7.22-7.18 (m, 1H), 6.06 (d, J = 2.4 Hz, 1H), 
5.84 (d, J = 2.4 Hz, 1H), 5.00 (q, J = 6.9 Hz, 1H), 3.77 (s, 3H), 
3.74 (s, 3H), 1.49 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 205.8, 
168.0, 165.9, 162.1, 142.4, 128.3, 127.7, 126.3, 105.4, 93.6, 90.8, 55.4, 55.1, 50.8, 19.7 
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ppm; GC-MS m/z = 286 (M+); Anal. Calcd for C17H18O4: C, 71.31; H, 6.34. Found: C, 
71.26; H, 6.34. 
Data for 81s: 1H NMR (400 MHz, CDCl3) δ 13.96 (s, 1H), 8.55-
8.52 (m, 1H), 7.80-7.76 (m, 1H), 7.74-7.71 (m, 2H), 7.69-7.64 (m, 
1H), 7.63-7.51 (m, 5H), 7.23 (d, J = 8.8 Hz, 1H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 201.4, 163.9, 138.2, 137.3, 131.6, 130.4, 129.1, 128.3, 127.4, 
127.3, 126.0, 125.3, 124.5, 117.8, 112.5 ppm; GC-MS m/z = 248 (M+); Anal. Calcd for 
C17H12O2: C, 82.24; H, 4.87. Found: C, 82.01; H, 4.89. 
Data for 81t: 1H NMR (400 MHz, CDCl3) δ 13.84 (s, 1H), 8.54-
8.51 (m, 1H), 7.79-7.74 (m, 3H), 7.69-7.64 (m, 1H), 7.59-7.55 
(m, 1H), 7.52 (d, J = 8.9 Hz, 1H), 7.26-7.19 (m, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 199.8, 164.8 (d, JCF = 253.4 Hz), 163.9, 137.3, 134.3 
(d, JCF = 3.3 Hz), 131.7 (d, JCF = 9.0 Hz), 130.4, 127.4, 127.0, 126.1, 125.2, 124.5, 118.0, 
115.5 (d, JCF = 22.0 Hz), 112.4 ppm; GC-MS m/z = 266 (M
+); Anal. Calcd for C17H11FO2: 
C, 76.68; H, 4.16. Found: C, 76.46; H, 4.36. 
Data for 81u: 1H NMR (400 MHz, CDCl3) δ 14.09 (s, 1H), 8.46 (dd, 
J = 8.3, 1.3 Hz, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.67 (d, J = 8.9 Hz, 1H), 
7.62 (ddd, J = 8.1, 6.9, 1.3 Hz, 1H), 7.52 (ddd, J = 8.3, 6.9, 1.2 Hz, 
1H), 7.26 (d, J = 8.9 Hz, 1H) 3.10 (q. J = 7.3 Hz, 2H), 1.29 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 206.9, 162.3, 137.2, 129.9, 127.3, 125.8, 125.3, 124.4, 124.2, 
118.2, 112.7, 31.9, 8.2 ppm; GC-MS m/z = 200 (M+); Anal. Calcd for C13H12O2: C, 77.98; 
H, 6.04. Found: C, 78.16; H, 6.05. 
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Data for 81v: 1H NMR (400 MHz, CDCl3) δ 14.40 (s, 1H), 8.47 
(dd, J = 8.4, 1.3 Hz, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.69 (d, J = 8.9 
Hz, 1H), 7.62 (ddd, J = 8.1, 6.9, 1.3 Hz, 1H), 7.52 (ddd, J = 8.4, 
6.9, 1.3 Hz, 1H), 7.26 (d, J = 8.9 Hz, 1H), 3.35 (tt, J = 11.4, 3.1 Hz, 1H), 1.99-1.86 (m, 
4H), 1.82-1.75 (m, 1H), 1.65-1.54 (m, 2H), 1.50-1.38 (m, 2H), 1.36-1.25 (m, 1H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 209.8, 163.3, 137.2, 129.9, 127.3, 125.8, 125.6, 124.4, 
124.2, 118.0, 111.8, 45.3, 29.4, 25.9, 25.8 ppm; GC-MS m/z = 254 (M+); Anal. Calcd for 
C17H18O2: C, 80.28; H, 7.13. Found: C, 80.22; H, 7.15. 
Data for 81w: 1H NMR (400 MHz, CDCl3) δ 14.32 (s, 1H), 8.48 
(dd, J = 8.4, 1.3 Hz, 1H), 7.76 (d, J = 8.1 Hz, 1H), 7.71 (d, J = 8.9 
Hz, 1H), 7.63 (ddd, J = 8.1, 6.9, 1.3 Hz, 1H), 7.53 (ddd, J = 8.4, 
6.9, 1.3 Hz, 1H), 7.27 (d, J = 8.9 Hz, 1H), 5.82-5.78 (m, 2H), 3.68-3.59 (m, 1H), 2.50-2.40 
(m, 1H), 2.32-2.17 (m, 3H), 2.09-2.02 (m, 1H), 1.89-1.78 (m, 1H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 209.3, 163.4, 137.2, 130.0, 127.3, 126.6, 125.9, 125.6, 125.5, 124.4, 
124.1, 118.2, 111.9, 41.2, 27.9, 25.8, 24.9 ppm; GC-MS m/z = 252 (M+); Anal. Calcd for 
C17H16O2: C, 80.93; H, 6.39. Found: C, 80.95; H, 6.47. 
Data for 81x: 1H NMR (400 MHz, CDCl3) δ 14.20 (s, 1H), 8.46-
8.43 (m, 1H), 7.71-7.67 (m, 2H), 7.61-7.57 (m, 1H), 7.52-7.47 
(m, 1H), 7.36-7.29 (m, 4H), 7.25-7.20 (m, 1H), 7.16 (d, J = 9.0 
Hz, 1H), 4.80 (q, J = 6.9 Hz, 1H), 1.60 (t, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 206.2, 163.4, 141.3, 137.1, 130.1, 129.0, 127.6, 127.3, 127.1, 125.9, 125.4, 124.5, 
124.4, 118.2, 112.3, 47.5, 19.2 ppm; GC-MS m/z = 276 (M+); Anal. Calcd for C19H16O2: 
C, 82.58; H, 5.84. Found: C, 82.27; H, 5.81. 
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Data for 81y: 1H NMR (400 MHz, CDCl3) δ 11.24 (s, 1H), 7.94 (d, J = 
9.0 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.65-7.62 (m, 2H), 7.56 (tt, J = 7.5, 
1.3 Hz, 1H), 7.43-7.39 (m, 2H), 7.33-7.26 (m, 2H), 7.25 (d, J = 9.0 Hz, 
1H), 7.16 (dd, J = 7.0, 1.5 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 200.4, 161.4, 140.3, 136.3, 132.6, 132.3, 129.4, 128.5, 128.5, 128.4, 126.7, 126.3, 
123.7, 119.1, 114.3 ppm; GC-MS m/z = 248 (M+); Anal. Calcd for C17H12O2: C, 82.24; H, 
4.87. Found: C, 81.97; H, 4.67. 
Data for 81z: 1H NMR (400 MHz, CDCl3) δ 11.95 (s, 1H), 7.91-7.88 (m, 
1H), 7.86 (d, J = 9.0 Hz, 1H), 7.80-7.77 (m, 1H), 7.58-7.53 (m, 1H), 
7.42-7.37 (m, 1H), 7.14 (d, J = 9.0 Hz, 1H), 3.49 (tt, J = 11.5, 3.2 Hz, 
1H), 1.99-1.91 (m, 2H), 1.88-1.81 (m, 2H), 1.77-1.62 (m, 3H), 1.40-1.24 
(m, 3H) ppm; 13C{1H} NMR (75.5 MHz, CDCl3) δ 212.0, 161.1, 136.1, 131.6, 129.2, 128.6, 
127.8, 124.2, 123.8, 119.4, 115.5, 50.2, 29.9, 25.7, 25.6 ppm; GC-MS m/z = 254 (M+); 
Anal. Calcd for C17H18O2: C, 80.28; H, 7.13. Found: C, 79.97; H, 6.99. 
Data for 83a: 1H NMR (400 MHz, CDCl3) δ 6.86 (d, J = 8.2 Hz, 
1H), 6.40 (dd, J = 8.2, 2.5 Hz, 1H), 6.37 (d, J = 2.5 Hz, 1H), 
6.34 (dd, J = 9.9, 1.6 Hz, 1H), 5.54 (dd, J = 9.9, 3.3 Hz, 1H), 4.85-4.80 (m, 1H), 3.77 (s, 
3H), 1.83-1.74 (m, 1H), 1.67-1.42 (m, 3H), 0.95 (t, J = 7.3, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 160.5, 154.8, 127.0, 123.5, 123.0, 115.3, 106.6, 101.8, 75.1, 55.3, 37.5, 
18.1, 14.0 ppm; GC-MS m/z = 204 (M+); Anal. Calcd for C13H16O2: C, 76.44; H, 7.90. 
Found: C, 76.52; H, 7.89. 
Data for 83b: 1H NMR (400 MHz, CDCl3) δ 7.48-7.45 (m, 2H), 
7.41-7.31 (m, 3H), 6.94 (d, J = 8.2, 1H), 6.50 (dd, J = 9.8, 1.8 Hz, 
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1H), 6.44 (dd, J = 8.2, 2.5 Hz, 1H), 6.40 (d, J = 2.5 Hz, 1H), 5.90 (dd, J = 3.4, 1.8 Hz, 1H), 
5.67 (dd, J = 9.8, 3.4 Hz, 1H), 3.76 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.8, 
154.3, 140.9, 128.6, 128.3, 127.2, 127.0, 123.6, 121.8, 114.6, 107.0, 101.8, 77.3, 55.3 ppm; 
GC-MS m/z = 238 (M+). 1H and 13C NMR spectral data are in good agreement with the 
literature data.101 
Data for 83c: 1H NMR (400 MHz, CDCl3) δ 7.41-7.31 (m, 5H), 
6.89 (d, J = 8.3, 1H), 6.42 (dd, J = 8.3, 2.5 Hz, 1H), 6.33 (d, J = 
2.5 Hz, 1H), 6.31 (s, 1H), 5.64 (s, 1H), 3.73 (s, 3H), 1.69 (s, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 160.1, 152.6, 139.3, 129.4, 128.6, 128.5, 127.5, 126.1, 119.4, 115.2, 106.6, 
101.6, 81.2, 55.2, 19.8 ppm; GC-MS m/z = 252 (M+); HRMS (APCI) Calcd for C17H17O2 
([M+H]+): 253.1223. Found: 253.1229. 
Data for 83d: 1H NMR (400 MHz, CDCl3) δ 7.40-7.36 (m, 
2H), 7.34-7.29 (m, 3H), 6.90 (d, J = 8.3 Hz, 1H), 6.41 (dd, J 
= 8.3, 2.5 Hz, 1H), 6.32 (s, 1H), 6.30 (d, J = 2.5 Hz, 1H), 5.66 (s, 1H), 3.72 (s, 3H), 1.97-
1.91 (m, 2H), 1.54-1.40 (m, 2H), 1.33-1.19 (m, 6H), 0.87 (t, J = 6.9 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 160.1, 152.7, 139.4, 133.7, 128.6, 128.5, 127.7, 126.3, 118.3, 
115.5, 106.7, 101.7, 80.2, 55.2, 33.0, 31.6, 28.9, 27.0, 22.5, 14.1 ppm; GC-MS m/z = 322 
(M+); HRMS (ESI) Calcd for C22H26O2 (M
+): 322.1927. Found: 322.1903. 
Data for 83e: 1H NMR (400 MHz, CDCl3) δ 7.46-7.43 (m, 4H), 
7.35-7.24 (m, 6H), 6.92 (d, J = 8.3 Hz, 1H), 6.58 (d, J = 9.8 Hz, 
1H), 6.53 (d, J = 2.5 Hz, 1H), 6.41 (dd, J = 8.3, 2.5 Hz, 1H), 6.03 (d, J = 9.8 Hz, 1H), 3.77 
(s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.9, 153.7, 145.0, 128.1, 127.4, 127.2, 
127 
 
127.0, 125.9, 123.0, 114.4, 107.1, 102.1, 82.8, 55.3 ppm; GC-MS m/z = 314 (M+); HRMS 
(ESI) Calcd for C22H18O2 (M
+): 314.1301. Found: 314.1289. 
Data for 83f: 1H NMR (400 MHz, CDCl3) δ 6.74 (d, J = 8.2 Hz, 
1H), 6.33 (dd, J = 8.2, 2.5 Hz, 1H), 6.29 (d, J = 2.5 Hz, 1H), 5.97-
5.95 (m, 1H), 4.94-4.88 (m, 1H), 3.74 (s, 3H), 2.43-2.36 (m, 1H), 2.23-2.16 (m, 1H), 2.08-
1.98 (m, 1H), 1.92-1.85 (m, 1H), 1.80-1.68 (m, 2H), 1.51-1.39 (m, 1H), 1.38-1.27 (m, 1H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.8, 154.0, 134.7, 126.0, 115.8, 114.8, 106.0, 
100.9, 77.4, 55.3, 35.1, 32.9, 26.7, 24.4 ppm; GC-MS m/z = 216 (M+); HRMS (APCI) 
Calcd for C14H17O2 ([M+H]
+): 217.1223. Found: 217.1229. 
Data for 83g: 1H NMR (400 MHz, CDCl3) δ 6.64 (dd, J = 9.9, 
1.6 Hz, 1H), 6.04 (d, J = 2.3 Hz, 1H), 6.01 (d, J = 2.3 Hz, 1H), 
5.49 (dd, J = 9.9, 3.4 Hz, 1H), 4.80-4.75 (m, 1H), 3.78 (s, 3H), 
3.76 (s, 3H), 1.84-1.74 (m, 1H), 1.68-1.42 (m, 3H), 0.95 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 160.9, 156.1, 155.3, 120.9, 118.4, 104.9, 93.7, 91.5, 74.9, 55.5, 
55.3, 37.2, 18.1, 13.9 ppm; GC-MS m/z = 234 (M+); HRMS (ESI) Calcd for C14H18O3 (M
+): 
234.1250. Found: 234.1239; Anal. Calcd for C14H18O3: C, 71.77; H, 7.74. Found: C, 71.78; 
H, 7.89. 
Data for 83h: 1H NMR (400 MHz, CDCl3) δ 6.39-6.37 (m, 1H), 
6.06 (d, J = 2.3 Hz, 1H), 6.01 (d, J = 2.3 Hz, 1H), 4.51 (dd, J = 
8.7, 3.5 Hz, 1H), 3.78 (s, 3H), 3.76 (s, 3H), 1.82-1.81 (m, 3H), 
1.78-1.56 (m, 2H), 1.01 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.1, 
155.3, 153.1, 129.5, 113.2, 105.3, 93.8, 91.4, 80.1, 55.5, 55.3, 25.4, 19.7, 9.7 ppm; GC-
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MS m/z = 234 (M+); HRMS (APCI) Calcd for C14H19O3 ([M+H]
+): 235.1329. Found: 
235.1339. 
Data for 83i: 1H NMR (400 MHz, CDCl3) δ 7.51-7.47 (m, 2H), 
7.42-7.32 (m, 3H), 6.84 (dd, J = 9.9, 1.9 Hz, 1H), 6.09 (d, J = 2.1 
Hz, 1H), 6.06 (d, J = 2.1 Hz, 1H), 5.86 (dd, J = 3.5, 1.9 Hz, 1H), 
5.64 (dd, J = 9.9, 3.5 Hz, 1H), 3.82 (s, 3H), 3.76 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 161.2, 156.2, 154.8, 140.8, 128.5, 128.2, 127.1, 119.7, 118.7, 104.3, 93.7, 91.7, 
77.1, 55.5, 55.3 ppm; GC-MS m/z = 268 (M+). 1H and 13C NMR spectral data are in good 
agreement with the literature data.102 
Data for 83j: 1H NMR (400 MHz, CDCl3) δ 7.47-7.42 (m, 
2H), 7.08-7.02 (m, 2H), 6.84 (dd, J = 9.9, 1.8 Hz, 1H), 6.04 
(s, 2H), 5.82 (dd, J = 3.5, 1.8 Hz, 1H), 5.59 (dd, J = 9.9, 3.5 
Hz, 1H), 3.81 (s, 3H), 3.75 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 162.6 (d, JCF 
= 246.8 Hz), 161.3, 156.2, 154.6, 136.6 (d, JCF = 3.2 Hz), 129.0 (d, JCF = 8.3 Hz), 119.3, 
119.0, 115.4 (d, JCF = 21.5 Hz), 104.3, 93.7, 91.8, 76.3, 55.5, 55.3 ppm; GC-MS m/z = 286 
(M+); Anal. Calcd for C17H15FO3: C, 71.32; H, 5.28. Found: C, 71.18; H, 5.05. 
Data for 83k: 1H NMR (400 MHz, CDCl3) δ 7.42-7.39 (m, 2H), 
7.36-7.30 (m, 3H), 6.64-6.62 (m, 1H), 6.03 (d, J = 2.3 Hz, 1H), 
5.99 (d, J = 2.3 Hz, 1H), 5.62 (br s, 1H), 3.82 (s, 3H), 3.71 (s, 3H), 
1.72-1.71 (m, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.3, 155.3, 153.1, 139.3, 
128.6, 128.5, 127.6, 127.4, 114.1, 104.6, 93.6, 91.6, 81.0, 55.5, 55.2, 19.9 ppm; GC-MS 
m/z = 282 (M+); HRMS (APCI) Calcd for C18H19O3 ([M+H]
+): 283.1329. Found: 283.1334. 
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Data for 83l: 1H NMR (400 MHz, CDCl3) δ 7.41-7.37 (m, 
2H), 7.34-7.28 (m, 3H), 6.63-6.61 (m, 1H), 6.02 (d, J = 2.3 
Hz, 1H), 5.96 (d, J = 2.3 Hz, 1H), 5.63 (br s, 1H), 3.82 (s, 
3H), 3.70 (s, 3H), 2.04-1.89 (m, 2H), 1.54-1.39 (m, 2H), 1.33-1.18 (m, 6H), 0.86 (t, J = 
7.0, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.3, 155.5, 153.1, 139.4, 131.8, 128.5, 
128.4, 127.8, 113.0, 104.9, 93.7, 91.6, 80.0, 55.5, 55.3, 33.3, 31.6, 29.0, 27.2, 22.5, 14.1 
ppm; GC-MS m/z = 352 (M+); HRMS (ESI) Calcd for C23H28O3 (M
+): 352.2033. Found: 
352.2014. 
Data for 83m: 1H NMR (400 MHz, CDCl3) δ 7.46-7.43 (m, 4H), 
7.35-7.23 (m, 6H), 6.89 (dd, J = 9.9, 0.6 Hz, 1H), 6.19 (dd, J = 2.2, 
0.6 Hz, 1H), 6.00 (d, J = 2.2 Hz, 1H), 5.96 (d, J = 9.9 Hz, 1H), 3.77 
(s, 3H), 3.76 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.3, 156.2, 154.1, 145.0, 
128.0, 127.3, 126.9, 123.9, 118.0, 104.2, 94.0, 91.7, 82.6, 55.4, 55.3 ppm; GC-MS m/z = 
344 (M+); HRMS (APCI) Calcd for C23H21O3 ([M+H]
+): 345.1485. Found: 345.1491. 
Data for 83n: 1H NMR (400 MHz, CDCl3) δ 8.22-8.15 (m, 1H), 
7.77-7.73 (m, 1H), 7.48-7.41 (m, 2H), 7.36 (d, J = 8.3 Hz, 1H), 
7.15 (d, J = 8.3 Hz, 1H), 6.52 (dd, J = 9.7, 1.6 Hz, 1H), 5.73 (dd, J 
= 9.7, 3.5 Hz, 1H), 5.10-5.05 (m, 1H), 2.00-1.90 (m, 1H), 1.74-1.53 (m, 3H), 1.00 (t, J = 
7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.7, 134.4, 127.6, 126.1, 125.3, 
124.7, 124.6, 124.6, 124.3, 121.8, 120.0, 116.3, 75.4, 37.3, 18.1, 13.9 ppm; GC-MS m/z = 
224 (M+); HRMS (ESI) Calcd for C16H16O (M
+): 224.1196. Found: 224.1202. Anal. Calcd 
for C16H16O: C, 85.68; H, 7.19. Found: C, 85.86; H, 7.49. 
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Data for 83o: 1H NMR (400 MHz, CDCl3) δ 8.22-8.19 (m, 1H), 7.77-
7.73 (m, 1H), 7.56-7.53 (m, 2H), 7.45-7.33 (m, 6H), 7.19 (d, J = 8.3 
Hz, 1H), 6.67 (dd, J = 9.7, 1.7 Hz, 1H), 6.15 (dd, J = 3.6, 1.7 Hz, 1H), 
5.90 (dd, J = 9.7, 3.6 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.4, 141.0, 
134.5, 128.6, 128.2, 127.5, 126.7, 126.3, 125.4, 124.6, 124.5, 124.5, 123.2, 121.9, 120.3, 
115.6, 77.1 ppm; GC-MS m/z = 258 (M+); HRMS (ESI) Calcd for C19H14O (M
+): 258.1039. 
Found: 258.1038. 
Data for 83p: 1H NMR (400 MHz, CDCl3) δ 8.13-8.09 (m, 1H), 7.74-
7.70 (m, 1H), 7.50-7.46 (m, 2H), 7.40-7.30 (m, 6H), 7.18 (d, J = 8.3 
Hz, 1H), 6.50 (s, 1H), 5.92 (s, 1H), 1.83 (s, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 146.5, 139.4, 134.0, 131.2, 128.6, 128.5, 127.4, 127.4, 125.7, 125.2, 
124.4, 124.2, 121.7, 120.3, 120.2, 116.2, 81.2, 20.0 ppm; GC-MS m/z = 272 (M+); HRMS 
(APCI) calcd for C20H17O ([M+H]
+): 273.1274. Found: 273.1279. 
Data for 83q: 1H NMR (400 MHz, CDCl3) δ 8.19-8.15 (m, 1H), 
7.78-7.74 (m, 1H), 7.55-7.52 (m, 2H), 7.44-7.32 (m, 6H), 7.25 
(d, J = 8.3 Hz, 1H), 6.57 (s, 1H), 6.00 (s, 1H), 2.19-2.09 (m, 2H), 
1.71-1.55 (m, 2H), 1.46-1.32 (m, 6H), 0.98 (t, J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 146.5, 139.4, 135.4, 134.0, 128.5, 128.5, 127.6, 127.4, 125.7, 125.2, 124.5, 
124.3, 121.7, 120.2, 119.2, 116.4, 80.1, 33.3, 31.7, 29.0, 27.0, 22.6, 14.1 ppm; GC-MS m/z 
= 342 (M+); HRMS (ESI) Calcd for C25H26O (M
+): 342.1978. Found: 342.1979. 
Data for 83r: 1H NMR (400 MHz, CDCl3) δ 8.70-8.66 (m, 2H), 
8.47-8.43 (m, 1H), 8.09-8.05 (m, 1H), 7.72-7.63 (m, 2H), 7.61-7.56 
(m, 1H), 7.42-7.40 (m, 1H), 7.18 (dd, J = 9.9, 1.6 Hz, 1H), 5.90 
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(dd, J = 9.9, 3.7 Hz, 1H), 5.12-5.07 (m, 1H), 2.11-2.02 (m, 1H), 1.82-1.60 (m, 3H), 1.07 
(t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 147.3, 131.0, 129.2, 127.0, 
126.9, 126.5, 126.3, 125.5, 124.1, 123.9, 122.9, 122.5, 122.4, 121.8, 120.4, 111.5, 75.0, 
36.6, 18.2, 13.9 ppm; HRMS (ESI) Calcd for C20H18O (M
+): 274.1352. Found: 274.1366; 
Anal. Calcd for C20H18O: C, 87.56; H, 6.61. Found: C, 87.56; H, 6.69. 
Data for 83s: 1H NMR (400 MHz, CDCl3) δ 8.69-8.62 (m, 2H), 8.37-
8.34 (m, 1H), 8.19-8.16 (m, 1H), 7.70-7.54 (m, 6H), 7.37-7.31 (m, 3H), 
7.18 (s, 1H), 5.97 (s, 1H), 2.00 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 144.8, 138.9, 130.9, 130.6, 129.0, 128.5, 128.4, 127.5, 126.8, 126.6, 126.5, 126.4, 
125.4, 124.0, 123.0, 122.3, 121.7, 116.2, 111.0, 80.5, 20.5 ppm; GC-MS m/z = 322 (M+); 
HRMS (APCI) Calcd for C24H19O ([M+H]
+): 323.1430. Found: 323.1444. 
Data for 83t: 1H NMR (400 MHz, CDCl3) δ 8.64-8.54 (m, 2H), 8.07-
8.03 (m, 1H), 7.69-7.64 (m, 2H), 7.61-7.56 (m, 5H), 7.54-7.49 (m, 1H), 
7.41-7.30 (m, 5H), 7.27-7.23 (m, 2H) 6.35 (d, J = 9.9 Hz, 1H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 146.2, 144.9, 131.3, 129.0, 128.1, 127.5, 127.2, 127.0, 
126.9, 126.8, 126.7, 126.5, 125.5, 124.3, 123.0, 122.7, 122.5, 121.9, 120.1, 110.9, 82.8 
ppm; GC-MS m/z = 384 (M+); Anal. Calcd for C29H20O: C, 90.60; H, 5.24. Found: C, 90.44; 
H, 5.34. 
Data for 84a: 1H NMR (400 MHz, CDCl3) δ 11.74 (s, 
1H), 7.63 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 8.7 Hz, 2H), 
7.48 (d, J = 8.5 Hz, 2H), 7.45 (s, 1H), 7.41 (s, 1H), 
7.39 (d, J = 8.5 Hz, 2H), 6.83 (s, 1H), 3.01-2.91 (m, 
3H), 2.52 (ddd, J = 15.5, 12.6, 2.9 Hz, 1H), 2.30-2.01 
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(m, 3H), 1.78-1.23 (m, 6H), 0.99 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 208.9, 
199.7, 161.0, 147.0, 138.3, 136.4, 136.1, 135.2, 133.9, 132.0, 131.4, 130.8, 130.5, 129.9, 
129.0, 128.7, 117.9, 117.0, 48.4, 47.6, 43.6, 37.6, 31.4, 29.8, 29.0, 26.3, 25.7, 14.5 ppm; 
HRMS (ESI) Calcd for C32H29Cl2O3 ([M+H]
+): 531.1488. Found: 531.1485. 
Data for 84b: 1H NMR (400 MHz, CDCl3) δ 12.38 (s, 
1H), 7.65 (s, 1H), 6.70 (s, 1H), 6.49 (ddd, J = 9.6, 2.6, 
1.8 Hz, 1H), 3.30-3.22 (m, 1H), 2.96-2.84 (m, 2H), 
2.67 (ddd, J = 15.2, 6.4, 1.7 Hz, 1H), 2.43-2.37 (m, 1H), 
2.30-1.99 (m, 5H), 1.91-1.81 (m, 4H), 1.80-1.14 (m, 21H), 0.92 (s, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 209.6, 209.2, 160.8, 146.4, 142.5, 134.6, 130.7, 126.2, 117.9, 
116.2, 48.1, 47.9, 45.0, 43.6, 38.9, 37.6, 31.7, 31.4, 29.7, 29.6, 26.3, 26.0, 25.9, 25.8, 25.7, 
25.5, 25.5, 14.4 ppm; HRMS (ESI) Calcd for C32H43O3 ([M+H]
+): 475.3207. Found: 
474.3209. 
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5.3.5 X-ray Crystal Data and Structure Refinements 
Table 5.1 X-ray crystal data for 81v 
Empirical formula  C17H18O2  
Formula weight  254.31  
Temperature/K  100.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  7.08927(18)  
b/Å  10.1152(2)  
c/Å  18.6070(5)  
α/°  90.00  
β/°  96.927(2)  
γ/°  90.00  
Volume/Å3  1324.56(6)  
Z  4  
ρcalcmg/mm3  1.275  
m/mm-1  0.082  
F(000)  544.0  
Crystal size/mm3  0.28 × 0.14 × 0.11  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection  5.78 to 58.8°  
Index ranges  -9 ≤ h ≤ 9, -13 ≤ k ≤ 13, -25 ≤ l ≤ 24  
Reflections collected  15224  
Independent reflections  3372 [Rint = 0.0343, Rsigma = 0.0279]  
Data/restraints/parameters  3372/0/176  
Goodness-of-fit on F2  1.076  
Final R indexes [I>=2σ (I)]  R1 = 0.0467, wR2 = 0.1265  
Final R indexes [all data]  R1 = 0.0592, wR2 = 0.1374  
Largest diff. peak/hole / e Å-3  0.38/-0.23  
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Table 5.2 X-ray crystal data for 83t 
Empirical formula  C29H20O  
Formula weight  384.45  
Temperature/K  100.00(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  11.6412(4)  
b/Å  11.9623(5)  
c/Å  14.3355(6)  
α/°  94.336(3)  
β/°  103.650(3)  
γ/°  90.068(3)  
Volume/Å3  1933.99(12)  
Z  4  
ρcalcmg/mm3  1.320  
m/mm-1  0.605  
F(000)  808.0  
Crystal size/mm3  0.42 × 0.35 × 0.18  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  6.36 to 147.4°  
Index ranges  -14 ≤ h ≤ 10, -14 ≤ k ≤ 14, -17 ≤ l ≤ 17  
Reflections collected  18380  
Independent reflections  7504 [Rint = 0.0657, Rsigma = 0.0456]  
Data/restraints/parameters  7504/0/541  
Goodness-of-fit on F2  1.044  
Final R indexes [I>=2σ (I)]  R1 = 0.0743, wR2 = 0.2135  
Final R indexes [all data]  R1 = 0.0827, wR2 = 0.2229  
Largest diff. peak/hole / e Å-3  0.45/-0.35  
 
135 
 
Table 5.3 X-ray crystal data for 84b 
Empirical formula  C32H42O3  
Formula weight  474.66  
Temperature/K  99.8(5)  
Crystal system  triclinic  
Space group  P1  
a/Å  6.6192(2)  
b/Å  6.9546(2)  
c/Å  14.6658(7)  
α/°  99.503(3)  
β/°  96.444(3)  
γ/°  95.740(3)  
Volume/Å3  656.79(4)  
Z  1  
ρcalcg/cm3  1.200  
μ/mm-1  0.581  
F(000)  258.0  
Crystal size/mm3  0.18 × 0.14 × 0.02  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  13 to 146.86  
Index ranges  -8 ≤ h ≤ 8, -8 ≤ k ≤ 8, -17 ≤ l ≤ 18  
Reflections collected  11892  
Independent reflections  4532 [Rint = 0.0521, Rsigma = 0.0369]  
Data/restraints/parameters  4532/3/321  
Goodness-of-fit on F2  1.127  
Final R indexes [I>=2σ (I)]  R1 = 0.0644, wR2 = 0.1789  
Final R indexes [all data]  R1 = 0.0667, wR2 = 0.1804  
Largest diff. peak/hole / e Å-3  0.29/-0.30  
Flack parameter -0.1(4) 
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5.4 Experimental Procedures and Data for the Chapter 3 
5.4.1 General Procedures for the Catalytic C-H Coupling reaction of Phenols with 
Ketones 
 In a glove box, a phenol (0.5 mmol), a ketone (1.0-1.5 mmol), and complex 26 (9 
mg, 3 mol %) were dissolved in 1,2-dichloroethane (2 mL) in a 25 mL Schlenk tube 
equipped with a Teflon stopcock and a magnetic stirring bar. The tube was brought out of 
the glove box, and was stirred in an oil bath set at 125-140 °C for 16-72 h. The reaction 
tube was taken out of the oil bath, and was cooled to room temperature. After the tube was 
open to air, the solution was filtered through a short silica gel column by eluting with 
CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. Analytically pure product was 
isolated by a simple column chromatography on silica gel (280-400 mesh, hexanes/EtOAc). 
The product was completely characterized by NMR and GC-MS spectroscopic methods. 
5.4.2 General Procedures for the Mechanistic Studies 
Deuterium Labeling Study. In a glove box, 3,5-dimethoxyphenol (0.77 g, 5.0 
mmol), cyclohexanone-2,2,6,6-d4 (93 % D, 1.5 mmol), and complex 26 (3 mol %) were 
dissolved in 1,2-dichloroethane (2 mL) in a 25 mL Schlenk tubes equipped with a Teflon 
screw cap stopcock. The tube were brought out of the box, and immersed in an oil bath 
preset at 125 °C for 16 h. The reaction tube was taken out of the oil bath, and was cooled 
to room temperature. After the tube was open to air, the solution was filtered through a 
short silica gel column by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by 
GC-MS. Analytically pure was isolated by a simple column chromatography on silica gel 
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(280-400 mesh, hexanes/EtOAc = 100:1 to 10:1), then were completely characterized by 
1H, 2H NMR and GC-MS spectroscopic methods. 
 Deuterium Isotope Effect Study. In a glove box, 3,5-methoxyphenol (0.5 mmol), 
cyclohexanone-2,2,6,6-d4 (1.5 mmol), and complex 26 were dissolved in 1,2-
dichlorobenzene (2 mL) in 25 mL Schlenk tubes equipped with a Teflon screw cap 
stopcock. The tubes were brought out of the box, and immersed in an oil bath preset at 
125 °C. The reaction rate was measured by monitoring the appearance of the product 
signals on 1H NMR, which were normalized against the internal standard 
methylsulfonylmethane in 20-60 min intervals for 300 min of the reaction time. The 
experiment was repeated by using cyclohexanone. The kobs was determined from a first-
order plot of -ln[(3,5-methoxyphenol)t/(3,5-methoxyphenol)0] vs time. 
5.4.3 X-Ray Crystallographic Determination of 98k and 101 
For 98k: Colorless prisms of 98k were grown in CH2Cl2 at room temperature. A 
suitable crystal with the dimension of 0.51  0.5  0.45 mm3 was selected and mounted on 
an Oxford SuperNova diffractometer equipped with dual microfocus Cu/Mo X-ray sources, 
X-ray mirror optics, and Atlas CCD area detector. A total of 16395 reflection data were 
collected by using MoKα (λ = 0.71073) radiation while the crystal sample was cooled at 
100.00 K during the data collection. Using Olex2, the molecular structure was solved with 
the ShelXS structure solution program by using Direct Methods, and the data was refined 
with the XL refinement package using Least Squares minimization. The molecular 
structure of 98k is shown in Figure 3.1. 
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For 101: Colorless flat needles of 101 were grown in CH2Cl2 at room temperature. 
A suitable crystal with the dimension of 0.58  0.24  0.10 mm3 was selected and mounted 
on an Oxford SuperNova diffractometer equipped with dual microfocus Cu/Mo X-ray 
sources, X-ray mirror optics, and Atlas CCD area detector. A total of 11890 reflection data 
were collected by using CuKα (λ = 1.54184) radiation while the crystal sample was cooled 
at 100.00 K during the data collection. Using Olex2, the molecular structure was solved 
with the ShelXS structure solution program by using Direct Methods, and the data was 
refined with the XL refinement package using Least Squares minimization. The molecular 
structure of 101 is shown in Figure 3.2. 
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5.4.4 Characterization Data of the Products 
Data for 98a: 1H NMR (400 MHz, CDCl3) δ 6.17 (d, J = 2.3 Hz, 1H), 
6.05 (d, J = 2.3 Hz, 1H), 5.79 (s, 1H), 5.79-5.76 (m, 1H), 3.77 (s, 
3H), 3.76 (s, 3H), 2.26-2.18 (m, 4H), 1.78-1.67 (m, 4H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 160.06, 158.13, 153.43, 133.09, 129.31, 111.50, 92.10, 91.18, 
55.59, 55.28, 28.81, 25.50, 22.86, 22.02 ppm; GC-MS m/z = 234 (M+). 
Data for 98c: 1H NMR (400 MHz, CDCl3) δ 6.16 (d, J = 2.3 Hz, 
1H), 6.06 (d, J = 2.3 Hz, 1H), 5.84 (s, 1H), 5.73 (t, J = 8.1 Hz, 1H), 
3.78 (s, 3H), 3.75 (s, 3H), 2.48-2.41 (m, 2H), 2.37-2.29 (m, 2H), 
1.70-1.48 (m, 8H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.95, 158.06, 153.86, 
136.28, 132.17, 112.18, 92.10, 91.21, 55.44, 55.27, 30.76, 29.66, 28.86, 26.88, 26.70, 26.52 
ppm; GC-MS m/z = 262 (M+); HRMS Calcd for C16H22O3 ([M+H]
+): 263.1642, Found: 
263.1631. 
Data for 98d: 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 7.4 Hz, 
1H), 7.46 (d, J = 7.4 Hz, 1H), 7.34 (t, J = 7.4 Hz, 1H), 7.26 (t, J 
= 7.4 Hz, 1H), 6.98 (s, 1H), 6.28 (d, J = 2.4 Hz, 1H), 6.17 (d, J 
= 2.4 Hz, 1H), 5.90 (s, 1H), 3.88 (s, 2H), 3.84 (s, 3H), 3.80 (s, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 160.79, 158.54, 154.38, 144.24, 144.10, 141.34, 130.93, 126.26, 
124.80, 123.46, 120.89, 105.47, 92.62, 91.38, 55.48, 55.30, 42.20 ppm; GC-MS m/z = 268 
(M+); HRMS Calcd for C17H16O3 ([M-H]
-): 267.1027, Found: 267.1028. 
140 
 
Data for 98f: 1H NMR (400 MHz, CDCl3) δ 6.99 (d, J = 8.4 Hz, 1H), 
6.51 (d, J = 2.5 Hz, 1H), 6.46 (dd, J = 8.4, 2.5 Hz, 1H), 5.85-5.81 (m, 
1H), 5.79 (s, 1H), 3.78 (s, 3H), 2.28-2.17 (m, 4H), 1.82-1.65 (m, 4H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.46, 152.98, 134.64, 128.44, 127.43, 122.37, 
106.17, 100.55, 55.22, 29.96, 25.40, 22.96, 21.86 ppm; GC-MS m/z = 204 (M+). 
Data for 98g: 1H NMR (400 MHz, CDCl3) δ 8.26-8.22 (m, 1H), 7.79-
7.74 (m, 1H), 7.50-7.43 (m, 2H), 7.38 (d, J = 8.5 Hz, 1H), 7.21 (d, J 
= 8.5 Hz, 1H), 6.30 (s, 1H), 6.01-5.98 (m, 1H), 2.37-2.24 (m, 4H), 
1.88-1.72 (m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 147.08, 135.33, 133.45, 
128.39, 127.33, 126.03, 125.53, 125.23, 123.98, 122.90, 122.53, 119.37, 29.82, 25.49, 
23.00, 21.96 ppm; GC-MS m/z = 224 (M+). 
Data for 98h: 1H NMR (400 MHz, CDCl3) δ 8.31-8.26 (m, 1H), 
7.84-7.79 (m, 1H), 7.57-7.44 (m, 6H), 7.39-7.33 (m, 1H), 7.31-
7.25 (m, 2H), 6.26 (s, 1H), 3.90 (s, 2H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 148.64, 144.83, 143.98, 142.86, 133.79, 129.18, 127.51, 126.79, 126.59, 
125.87, 125.69, 125.08, 124.37, 123.65, 122.26, 121.16, 120.23, 116.64, 41.96 ppm; GC-
MS m/z = 258 (M+); HRMS Calcd for C19H14O ([M+H]
+): 259.1117, Found: 259.1111. 
Data for 98i: 1H NMR (400 MHz, CDCl3) δ 7.39-7.33 (m, 2H), 7.33-
7.27 (m, 3H), 6.26 (d, J = 2.3 Hz, 1H), 6.12 (d, J = 2.3 Hz, 1H), 6.08 
(d, J = 1.4 Hz, 1H), 5.62 (s, 1H), 5.38 (d, J = 1.4 Hz, 1H), 3.83 (s, 
3H), 3.59 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.97, 158.46, 154.55, 141.38, 
139.43, 128.30, 128.06, 126.00, 117.55, 109.12, 92.46, 91.59, 55.70, 55.32 ppm; GC-MS 
m/z = 256 (M+); HRMS Calcd for C16H16O3 ([M-H]
-): 255.1027, Found: 255.1029. 
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Data for 98j: 1H NMR (400 MHz, CDCl3) δ 7.29-7.23 (m, 4H), 
6.24 (d, J = 2.3 Hz, 1H), 6.09 (d, J = 2.3 Hz, 1H), 6.03 (d, J = 
1.3 Hz, 1H), 5.58 (s, 1H), 5.37 (d, J = 1.3 Hz, 1H), 3.82 (s, 
3H), 3.58 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.15, 158.39, 154.54, 140.51, 
138.10, 133.82, 128.43, 127.35, 117.79, 108.59, 92.54, 91.61, 55.68, 55.35 ppm; GC-MS 
m/z = 290 (M+); HRMS Calcd for C16H15O3Cl ([M-H]
-): 289.0637, Found: 289.0642. 
Data for 98l: 1H NMR (400 MHz, CDCl3) δ 7.34-7.20 (m, 5H), 6.51 
(t, J = 7.3 Hz, 1H), 6.26 (d, J = 2.3 Hz, 1H), 6.16 (d, J = 2.3 Hz, 1H), 
5.26 (s, 1H), 3.83 (s, 3H), 3.64 (s, 3H), 2.07-1.99 (m, 2H), 1.49 (sextet, 
J = 7.4 Hz, 2H), 0.93 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 160.91, 158.47, 154.09, 140.19, 134.47, 131.75, 128.29, 127.13, 125.75, 
106.95, 92.19, 91.52, 55.58, 55.21, 31.95, 22.35, 13.81 ppm; GC-MS m/z = 298 (M+); 
HRMS Calcd for C19H22O3 ([M+H]
+): 299.1642, Found: 299.1631. 
Data for 98m: 1H NMR (400 MHz, CDCl3) δ 7.43-7.39 (m, 2H), 7.36-
7.27 (m, 4H), 7.24-7.15 (m, 5H), 6.19 (d, J = 2.3 Hz, 1H), 6.17 (d, J 
= 2.3 Hz, 1H), 5.27 (s, 1H), 3.83 (s, 3H), 3.57 (s, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 161.35, 158.86, 153.81, 141.47, 136.41, 132.76, 131.47, 128.46, 
128.33, 128.26, 127.67, 127.65, 126.05, 107.46, 92.77, 92.07, 55.64, 55.17 ppm; GC-MS 
m/z = 332 (M+); HRMS Calcd for C22H20O3 ([M-H]
-): 331.1340, Found: 331.1343. 
Data for 98n: 1H NMR (400 MHz, CDCl3) δ 7.25-7.21 (m, 2H), 
6.98-6.91 (m, 2H), 6.47 (q, J = 6.8 Hz, 1H), 6.23 (d, J = 2.3 Hz, 
1H), 6.14 (d, J = 2.3 Hz, 1H), 5.18 (s, 1H), 3.82 (s, 3H), 3.63 
(s, 3H), 1.69 (d, J = 6.8 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 163.36, 161.16, 
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160.92, 158.47, 154.14, 136.54, 136.50, 132.13, 128.39, 128.38, 127.32, 127.24, 115.22, 
115.00, 106.35, 92.35, 91.72, 55.72, 55.31, 15.49 ppm; GC-MS m/z = 288 (M+); HRMS 
Calcd for C17H17O3F ([M+H]
+): 289.1234, Found: 289.1228. 
Data for 98o: 1H NMR (400 MHz, CDCl3) δ 7.23-7.18 (m, 4H), 
6.52 (q, J = 6.9 Hz, 1H), 6.23 (d, J = 2.3 Hz, 1H), 6.14 (d, J = 
2.3 Hz, 1H), 5.18 (s, 1H), 3.82 (s, 3H), 3.62 (s, 3H), 1.70 (s, J 
= 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.19, 158.46, 154.16, 138.96, 
132.77, 132.13, 129.07, 128.39, 127.00, 106.03, 92.38, 91.70, 55.69, 55.29, 15.53 ppm; 
GC-MS m/z = 304 (M+); HRMS Calcd for C17H17O3Cl ([M+H]
+): 305.0939, Found: 
305.0937. 
Data for 98p: 1H NMR (400 MHz, CDCl3) δ 7.24-7.20 (m, 
2H), 6.82-6.78 (m, 2H), 6.45 (q, J = 6.8 Hz, 1H), 6.24 (d, J 
= 2.3 Hz, 1H), 6.15 (d, J = 2.3 Hz, 1H), 5.25 (s, 1H), 3.82 
(s, 3H), 3.78 (s, 3H), 3.65 (s, 3H), 1.68 (d, J = 6.8 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 160.94, 158.86, 158.47, 154.16, 132.82, 132.25, 126.80, 126.64, 113.67, 106.69, 
92.27, 91.60, 55.72, 55.25, 55.15, 15.38 ppm; GC-MS m/z = 300 (M+); HRMS Calcd for 
C18H20O4 ([M-H]
-): 299.1289, Found: 299.1294. 
Data for 98q: 1H NMR (400 MHz, CDCl3) δ 7.21-7.17 (m, 2H), 
7.10-7.06 (m, 2H), 6.53 (q, J = 6.9 Hz, 1H), 6.25 (d, J = 2.3 Hz, 
1H), 6.16 (d, J = 2.3 Hz, 1H), 5.23 (s, 1H), 3.83 (s, 3H), 3.65 (s, 
3H), 2.33 (s, 3H), 1.71 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.93, 
158.48, 154.16, 137.36, 136.87, 132.70, 129.04, 127.72, 125.54, 106.63, 92.21, 91.59, 
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55.71, 55.25, 21.02, 15.42 ppm; GC-MS m/z = 284 (M+); HRMS Calcd for C18H20O3 
([M+H]+): 285.1485, Found: 285.1478. 
Data for 98r: 1H NMR (400 MHz, CDCl3) δ 7.18-7.10 (m, 3H), 7.10-
7.05 (m, 2H), 6.76-6.74 (m, 1H), 6.17 (d, J = 2.3 Hz, 1H), 6.09 (d, J = 
2.3 Hz, 1H), 5.27 (s, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 2.14 (d, J = 1.4 
Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.78, 158.28, 152.14, 136.23, 131.22, 
130.74, 128.28, 127.80, 127.21, 109.06, 92.67, 91.75, 55.71, 55.28, 25.41 ppm; GC-MS 
m/z = 270 (M+); HRMS Calcd for C17H18O3 ([M-H]
-): 269.1183, Found: 269.1186. 
Data for 98v: 1H NMR (400 MHz, CDCl3) δ 7.29-7.20 (m, 5H), 6.50 
(q, J = 6.9 Hz, 1H), 6.40 (s, 1H), 5.10 (s, 1H), 3.87 (s, 3H), 3.79 (s, 
3H), 3.49 (s, 3H), 1.74 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 153.77, 151.46, 148.90, 140.92, 136.03, 133.60, 
128.47, 128.34, 127.29, 125.96, 111.27, 94.59, 60.97, 60.50, 55.80, 15.66 ppm; GC-MS 
m/z = 300 (M+); HRMS Calcd for C18H20O4 ([M-H]
-): 299.1289, Found: 299.1294. 
Data for 98w: 1H NMR (400 MHz, CDCl3) δ 7.30-7.20 (m, 5H), 6.60 
(q, J = 6.9 Hz, 1H), 6.45-6.44 (m, 1H), 6.42-6.41 (m, 1H), 5.14 (s, 
1H), 3.81 (s, 3H), 1.97-1.95 (m, 3H), 1.67 (d, J = 6.9 Hz, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 159.91, 153.56, 139.81, 138.62, 135.34, 128.55, 
128.43, 127.37, 125.77, 117.12, 108.28, 97.61, 55.16, 19.88, 15.32 ppm; GC-MS m/z = 
254 (M+); HRMS Calcd for C17H18O2 ([M-H]
-): 253.1234, Found: 253.1237. 
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Data for 98x: 1H NMR (400 MHz, CDCl3) δ 7.30-7.19 (m, 5H), 6.56 (q, 
J = 6.9 Hz, 1H), 6.52-6.50 (m, 1H), 6.38-6.36 (m, 1H), 5.08 (s, 1H), 3.65 
(s, 3H), 2.38-2.37 (m, 3H), 1.70 (d, J = 6.9 Hz, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 157.56, 153.30, 140.14, 139.60, 133.15, 128.51, 128.34, 127.16, 
125.71, 111.05, 108.44, 104.25, 55.77, 21.88, 15.52 ppm; GC-MS m/z = 254 (M+). 
Data for 98ae: 1H NMR (400 MHz, CDCl3) δ 6.15 (d, J 
= 2.3 Hz, 1H), 6.04 (d, J = 2.3 Hz, 1H), 5.96 (br s, 1H), 
5.61 (s, 1H), 5.47-5.42 (m, 1H), 3.76 (s, 3H), 3.73 (s, 
3H), 2.68-2.42 (m, 5H), 2.38-1.89 (m, 8H), 1.76-1.64 
(m, 1H), 1.31-1.22 (m, 1H), 1.25 (s, 3H), 0.88 (s, 3H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 217.55, 208.76, 160.37, 158.49, 153.46, 141.57, 
132.20, 129.45, 122.41, 110.49, 92.29, 91.34, 59.34, 55.66, 55.33, 50.50, 50.48, 50.22, 
36.16, 34.96, 33.05, 32.63, 31.50, 26.47, 21.70, 18.76, 14.74 ppm; GC-MS m/z = 436 (M+); 
HRMS Calcd for C27H32O5 ([M+H]
+): 437.2323, Found: 437.2309. 
Data for 100: 1H NMR (400 MHz, CDCl3) δ 7.33-7.23 (m, 4H), 7.21-
7.17 (m, 1H), 6.24 (d, J = 2.4 Hz, 1H), 6.14 (d, J = 2.4 Hz, 1H), 4.90 
(d, J = 4.8 Hz, 1H), 4.63 (d, J = 4.8 Hz, 1H), 3.81 (s, 3H), 3.61 (s, 
3H), 1.97 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.62, 158.26, 152.70, 147.35, 
146.20, 127.99, 127.62, 125.73, 105.10, 101.79, 93.88, 92.61, 55.33, 55.22, 36.27, 19.12 
ppm; GC-MS m/z = 282 (M+); HRMS Calcd for C18H18O3 ([M+H]
+): 283.1329, Found: 
283.1349. 
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Data for 101: 1H NMR (400 MHz, CDCl3) δ 6.02 (d, J = 2.3 Hz, 
1H), 6.00 (d, J = 2.3 Hz, 1H), 3.74 (s, 3H), 3.72 (s, 3H), 3.71-3.68 
(br s, 1H), 3.43-3.38 (m, 1H), 2.09-2.01 (m, 1H), 1.96 (dd, J = 12.4, 
2.9 Hz, 1H), 1.87-1.80 (m, 1H), 1.77-1.63 (m, 2H), 1.59-1.45 (m, 2H), 1.44-1.29 (m, 1H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 159.43, 156.90, 156.67, 106.08, 98.64, 92.12, 
90.74, 55.24, 55.10, 38.69, 36.36, 29.51, 28.10, 19.13 ppm; GC-MS m/z = 250 (M+); 
HRMS Calcd for C14H18O4 ([M+H]
+): 251.1278, Found: 251.1271. 
Data for 103: 1H NMR (400 MHz, CDCl3) δ 6.00 (d, J = 2.4 Hz, 1H), 
5.96 (d, J = 2.4 Hz, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 2.35-2.21 (m, 2H), 
2.10-2.01 (m, 1H), 1.95-1.85 (m, 1H), 1.81 (s, 3H), 1.67 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 159.91, 156.62, 153.24, 110.33, 106.81, 93.10, 91.51, 
83.21, 55.14, 55.05, 42.74, 38.37, 24.10, 23.10 ppm; GC-MS m/z = 250 (M+); HRMS Calcd 
for C14H18O4 ([M+H]
+): 251.1278, Found: 251.1274. 
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5.4.5 X-ray Crystal Data and Structure Refinements 
Table 5.4 X-ray crystal data for 98k 
Empirical formula  C17H18O3  
Formula weight  270.31  
Temperature/K  100.00(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  9.9036(2)  
b/Å  9.5634(2)  
c/Å  15.2192(4)  
α/°  90.00  
β/°  93.961(2)  
γ/°  90.00  
Volume/Å3  1438.01(6)  
Z  4  
ρcalcg/cm3  1.249  
μ/mm-1  0.085  
F(000)  576.0  
Crystal size/mm3  0.51 × 0.5 × 0.45  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.62 to 59.1  
Index ranges  -13 ≤ h ≤ 13, -12 ≤ k ≤ 13, -20 ≤ l ≤ 20  
Reflections collected  16395  
Independent reflections  3669 [Rint = 0.0346, Rsigma = 0.0323]  
Data/restraints/parameters  3669/0/185  
Goodness-of-fit on F2  1.034  
Final R indexes [I>=2σ (I)]  R1 = 0.0444, wR2 = 0.1001  
Final R indexes [all data]  R1 = 0.0628, wR2 = 0.1117  
Largest diff. peak/hole / e Å-3  0.31/-0.26  
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Table 5.5 X-ray crystal data for 110 
Empirical formula  C14H18O4  
Formula weight  250.28  
Temperature/K  100.00(10)  
Crystal system  monoclinic  
Space group  P21  
a/Å  5.53828(6)  
b/Å  24.4737(4)  
c/Å  8.98955(14)  
α/°  90.00  
β/°  91.2110(12)  
γ/°  90.00  
Volume/Å3  1218.19(3)  
Z  4  
ρcalcg/cm3  1.365  
μ/mm-1  0.816  
F(000)  536.0  
Crystal size/mm3  0.576 × 0.2375 × 0.1009  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.22 to 147.84  
Index ranges  -6 ≤ h ≤ 6, -29 ≤ k ≤ 29, -11 ≤ l ≤ 10  
Reflections collected  11890  
Independent reflections  4642 [Rint = 0.0312, Rsigma = 0.0317]  
Data/restraints/parameters  4642/1/338  
Goodness-of-fit on F2  1.034  
Final R indexes [I>=2σ (I)]  R1 = 0.0372, wR2 = 0.0971  
Final R indexes [all data]  R1 = 0.0399, wR2 = 0.1010  
Largest diff. peak/hole / e Å-3  0.19/-0.25  
Flack parameter 0.0(5) 
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5.5 Experimental Procedures and Data for the Chapter 4 
5.5.1 General Procedures for the Catalytic Synthesis of Indole and Quinoline 
Products 
In a glove box, complex 79 (13 mg, 0.75 mol %) and HBF4·OEt2 (12 mg, 7 mol %) 
were dissolved in 1,4-dioxane (1 mL) in a 25 mL Schlenk tube equipped with a Teflon 
stopcock and a magnetic stirring bar. The resulting mixture was stirred for 5 to 10 min until 
the solution turned to a pale green color. In an alternative procedure, the complex 26 (17 
mg, 3 mol %) and HBF4·OEt2 (12 mg, 7 mol %) were dissolved in 1,4-dioxane (1 mL). An 
arylamine (1.0 mmol), a diol (1.5 mmol), cyclopentene (204 mg, 3 equiv) and 1,4-dioxane 
(2 mL) were added to the reaction tube. After the tube was sealed, it was brought out of the 
glove box, and was stirred in an oil bath set at 110-130 °C (130-150 °C for the quinoline 
products) for 14 h. The reaction tube was taken out of the oil bath, and was cooled to room 
temperature. After the tube was open to air, the solution was filtered through a short silica 
gel column by eluting with CH2Cl2 (10 mL), and the filtrate was analyzed by GC-MS. 
Analytically pure product was isolated by a simple column chromatography on silica gel 
(280-400 mesh, hexanes/EtOAc). 
5.5.2 General Procedures for the Deuterium Labeling Study and Control 
Experiments 
Deuterium Labeling Study. In a glove box, complex 79 (13 mg, 0.75 mol %) and 
HBF4·OEt2 (12 mg, 7 mol %) were dissolved in 1,4-dioxane (1 mL) in a 25 mL Schlenk 
tube equipped with a Teflon stopcock and a magnetic stirring bar. The resulting mixture 
was stirred for 5 to 10 minutes until the solution turned to a pale green color. Then, aniline-
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2,3,4,5,6-d5 (98 mg, 0.5 mmol), 1-phenyl-1,2-ethanediol (104 mg, 0.75 mmol), and 
cyclopentene (102 mg, 3 equiv) in 1,4-dioxane (1 mL) were added to the reaction tube. 
After the tube was sealed, it was brought out of the glove box, and was stirred in an oil 
bath set at 110 °C for 14 h. Analytically pure product was isolated by column 
chromatography on silica gel (280-400 mesh, n-hexane/EtOAc). 
Reaction of Aniline with n-Butanol. In a glove box, complex 79 (7 mg, 0.75 
mol %) and HBF4·OEt2 (6 mg, 7 mol %) were dissolved in 1,4-dioxane (1 mL) in a 25 mL 
Schlenk tube equipped with a Teflon stopcock and a magnetic stirring bar. The resulting 
mixture was stirred for 5 to 10 min until the solution turned to a pale green color. Aniline 
(50 mg, 1.0 mmol), n-butanol (111 mg, 1.5 mmol) and 1,4-dioxane (2 mL) were added to 
the reaction tube. After the tube was sealed, it was brought out of the glove box, and was 
stirred in an oil bath set at 110 °C for 14 h. The reaction tube was taken out of the oil bath, 
and was cooled to room temperature. Analytically pure product was isolated by column 
chromatography on silica gel (280-400 mesh, n-hexane/EtOAc). 
Reaction of Aniline with α–Hydroxyketone. In a glove box, complex 79 (13 mg, 
0.75 mol %) and HBF4·OEt2 (12 mg, 7 mol %) were dissolved in 1,4-dioxane (1 mL) in a 
25 mL Schlenk tube equipped with a Teflon stopcock and a magnetic stirring bar. The 
resulting mixture was stirred for 5 to 10 min until the solution turned to a pale green color. 
Then, 3-methoxyaniline (123 mg, 1.0 mmol), benzoin (318 mg, 1.5 mmol) and 1,4-dioxane 
(2 mL) were added to the reaction tube. After the tube was sealed, it was brought out of 
the glove box, and was stirred in an oil bath set at 130 °C for 14 h. The reaction tube was 
taken out of the oil bath, and was cooled to room temperature. Analytically pure product 
was isolated by column chromatography on silica gel (280-400 mesh, n-hexane/EtOAc). 
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Dehydrogenation of 1-Phenyl-1,2-ethanediol. In a glove box, complex 79 (13 mg, 
0.75 mol %), 1-phenyl-1,2-ethanediol (138 mg, 1.0 mmol) and cyclopentene (204 mg, 3 
equiv) were dissolved in 1,4-dioxane (3 mL) in a 25 mL Schlenk tube equipped with a 
Teflon stopcock and a magnetic stirring bar. The tube was brought out of the glove box, 
and was stirred in an oil bath set at 110 °C for 3 h. The reaction tube was taken out of the 
oil bath, and was cooled to room temperature. The crude mixture was analyzed by 1H NMR. 
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5.5.3 Characterization Data of the Products 
Data for 106a: 1H NMR (400 MHz, CDCl3) δ 8.31 (br s, 1H), 7.69-
7.65 (m, 3H), 7.49-7.44 (m, 2H), 7.43-7.40 (m, 1H), 7.38-7.33 (m, 
1H), 7.26-7.21 (m, 1H), 7.19-7.14 (m, 1H), 6.87-6.85 (m, 1H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 137.8, 136.8, 132.3, 129.2, 129.0, 127.7, 125.1, 122.3, 
120.6, 120.2, 110.9, 99.9 ppm; GC-MS m/z = 193 (M+). 1H and 13C NMR spectral data are 
in good agreement with the literature data.103,104 
Data for 106b: 1H NMR (400 MHz, CDCl3) δ 7.80 (br s, 1H), 7.58-
7.55 (m, 1H), 7.32-7.29 (m, 1H), 7.18-7.09 (m, 2H), 6.29-6.26 (m, 
1H), 2.80-2.73 (m, 2H), 1.77-1.69 (m, 2H), 1.45 (sextet, J = 7.4 Hz, 
2H), 0.99 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 140.0, 135.7, 128.8, 
120.8, 119.7, 119.5, 110.2, 99.4, 31.2, 27.9, 22.4, 13.8 ppm; GC-MS m/z = 173 (M+). 1H 
and 13C NMR spectral data are in good agreement with the literature data.103 
Data for 106c: 1H NMR (400 MHz, CDCl3) δ 7.77 (br s, 1H), 7.57-7.53 (m, 
1H), 7.30-7.27 (m, 1H), 7.17-7.08 (m, 2H), 6.26-6.24 (m, 1H), 2.44 (d, J = 
0.9 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 136.0, 135.0, 129.0, 
120.9, 119.6(2C), 110.2, 100.3, 13.7 ppm; GC-MS m/z = 131 (M+). 1H and 13C NMR 
spectral data are in good agreement with the literature data.105,106 
Data for 106d: 1H NMR (400 MHz, CDCl3) δ 7.65 (br s, 1H), 7.50-7.47 (m, 
1H), 7.27-7.24 (m, 1H), 7.15-7.07 (m, 2H), 2.37 (s, 3H), 2.24 (s, 3H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 135.1, 130.6, 129.4, 120.8, 119.0, 
117.9, 110.0, 107.1, 11.5, 8.4 ppm; GC-MS m/z = 145 (M+). 1H and 13C NMR spectral data 
are in good agreement with the literature data.107 
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Data for 106f: 1H NMR (400 MHz, CDCl3) δ 7.74 (br s, 1H), 
7.41 (d, J = 8.5 Hz, 1H), 6.80 (d, J = 2.3 Hz, 1H), 6.77 (dd, J 
= 8.5, 2.3 Hz, 1H), 6.18-6.16 (m, 1H), 3.85 (s, 3H), 2.72 (t, J 
= 7.5 Hz, 2H), 1.74-1.64 (m, 2H), 1.48-1.37 (m, 2H), 0.97 (t, J = 7.3 Hz, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 155.6, 138.8, 136.4, 123.0, 120.1, 108.9, 99.0, 94.5, 55.7, 31.3, 
27.9, 22.4, 13.9 ppm; GC-MS m/z = 203 (M+). 1H and 13C NMR spectral data are in good 
agreement with the literature data.108 
Data for 106g: 1H NMR (400 MHz, CDCl3) δ 8.24 (br s, 1H), 
7.64-7.60 (m, 2H), 7.51 (d, J = 8.6 Hz, 1H), 7.45-7.40 (m, 2H), 
7.32-7.27 (m, 1H), 6.90 (d, J = 2.3 Hz, 1H), 6.81 (dd, J = 8.6, 
2.3 Hz, 1H), 6.77-6.76 (m, 1H), 3.87 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
156.6, 137.6, 136.8, 132.5, 129.0, 127.2, 124.7, 123.5, 121.3, 110.2, 99.8, 94.4, 55.6 ppm; 
GC-MS m/z = 223 (M+). 1H and 13C NMR spectral data are in good agreement with the 
literature data.109 
Data for 106h: 1H NMR (400 MHz, CDCl3) δ 7.71 (br s, 1H), 7.33 
(d, J = 8.5 Hz, 1H), 6.83 (d, J = 2.3 Hz, 1H), 6.75 (dd, J = 8.5, 2.3 
Hz, 1H), 3.84 (s, 3H), 2.86-2.77 (m, 4H), 2.56-2.48 (m, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 155.3, 142.2, 141.7, 119.5, 119.3, 118.9, 108.5, 95.8, 
55.8, 28.6, 25.9, 24.5 ppm; GC-MS m/z = 187 (M+). 1H and 13C NMR spectral data are in 
good agreement with the literature data.110 
Data for 106i: 1H NMR (400 MHz, CDCl3) δ 7.55 (br s, 1H), 7.33 
(d, J = 8.5 Hz, 1H), 6.80 (d, J = 2.3 Hz, 1H), 6.75 (dd, J = 8.5, 2.3 
Hz, 1H), 3.84 (s, 3H), 2.72-2.64 (m, 4H), 1.93-1.82 (m, 4H) ppm; 
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13C{1H} NMR (100 MHz, CDCl3) δ 155.7, 136.3, 132.8, 122.3, 118.2, 109.9, 108.2, 94.8, 
55.8, 23.3, 23.2, 23.2, 20.9 ppm; GC-MS m/z = 201 (M+). 1H and 13C NMR spectral data 
are in good agreement with the literature data.111 
Data for 106j: 1H NMR (400 MHz, DMSO-d6) δ 10.43 (br s, 1H), 
7.24 (d, J = 8.5 Hz, 1H), 6.79 (d, J = 2.2 Hz, 1H), 6.60 (dd, J = 
8.5, 2.2 Hz, 1H), 3.74 (s, 3H), 2.81-2.72 (m, 4H), 1.71-1.59 (m, 
4H), 1.43-1.31 (m, 4H) ppm; 13C{1H} NMR (100 MHz, DMSO-d6) δ 154.7, 135.6, 134.5, 
122.6, 117.5, 109.5, 107.6, 94.3, 55.2, 29.7, 29.3, 25.6(2C), 25.1, 21.8 ppm; GC-MS m/z 
= 229 (M+); HRMS (IT-TOF/ESI) Calcd for C15H20NO ([M+H]
+): 230.1539, Found: 
230.1530. 
Data for 106k: 1H NMR (400 MHz, CDCl3) δ 8.37 (br s, 1H), 
7.63-7.60 (m, 2H), 7.44-7.39 (m, 2H), 7.31-7.27 (m, 1H), 6.86 
(dd, J = 2.3, 0.6 Hz, 1H), 6.63 (d, J = 0.6 Hz, 1H), 4.14 (s, 3H), 
3.90 (s, 3H), 3.86 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 151.3, 145.7, 136.0, 
135.8, 133.9, 132.3, 129.0, 127.2, 124.6, 116.4, 97.5, 89.4, 61.5, 60.8, 56.2 ppm; GC-MS 
m/z = 283 (M+); Anal. Calcd for C17H17NO3: C, 72.07; H, 6.05; N, 4.94. Found: C, 72.27; 
H, 6.28; N, 4.97. 
Data for 106l: 1H NMR (400 MHz, CDCl3) δ 8.42 (br s, 1H), 
7.53-7.50 (m, 1H), 7.40-7.37 (m, 1H), 7.31-7.27 (m, 1H), 7.20-
7.15 (m, 1H), 6.67 (s, 1H), 4.12 (s, 3H), 3.93 (s, 3H), 3.87 (s, 
3H), 3.80 (s, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 150.7, 147.4, 145.5, 141.6, 
137.4, 136.4, 135.0, 126.5, 125.2, 124.1, 120.2, 116.7, 113.0, 91.2, 61.6, 61.4, 56.3, 31.7 
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ppm; GC-MS m/z = 295 (M+); HRMS (IT-TOF/ESI) Calcd for C18H18NO3 ([M+H]
+): 
296.1281, Found: 296.1274. 
Data for 106m: 1H NMR (400 MHz, CDCl3) δ 8.58 (br s, 1H), 
7.97-7.92 (m, 2H), 7.68 (d, J = 8.6 Hz, 1H), 7.54-7.49 (m, 1H), 
7.52 (d, J = 8.6 Hz, 1H), 7.44-7.39 (m, 1H), 6.42-6.41 (m, 1H), 
2.86 (t, J = 7.6 Hz, 2H), 1.79 (quintet, J = 7.6 Hz, 2H), 1.48 (sextet, J = 7.5 Hz, 2H), 1.01 
(t, J = 7.5 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 138.1, 129.8, 128.9, 125.2, 
124.6, 123.2, 121.4, 120.3, 120.3, 119.0, 101.1, 31.6, 28.0, 22.4, 13.9 ppm (one carbon 
signal obscured or overlapping); GC-MS m/z = 223 (M+). 1H and 13C NMR spectral data 
are in good agreement with the literature data.103 
Data for 106n: 1H NMR (400 MHz, CDCl3) δ 9.01 (br s, 1H), 8.07 
(d, J = 8.2 Hz, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.76-7.71 (m, 3H), 
7.59-7.53 (m, 2H), 7.52-7.43 (m, 3H), 7.37-7.33 (m, 1H), 6.98 (d, 
J = 2.3 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 136.2, 132.5, 131.3, 130.5, 129.1, 
129.0, 127.4, 125.6, 125.3, 124.9, 123.9, 121.5, 121.2, 120.6, 119.3, 101.7 ppm; GC-MS 
m/z = 243 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
data.103,104 
Data for 106o: 1H NMR (400 MHz, CDCl3) δ 8.40 (br s, 1H), 7.92 (d, J 
= 8.3, 2H), 7.63 (d, J = 8.5 Hz, 1H), 7.51 (d, J = 8.5 Hz, 1H), 7.52-7.47 
(m, 1H), 7.41-7.36 (m, 1H), 2.46 (s, 3H), 2.32 (s, 3H) ppm; 13C{1H} 
NMR (100 MHz, CDCl3) δ 129.9, 129.1, 128.9, 128.8, 125.1, 124.9, 123.1, 121.2, 119.7, 
119.1, 118.6, 108.9, 11.6, 8.6 ppm; GC-MS m/z = 195 (M+). 1H and 13C NMR spectral data 
are in good agreement with the literature data.112 
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Data for 106p: 1H NMR (400 MHz, CDCl3) δ 8.93 (br s, 1H), 8.07 (d, 
J = 8.1 Hz, 1H), 7.98 (d, J = 8.0 Hz, 1H), 7.82-7.78 (m, 1H), 7.61-7.43 
(m, 9H), 7.42-7.31 (m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
135.0, 132.7, 132.5, 130.7, 130.5, 130.2, 128.9, 128.7, 128.5, 128.0, 127.4, 126.3, 125.6, 
124.5, 124.1, 121.4, 121.2, 119.5, 119.4, 116.8 ppm; GC-MS m/z = 319 (M+). 1H and 13C 
NMR spectral data are in good agreement with the literature data.113 
Data for 106q: 1H NMR (400 MHz, acetone-d6) δ 11.59 (br s, 1H), 
8.34-8.31 (m, 1H), 7.95-7.92 (m, 1H), 7.75 (d, J = 8.5 Hz, 1H), 
7.64-7.61 (m, 1H), 7.57-7.50 (m, 3H), 7.42-7.37 (m, 1H), 7.36-7.31 
(m, 1H), 7.21-7.16 (m, 1H), 3.77 (s, 2H) ppm; 13C{1H} NMR (100 MHz, acetone-d6) δ 
148.4, 143.1, 136.4, 136.0, 131.2, 129.6, 127.5, 126.3, 126.3, 125.2, 124.3, 124.0, 123.5, 
121.3, 121.3, 121.0, 120.2, 118.2, 30.7 ppm; GC-MS m/z = 255 (M+); HRMS (IT-TOF/ESI) 
Calcd for C19H14N ([M+H]
+): 256.1121, Found: 256.1114. 
Data for 106r: 1H NMR (400 MHz, CDCl3) δ 8.40 (br s, 1H), 8.00-
7.93 (m, 2H), 7.70 (d, J = 8.6 Hz, 1H), 7.56 (d, J = 8.6 Hz, 1H), 7.56-
7.51 (m, 1H), 7.46-7.41 (m, 1H), 3.02-2.94 (m, 4H), 1.87-1.78 (m, 
4H), 1.58-1.46 (m, 4H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 133.8, 129.8, 128.9, 
128.8, 125.1, 124.1, 123.0, 121.4, 119.6, 119.1, 118.5, 113.5, 29.9, 29.8, 26.0, 25.8, 25.8, 
22.2 ppm; GC-MS m/z = 249 (M+); HRMS (IT-TOF/ESI) Calcd for C18H20N ([M+H]
+): 
250.1590. Found 250.1582. 
Data for 106s: 1H NMR (400 MHz, CDCl3) δ 8.24 (br s, 1H), 
7.69-7.65 (m, 2H), 7.61 (d, J = 8.2 Hz, 1H), 7.49-7.44 (m, 2H), 
7.38-7.33 (m, 1H), 7.29-7.27 (m, 1H), 7.10 (dd, J = 8.2, 1.5 Hz, 
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1H), 6.84 (dd, J = 2.1, 0.8 Hz, 1H), 3.08 (septet, J = 7.0 Hz, 1H), 1.38 (d, J = 7.0 Hz, 6H) 
ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 143.6, 137.4, 137.1, 132.5, 128.9, 127.4, 127.4, 
124.9, 120.3, 119.7, 108.1, 99.8, 34.4, 24.4 ppm; GC-MS m/z = 235 (M+). 1H and 13C NMR 
spectral data are in good agreement with the literature data.104 
Data for 106t: 1H NMR (400 MHz, DMSO-d6) δ 11.50 (br 
s, 1H), 7.82-7.78 (m, 2H), 7.52 (d, J = 8.5 Hz, 1H), 7.46-
7.40 (m, 2H), 7.38-7.32 (m, 2H), 7.30-7.26 (m, 1H), 7.10-
7.05 (m, 1H), 7.01-6.96 (m, 3H), 6.90-6.88 (m, 1H), 6.75 (dd, J = 8.5, 2.2 Hz, 1H) ppm; 
13C{1H} NMR (100 MHz, DMSO-d6) δ 158.1, 152.0, 137.9, 137.6, 132.1, 129.9, 129.0, 
127.3, 125.3, 124.8, 122.7, 121.2, 117.9, 112.6, 101.5, 98.7 ppm; GC-MS m/z = 285 (M+); 
Anal. Calcd for C20H15NO: C, 84.19; H, 5.30; N, 4.91. Found: C, 84.34; H, 5.49; N, 4.96. 
Data for 106u: 1H NMR (400 MHz, DMSO-d6) δ 11.71 (br s, 
1H), 7.87-7.83 (m, 2H), 7.54 (d, J = 8.4 Hz, 1H), 7.50-7.44 (m, 
2H), 7.40 (d, J = 2.0 Hz, 1H), 7.36-7.31 (m, 1H), 7.01 (dd, J = 
8.4, 2.0 Hz, 1H), 6.94-6.93 (m, 1H) ppm; 13C{1H} NMR (100 MHz, DMSO-d6) δ 138.8, 
137.5, 131.7, 129.0, 127.8, 127.4, 126.0, 125.1, 121.4, 119.8, 110.8, 98.8 ppm; GC-MS 
m/z = 227 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
data.104,106 
Data for 106v: 1H NMR (400 MHz, CDCl3) δ 8.60 (br s, 1H), 7.80-
7.76 (m, 2H), 7.74-7.67 (m, 3H), 7.66-7.60 (m, 2H), 7.54-7.46 (m, 
3H), 7.40-7.36 (m, 1H), 7.33-7.29 (m, 2H), 6.98-6.97 (m, 1H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 139.2, 138.1, 134.6, 132.2, 129.6, 129.2, 128.9, 128.2, 
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127.7, 127.4, 125.4, 125.2, 122.2, 120.7, 119.9, 100.4 ppm; GC-MS m/z = 269 (M+); Anal. 
Calcd for C20H15NO: C, 89.19; H, 5.61; N, 5.20. Found: C, 89.00; H, 5.73; N, 5.27. 
Data for 106w: 1H NMR (400 MHz, CDCl3) δ 8.14 (br s, 1H), 
7.75-7.72 (m, 2H), 7.53-7.45 (m, 3H), 7.40-7.36 (m, 1H), 7.07-
7.04 (m, 1H), 6.87-6.86 (m, 1H), 2.49 (s, 6H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 137.1, 137.0, 132.6, 129.8, 128.9, 127.3, 127.1, 124.9, 123.0, 117.8, 
117.6, 100.4, 19.4, 13.1 ppm; GC-MS m/z = 221 (M+); Anal. Calcd for C16H15N: C, 86.84; 
H, 6.83; N, 6.33. Found: C, 86.99; H, 6.90; N, 6.43. 
Data for 106x: 1H NMR (400 MHz, CDCl3) δ 8.13 (br s, 1H), 7.69-
7.66 (m, 2H), 7.51-7.46 (m, 2H), 7.40-7.35 (m, 1H), 7.02 (s, 1H), 
6.90-6.87 (m, 2H), 2.64 (s, 3H), 2.51 (s, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 136.9, 136.5, 132.5, 132.3, 129.7, 128.9, 127.2, 126.9, 124.8, 122.3, 
108.4, 98.3, 21.7, 18.7 ppm; GC-MS m/z = 221 (M+); Anal. Calcd for C16H15N: C, 86.84; 
H, 6.83; N, 6.33. Found: C, 86.83; H, 6.84; N, 6.36. 
Data for 106y: 1H NMR (400 MHz, DMSO-d6) δ 11.6 (br s, 1H), 
7.86-7.81 (m, 2H), 7.56 (s, 1H), 7.47-7.43 (m, 2H), 7.34 (s, 1H), 
7.33-7.30 (m, 1H), 6.84-6.83 (m, 1H), 2.41 (s, 3H) ppm; 13C{1H} 
NMR (100 MHz, DMSO-d6) δ 138.6, 136.2, 131.9, 129.0, 128.1, 128.1, 127.7, 125.0, 
119.5, 113.0, 98.1, 20.4 ppm (one carbon signal obscured or overlapped); GC-MS m/z = 
241 (M+); HRMS (IT-TOF/ESI) Calcd for C15H13NCl ([M+H]
+): 242.0731. Found: 
242.0730. Data for 5-chloro-4-methyl-2-phenylindole: 1H NMR (400 MHz, DMSO-d6) δ 
11.7 (br s, 1H), 7.90-7.86 (m, 2H), 7.49-7.45 (m, 2H), 7.35-7.32 (m, 1H), 7.24 (d, J = 8.5 
Hz, 1H), 7.09 (d, J = 8.5 Hz, 1H), 7.04-7.02 (m, 1H), 2.52 (s, 3H) ppm; 13C{1H} NMR 
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(100 MHz, DMSO-d6) δ 138.4, 135.2, 131.9, 130.0, 129.0, 127.7, 126.0, 125.1, 123.5, 
122.2, 110.4, 98.0, 16.0 ppm. 
Data for 106z: 1H NMR (400 MHz, CDCl3) δ 8.13 (br s, 1H), 7.73-
7.69 (m, 2H), 7.52-7.45 (m, 3H), 7.37-7.33 (m, 1H), 7.12 (d, J = 
8.0 Hz, 1H), 6.89 (d, J = 2.1 Hz, 1H), 3.15-3.08 (m, 4H), 2.33-2.24 
(m, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 139.0, 137.0, 133.9, 132.6, 128.9, 127.8, 
127.3, 125.2, 124.9, 118.6, 117.2, 100.6, 33.2, 29.9, 25.4 ppm; GC-MS m/z = 233 (M+); 
Anal. Calcd for C17H15N: C, 87.52; H, 6.48; N, 6.00. Found: C, 87.56; H, 6.58; N, 6.06. 
Data for 106aa: 1H NMR (400 MHz, CDCl3) δ 8.23 (br s, 1H), 
7.61-7.57 (m, 2H), 7.44-7.39 (m, 2H), 7.30-7.25 (m, 1H), 7.00 
(s, 1H), 6.86 (s, 1H), 6.72-6.70 (m, 1H), 5.95 (s, 2H) ppm; 
13C{1H} NMR (100 MHz, CDCl3) δ 145.1, 143.2, 136.6, 132.4, 131.8, 129.0, 127.1, 124.5, 
123.1, 100.6, 100.2, 99.1, 91.9 ppm; GC-MS m/z = 237 (M+). 1H and 13C NMR spectral 
data are in good agreement with the literature data.114 
Data for 106ab: 1H NMR (400 MHz, DMSO-d6) δ 11.39 (br s, 1H), 
7.44-7.31 (m, 9H), 7.30-7.24 (m, 2H), 6.93 (d, J = 2.2 Hz, 1H), 
6.71 (dd, J = 8.7, 2.2 Hz, 1H), 3.80 (s, 3H) ppm; 13C{1H} NMR 
(100 MHz, DMSO-d6) δ 156.1, 136.9, 135.4, 132.7, 132.7, 129.7, 128.7, 128.5, 127.9, 
127.2, 126.1, 122.4, 119.4, 113.3, 110.0, 94.3, 55.2 ppm; GC-MS m/z = 299 (M+). 1H and 
13C NMR spectral data are in good agreement with the literature data.115 
Data for 108a: 1H NMR (400 MHz, CDCl3) δ 8.87 (dd, J = 4.2, 1.7 Hz, 
1H), 8.09 (d, J = 8.2 Hz, 1H), 7.93 (s, 1H), 7.74 (d, J = 8.4 Hz, 1H), 7.45 
(dd, J = 8.4, 1,7 Hz, 1H), 7.32 (dd, J = 8.2, 4.2 Hz, 1H), 3.12 (septet, J 
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= 6.9 Hz, 1H), 1.36 (d, J = 6.9 Hz, 6H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 150.5, 
150.2, 148.5, 135.6, 127.5, 126.6, 126.5, 125.5, 120.3, 34.2, 23.7 ppm; GC-MS m/z = 171 
(M+); HRMS (IT-TOF/ESI) Calcd for C12H14N ([M+H]
+): 172.1121, Found: 172.1111. 
Data for 108b: 1H NMR (400 MHz, CDCl3) δ 8.88 (dd, J = 4.2, 1.7 Hz, 
1H), 8.11-8.07 (m, 2H), 7.70 (d, J = 8.7 Hz, 1H), 7.46 (dd, J = 8.7, 2.2 
Hz, 1H), 7.36 (dd, J = 8.2, 4.2 Hz, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 151.2, 
148.4, 135.8, 135.2, 128.9, 128.3, 127.5, 126.5, 121.2 ppm; GC-MS m/z = 163 (M+). 1H 
and 13C NMR spectral data are in good agreement with the literature data.116 
Data for 109b: 1H NMR (400 MHz, CDCl3) δ 7.08 (t, J = 8.0 Hz, 
1H), 6.68-6.65 (m, 1H), 6.59-6.58 (m, 1H), 6.49-6.45 (m, 1H), 3.73 
(br s, 1H), 3.06 (t, J = 7.1 Hz, 2H), 1.65 (sextet, J = 7.2 Hz, 2H), 
1.01 (t, J = 7.2 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 149.5, 134.9, 130.1, 
116.7, 112.0, 111.0, 45.5, 22.5, 11.5 ppm; GC-MS m/z = 169 (M+); HRMS (IT-TOF/ESI) 
Calcd for C9H13NCl ([M+H]
+): 170.0731, Found: 170.0728. 
Data for 108c: 1H NMR (400 MHz, CDCl3) δ 8.87 (dd, J = 4.2, 1.7 Hz, 
1H), 8.04-8.00 (m, 1H), 8.01 (d, J = 9.0 Hz, 1H), 7.75 (d, J = 2.4 Hz, 1H), 
7.61 (dd, J = 9.0, 2.4 Hz, 1H), 7.38 (dd, J = 8.3, 4.2 Hz, 1H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 150.5, 146.5, 135.0, 132.2, 131.0, 130.3, 128.7, 126.3, 121.8 ppm; GC-
MS m/z = 163 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
data.118 
Data for 109c: 1H NMR (400 MHz, CDCl3) δ 7.13-7.09 (m, 2H), 
6.54-6.49 (m, 2H), 3.64 (br s, 1H), 3.05 (t, J = 7.1 Hz, 2H), 1.68-
1.58 (m, 2H), 1.00 (t, J = 7.4 Hz, 3H) ppm; 13C{1H} NMR (100 
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MHz, CDCl3) δ 147.0, 129.0, 121.5, 113.7, 45.8, 22.6, 11.6 ppm; GC-MS m/z = 169 (M+). 
1H and 13C NMR spectral data are in good agreement with the literature data.119 
Data for 108d: 1H NMR (400 MHz, CDCl3) δ 8.81 (dd, J = 4.2, 1.7 Hz, 
1H), 8.17-8.14 (m, 1H), 7.70 (s, 1H), 7.25 (dd, J = 8.4, 4.2 Hz, 1H), 7.13 
(s, 1H), 2.56 (s, 3H), 2.46 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) 
δ 149.7, 148.6, 139.1, 133.9, 132.0, 129.1, 126.4, 125.5, 119.7, 21.6, 18.2 ppm; GC-MS 
m/z = 157 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
data.120 
Data for 108e: 1H NMR (400 MHz, CDCl3) δ 9.20 (d, J = 2.4 Hz, 1H), 
8.23 (d, J = 2.4 Hz, 1H), 7.74-7.71 (m, 2H), 7.63 (d, J = 8.3 Hz, 1H), 
7.55-7.50 (m, 2H), 7.45-7.41 (m, 1H), 7.40, (d, J = 8.3 Hz, 1H), 2.81 
(s, 3H), 2.54 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.5, 146.4, 138.1, 137.1, 
134.1, 133.3, 132.3, 129.9, 129.1, 127.8, 127.2, 126.3, 125.0, 20.7, 13.3 ppm; GC-MS m/z 
= 233 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
data.117,121,122 
Data for 108f: 1H NMR (400 MHz, CDCl3) δ 9.10 (d, J = 2.3 Hz, 
1H), 8.23 (d, J = 2.3 Hz, 1H), 7.76 (d, J = 8.9 Hz, 1H), 7.71-7.68 
(m, 2H), 7.54-7.49 (m, 2H), 7.46 (d, J = 2.5 Hz, 1H), 7.44-7.39 (m, 1H), 7.24 (dd, J = 8.9, 
2.5 Hz, 1H), 3.98 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.7, 149.9, 149.0, 
138.0, 133.0, 131.8, 129.1, 129.0, 127.8, 127.2, 123.2, 120.2, 107.1, 55.5 ppm; GC-MS 
m/z = 235 (M+). 1H and 13C NMR spectral data are in good agreement with the literature 
data.117 
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Data for 108g: 1H NMR (400 MHz, CDCl3) δ 8.95 (d, J = 2.3 Hz, 
1H), 8.08 (d, J = 2.3 Hz, 1H), 7.68-7.64 (m, 2H), 7.52-7.47 (m, 2H), 
7.43-7.38 (m, 2H), 7.08 (s, 1H), 6.10 (s, 2H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 
150.6, 148.1, 147.3, 145.5, 137.9, 132.3, 132.2, 129.0, 127.8, 127.2, 125.0, 105.6, 102.8, 
101.7 ppm; GC-MS m/z = 249 (M+). 1H and 13C NMR spectral data are in good agreement 
with the literature data.117 
Data for 109g: 1H NMR (400 MHz, CDCl3) δ 7.36-7.31 (m, 2H), 
7.27-7.20 (m, 3H), 6.65 (d, J = 8.3 Hz, 1H), 6.21 (d, J = 2.3 Hz, 
1H), 6.01 (dd, J = 8.3, 2.3 Hz, 1H), 5.85 (s, 2H), 3.36 (br s, 1H), 
3.28 (dd, J = 12.2, 6.0 Hz, 1H), 3.17 (dd, J = 12.2, 8.4 Hz, 1H), 3.09-3.00 (m, 1H), 1.33 (d, 
J = 7.0 Hz, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 148.3, 144.4, 143.8, 139.5, 128.7, 
127.2, 126.6, 108.6, 104.6, 100.5, 96.1, 51.9, 39.1, 19.8 ppm; GC-MS m/z = 255 (M+). 
HRMS (IT-TOF/ESI) Calcd for C16H18NO2 ([M+H]
+): 256.1332, Found: 256.1330. 
Data for 108h: 1H NMR (400 MHz, DMSO-d6) δ 8.62 (s, 1H), 8.14 
(s, 1H), 6.95 (s, 1H), 6.43 (s, 1H), 3.89 (s, 3H), 3.88 (s, 3H), 2.41 (s, 
3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 160.2, 155.3, 152.4, 
148.3, 129.5, 127.2, 116.3, 99.3, 97.9, 55.5, 55.3, 18.4 ppm; GC-MS m/z = 203 (M+); 
HRMS (IT-TOF/ESI) Calcd for C12H14NO2 ([M+H]
+): 204.1019, Found: 204.1015. 
Data for 108i: 1H NMR (400 MHz, CDCl3) δ 9.09 (d, J = 2.4 Hz, 
1H), 8.61 (d, J = 2.4 Hz, 1H), 7.73-7.69 (m, 2H), 7.52-7.47 (m, 
2H), 7.42-7.37 (m, 1H), 7.05 (d, J = 2.2 Hz, 1H), 6.54 (d, J = 2.2 
Hz, 1H), 3.98 (s, 3H), 3.96 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 161.2, 156.1, 
150.1, 149.4, 138.3, 130.9, 129.0, 128.1, 127.6, 127.1, 116.5, 99.4, 98.4, 55.8, 55.6 ppm; 
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GC-MS m/z = 265 (M+); HRMS (IT-TOF/ESI) Calcd for C17H16NO2 ([M+H]
+): 266.1176, 
Found: 266.1170. 
Data for 108j: 1H NMR (400 MHz, CDCl3) δ 6.95 (d, J = 2.4 Hz, 
1H), 6.83-6.82 (m, 1H), 6.41 (d, J = 2.4 Hz, 1H), 3.89 (s, 3H), 3.86 
(s, 3H), 2.74 (s, 3H), 2.58 (s, 3H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 160.3, 158.7, 158.5, 151.3, 145.5, 121.9, 114.7, 100.1, 97.6, 55.4, 55.3, 24.6, 
24.0 ppm; GC-MS m/z = 217 (M+); HRMS (IT-TOF/ESI) Calcd for C13H16NO2 ([M+H]
+): 
218.1176, Found: 218.1171. 
Data for 108k: 1H NMR (400 MHz, CDCl3) δ 9.34-9.30 (m, 1H), 9.03-9.00 
(m, 1H), 8.17-8.14 (m, 1H), 7.91 (d, J = 7.7 Hz, 1H), 7.81 (d, J = 8.8 Hz, 
1H), 7.79-7.65 (m, 3H), 7.53-7.49 (m, 1H) ppm; 13C{1H} NMR (100 MHz, 
CDCl3) δ 148.8, 146.5, 135.8, 133.5, 131.4, 128.1, 127.8, 127.7, 127.0, 126.3, 125.3, 124.3, 
121.7 ppm; GC-MS m/z = 179 (M+). 1H and 13C NMR spectral data are in good agreement 
with the literature data.123 
Data for 108l: 1H NMR (400 MHz, CDCl3) δ 9.30-9.27 (m, 1H), 8.84 (d, 
J = 2.2 Hz, 1H), 7.90-7.86 (m, 2H), 7.78-7.72 (m, 2H), 7.70-7.65 (m, 
1H), 7.58 (d, J = 8.8 Hz, 1H), 2.52 (s, 3H) ppm; 13C{1H} NMR (100 
MHz, CDCl3) δ 150.2, 144.4, 135.0, 133.1, 131.4, 131.2, 127.7, 127.6, 127.6, 126.9, 126.0, 
125.0, 124.0, 18.5 ppm; GC-MS m/z = 193 (M+). 1H and 13C NMR spectral data are in 
good agreement with the literature data.124 
Data for 108m: 1H NMR (400 MHz, CDCl3) δ 9.34-9.31 (m, 1H), 9.28 
(d, J = 2.3 Hz, 1H), 8.31 (d, J = 2.3 Hz, 1H), 7.94-7.90 (m, 1H), 7.83 
(d, J = 8.8 Hz, 1H), 7.80-7.69 (m, 4H), 7.73 (d, J = 8.8 Hz, 1H), 7.57-
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7.52 (m, 2H), 7.48-7.43 (m, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 147.8, 145.5, 
137.9, 134.5, 133.5, 133.3, 131.3, 129.1, 128.1, 128.1, 128.0, 127.8, 127.3, 127.2, 126.1, 
125.4, 124.3 ppm; GC-MS m/z = 255 (M+). 1H and 13C NMR spectral data are in good 
agreement with the literature data.122 
Data for 108n: 1H NMR (400 MHz, CDCl3) δ 9.38-9.33 (m, 1H), 7.91-
7.88 (m, 1H), 7.87 (d, J = 9.0 Hz, 1H), 7.77 (d, J = 9.0 Hz, 1H), 7.73-
7.64 (m, 2H), 7.25 (s, 1H), 2.79 (s, 3H), 2.71 (s, 3H) ppm; 13C{1H} NMR 
(100 MHz, CDCl3) δ 157.2, 145.6, 143.9, 133.4, 131.6, 127.7, 127.5, 126.7, 126.2, 124.7, 
123.7, 123.3, 121.2, 25.3, 19.0 ppm; GC-MS m/z = 207 (M+). 1H and 13C NMR spectral 
data are in good agreement with the literature data.125 
 
  
164 
 
BIBLIOGRAPHY 
1. (a) Heck, R. F. J. Am. Chem. Soc. 1968, 90, 5518-5526. (b) Heck, R. F. J. Am. Chem. 
Soc. 1968, 90, 5526-5531. (c) Heck, R. F. J. Am. Chem. Soc. 1968, 90, 5531-5534.  (d) 
Heck, R. F. J. Am. Chem. Soc. 1968, 90, 5538-5542.  (e) Heck, R. F. J. Am. Chem. Soc. 
1968, 90, 5542-5546. (f) R. F. Heck, J. Am. Chem. Soc. 1969, 91, 6707-6714. (g) 
Heck, R. F.; Nolley, J. P. J. Org. Chem. 1972, 37, 2320-2322. 
2. (a) Tamao, K.; Sumitani, K.; Kumada, M. J. Am. Chem. Soc. 1972, 94, 4374-4376. (b) 
Miyaura, N.; Yamada, K.; Suzuki, A. Tetrahedron Lett. 1979, 3437-3440. (c) Miyaura, 
N.; Suzuki, A. J. Chem Soc., Chem. Commun. 1979, 866-867. (d) King, A. O.; 
Okukado, N.; Negishi, E. J. Chem. Soc., Chem. Commun. 1977, 19, 683-684. (e) 
Negishi, E. Acc. Chem. Res. 1982, 15, 340-348. (f) Milstein, D.; Stille, J. K. J. Am. 
Chem. Soc. 1978, 100, 3636-3638. (g) Hatanaka, Y.; Hiyama, T. J. Org. Chem. 1988, 
53, 918-920. 
3. Selected reviews for the transition metal-catalyzed cross-coupling reactions: (a) 
Corbet, J.-P.; Mignani, G. Chem. Rev. 2006, 106, 2651-2710. (b) Alberico, D.; Scott, 
M. E.; Lautens, M. Chem. Rev. 2007, 107, 174-238. (c) Kambe, N.; Iwasaki, T.; Terao, 
J. Chem. Soc. Rev. 2011, 40, 4937-4947. (d) Han, F.-S. Chem. Soc. Rev. 2013, 42, 
5270-5298. 
4. Selected reviews for the C-H functionalizations: (a) Labinger, J. A.; Bercaw, J. E. 
Nature 2002, 417, 507-514. (b) Hartwig, J. F. Nature 2008, 455, 314-322. (c) 
Ackermann, L.; Vicente, R.; Althammer, A. Org. Lett. 2008, 10, 2299-2302. (d) Giri, 
R.; Shi, B.-F.; Engle, K. M.; Maugel, N.; Yu, J.-Q. Chem. Soc. Rev. 2009, 38, 3242-
3272. (e) Mkhalid, I. A. I.; Barnard, J. H.; Marder, T. B.; Murphy, J. M.; Hartwig, J. F. 
Chem. Rev. 2010, 110, 890-931. (f) Hashiguchi, B. G.; Bischof, S. M.; Konnick, M. 
M.; Periana, R. A. Acc. Chem. Res. 2012, 45, 885-898. (g) Gensch, T; Hopkinson, M. 
N.; Glorius, F.; Wencel-Delord, J. Chem. Soc. Rev. 2016, 45, 2900-2936. 
5. (a) Li, C.-J. Acc. Chem. Res. 2009, 42, 335-344. (b) Chem, X.; Engle, K. M.; Wang, 
D.-H.; Yu, J.-Q. Angew. Chem. Int. Ed. 2009, 48, 5094-5115. (c) Scheuermann, C. J. 
Chem. Asian J. 2010, 5, 436-451. (d) Yeung, C. S.; Dong, V. M. Chem. Rev. 2011, 
111, 1215-1292. (e) Liu, C.; Zhang, H.; Shi, W.; Lei, A. Chem. Rev. 2011, 111, 1780-
1824. (f) Ackermann, L. Acc. Chem. Res. 2014, 47, 281-295. (g) Wu, Y.; Wang, J.; 
Mao, F.; Kwong, F. Y. Chem. Asian. J. 2014, 9, 26-47. (h) Li, S.-S.; Qin, L.; Dong, L. 
Org. Biomol. Chem. 2016, 14, 4554-4570. 
6. (a) Lyons, T. W.; Sanford, M. S. Chem. Rev. 2010, 110, 1147-1169. (b) Ackermann, L. 
Chem. Rev. 2011, 111, 1315-1345. (c) Engle, K. M.; Mei, T.-S.; Wasa, M.; Yu, J.-Q. 
Acc. Chem. Res. 2012, 45, 788-802. (d) Brückl, T.; Baxter, R. D.; Ishihara, Y.; Baran, 
P. S. Acc. Chem. Res. 2012, 45, 826-839. (e) Rouquet, G.; Chatani, N. Angew. Chem. 
Int. Ed. 2013, 52, 11726-11743. 
165 
 
7. (a) Ritleng, V.; Sirlin, C.; Pfeffer, M. Chem. Rev. 2002, 102, 1731-1770. (b) Beccalli, 
E. M.; Broggini, G.; Martinelli, M.; Sottocornola, S. Chem. Rev. 2007, 107, 5318-
5365. 
8. (a) Zhang, Y.; Li, C.-J. Eur. J. Org. Chem. 2007, 2007, 4654-4657. (b) Deng, G.; 
Ueda, K.; Yanagisawa, S.; Itami, K.; Li, C.-J. Chem. Eur. J. 2009, 15, 333-337. (c) 
Antonchick, A. P.; Burgmann, L. Angew. Chem., Int. Ed. 2013, 52, 3267-3271. 
9. (a) Fujiwara, Y.; Moritani, I.; Danno, S.; Asano, R.; Teranishi, S. J. Am. Chem. Soc. 
1969, 91, 7166-7169. (b) Moritani, I.; Fujiwara, Y. Synthesis 1973, 524-533. 
10. Piera, J.; Bäckvall, J.-E. Angew. Chem., Int. Ed. 2008, 47, 3506-3523. 
11. Boele, M. D. K.; van Strijdonck, G. P. F.; de Vries, A. H. M.; Kamer, P. C. J.; de 
Vries, J. G.; van Leeuwen, P. W. N. M. J. Am. Chem. Soc. 2002, 124, 1586-1587. 
12. Weissman, H.; Song, X.; Milstein, D. J. Am. Chem. Soc. 2001, 123, 337-338. 
13. (a) Chatani, N.; Asaumi, T.; Yorimitsu, S.; Ikeda, T.; Kakiuchi, F.; Murai, S. J. Am. 
Chem. Soc. 2001, 123, 10935-10941. (b) DeBoef, B.; Pastine, S. J.; Sames, D. J. Am. 
Chem. Soc. 2004, 126, 6556-6557. (c) Sezen, B.; Sames, D. J. Am. Chem. Soc. 2005, 
127, 5284-5285. 
14. Yi, C. S.; Yun, S. Y.; Guzei, I. A. Organometallics 2004, 23, 5392-5395. 
15. Kwon, K.-H.; Lee, D. W.; Yi, C. S. Organometallics 2010, 29, 5748-5750. 
16. (a) Yi, C. S.; Zeczycki, T. N.; Guzei, I. A. Organometallics 2006, 25, 1047-1051. (b) 
Yi, C. S.; Zeczycki, T. N.; Lindeman, S. V. Organometallics 2008, 27, 2030-2035. 
17. (a) Ullmann, F.; Bielecki, J. Ber. Dtsch. Chem. Ges. 1901, 34, 2174-2185. (b) 
Goldberg, I. Ber. Dtsch. Chem. Ges. 1906, 39, 1691-1692. 
18. Selected reviews for the oxidative direct arylations: (a) McGlacken, G. P.; Batemann, 
L. M. Chem. Soc. Rev. 2009, 38, 2447-2464. (b) Ashenhurst, J. A. Chem. Soc. Rev. 
2010, 39, 540-548. (c) You, S.-L.; Xia, J.-B. Top. Curr. Chem. 2010, 292, 165-194. 
19. Li, R.; Jiang, L.; Lu, W. Organometallics 2006, 25, 5973-5975. 
20. Lu, W.; Yamaoka, Y.; Taniguchi, Y.; Kitamura, T.; Takaki, K.; Fujiwara, Y. J. 
Organomet. Chem. 1999, 580, 290-294. 
21. Stuart, D. R.; Fagnou, K. Science 2007, 316, 1172-1175. 
22. Stuart, D. R.; Villemure, E.; Fagnou, K. J. Am. Chem. Soc. 2007, 129, 12072-12073. 
23. Zhao, X.; Yeung, C. S.; Dong, V. M. J. Am. Chem. Soc. 2010, 132, 5837-5844. 
166 
 
24. (a) Jia, C.; Piao, D.; Oyamada, J.; Lu, W.; Kitamura, T.; Fujiwara, Y. Science 2000, 
287, 1992-1995. (b) Jia, C.; Lu, W.; Oyamada, J.; Kitamura, T.; Matsuda, K.; Irie, M.; 
Fujiwara, Y. J. Am. Chem. Soc. 2000, 122, 7252-7263. 
25. Dupont, J.; Consorti, C. S.; Spencer, J. Chem. Rev. 2005, 105, 2527-2572. 
26. Ackermann, L.; Jeyachandran, R.; Potukuchi, H. K.; Novák, P.; Büttner, L. Org. Lett. 
2010, 12, 2056-2059. 
27. Cheng, C.; Chen, W.-W.; Xu, B.; Xu, M.-H. J. Org. Chem. 2016, 81, 11501-11507. 
28. Chatani, N.; Fukuyama, T.; Kakiuchi, F.; Murai, S. J. Am. Chem. Soc. 1996, 118, 
493-494. 
29. Tlili, A.; Schranck, J.; Pospech, J.; Neumann, H.; Beller, M. Angew. Chem., Int. Ed. 
2013, 52, 6293-6297. 
30. Selected reviews for the aldehydic C-H bond activations: (a) Park, Y. J.; Park, J.-W.; 
Jun, C.-H. Acc. Chem. Res. 2008, 41, 222-234. (b) Garralda, M. A. Dalton Trans. 
2009, 3635-3645. (c) Willis, M. C. Chem. Rev. 2010, 110, 725-748.  
31. Jia, X.; Zhang, S.; Wang, W.; Luo, F.; Cheng, J. Org. Lett. 2009, 11, 3120-3123. 
32. Chan, C.-W.; Zhou, Z.; Chan, A. S. C.; Yu, W.-Y. Org. Lett. 2010, 12, 3926-3929. 
33. Tang, B.-X.; Song, R.-J.; Wu, C.-Y.; Liu, Y.; Zhou, M.-B.; Wei, W.-T.; Deng, G.-B.; 
yin, D.-L.; Li, J.-H. J. Am. Chem. Soc. 2010, 132, 8900-8902. 
34. Review for the dehydrative cross-couplings: Kumar, R.; Van der Eyckn, E. V. Chem. 
Soc. Rev. 2013, 42, 1121-1146. 
35. (a) Tsuji, J.; Takahashi, H.; Morikawa, M. Tetrahedron Lett. 1965, 6, 4387-4388. (b) 
Trost, B. M.; Fullerton, T. J. J. Am. Chem. Soc. 1973, 95, 292-294. (c) Trost, B. M.; 
Crawley, M. L. Chem. Rev. 2003, 103, 2921-2944. 
36. (a) Sundararaju, B.; Achard, M.; Brunau, C. Chem. Soc. Rev. 2012, 41, 4467-4483. 
(b) Butt, N. A.; Zhang, W. Chem. Soc. Rev. 2015, 44, 7929-7967. (c) Gumrukcu, Y.; 
de Bruin, B.; Reek, J. N. H. Catalysts 2015, 5, 349-365. 
37. Ozawa, F.; Okamoto, H.; Kawagishi, S.; Yamamoto, S.; Minami, T. Yoshifuji, M. J. 
Am. Chem. Soc. 2002, 124, 10968-10969. 
38. Li, Y.-X.; Xuan, Q.-Q.; Liu, L.; Wang, D.; Chen, Y.-J.; Li, C.-J. J. Am. Chem. Soc. 
2013, 135, 12536-12539. 
39. Gumrukcu, Y.; de Bruin, B.; Reek, J. N. H. Chem. Eur. J. 2014, 20, 10905-10909. 
40. Bunno, Y.; Murakami, N.; Suzuki, Y.; Kanai, M.; Yoshino, T.; Matsunaga, S. Org. 
Lett. 2016, 18, 2216-2219. 
167 
 
41. Kumar, G. S.; Kapur, M. Org. Lett. 2016, 18, 1112-1115. 
42. Smith, M. B.; March, J. March’s Advanced Organic Chemistry; Wiley: New York, 
2001. 
43. Lee, D.-H.; Kwon, K.-H.; Yi, C. S. Science 2011, 333, 1613-1616. 
44. Lee, D.-H.; Kwon, K.-H.; Yi, C. S. J. Am. Chem. Soc. 2012, 134, 7325-7328. 
45. Ackermann, L.; Mulzer, M. Org. Lett. 2008, 10, 5043-5045. 
46. Ackermann, L.; Pospech, J.; Potukuchi, H. K. Org. Lett. 2012, 14, 2146-2149. 
47. (a) Ackermann, L.; Vicente, R.; Althammer, A. Org. Lett. 2008, 10, 2299-2302. (b) 
Ackermann, L.; Lygin, A. V.; Hofmann, N. Angew. Chem. In. Ed. 2011, 50, 6379-
6382. (c) Ackermann, L.; Pospech, J.; Graczyk, K.; Rauch, K. Org. Lett. 2012, 14, 
930-933. 
48. (a) Gore, P. H. Chem. Rev. 1955, 55, 229-281. (b) Olah, G. A. Friedel-Crafts 
Chemistry; Wiley: New York, 1973. (c) Sartori, G.; Maggi, R. Advances in Friedel-
Crafts Acylation Reactions; CRC Press: FL, 2010. 
49. (a) Yato, M.; Ohwada, T.; Shudo, K. J. Am. Chem. Soc. 1991, 113, 691-692. (b) Sato, 
Y.; Yato, M.; Ohwada, T.; Saito, S.; Shudo, K. J. Am. Chem. Soc. 1995, 117, 3037-
3043. 
50. (a) Barnard, C. F. J. Organometallics 2008, 27, 5402-5422. (b) Wu, J.; Lan, J.; Guo, 
S.; You, J. Org. Lett. 2014, 16, 5862-5865. (c) Froese, J.; Hudlicky, J. R.; Hudlicky, 
T. Org. Biomol. Chem. 2014, 12, 7810-7819. (d) Gadge, S. T.; Bhanage, B. M. RSC 
Adv. 2014, 4, 10367-10389. 
51. Halima, T. B.; Zhang, W.; Yalaoui, I.; Hong, X.; Yang, Y.-F.; Houk, K. N.; Newman, 
S. G. J. Am. Chem. Soc. 2017, 139, 1311-1318. 
52. Hu, J.; Adogla, E. A.; Ju, Y.; Fan, D.; Wang, Q. Chem. Commun. 2012, 48, 11256-
11258. 
53. Yi, C. S.; Lee, D. W. Organometallics 2010, 29, 1883-1885.  
54. Kwon, K.-H.; Lee, D. W.; Yi, C. S. Organometallics 2012, 31, 495-504. 
55. Kalutharage, N.; Yi, C. S. J. Am. Chem. Soc. 2015, 137, 11105-11114. 
56. (a) Hoshimoto, Y.; Ohashi, M.; Ogoshi, S. J. Am. Chem. Soc. 2011, 133, 4668-4671. 
(b) Curran, S. P.; Connon, S. J. Org. Lett. 2012, 14, 1074-1077. 
57. (a) Middleton, E. Jr.; Kandaswami, C.; Theoharides, T. C. Pharm. Rev. 2000, 52, 
673-751. (b) Boots, A. W.; Haenen, G. R.; Bast, A. Eur. J. Pharmacol. 2008, 585, 
325-337. 
168 
 
58. Selected recent examples: (a) Fristrup, P.; Kreis, M.; Palmelund, A.; Norrby, P.-O.; 
Madsen, R. J. Am. Chem. Soc. 2008, 130, 5206-5215. (b) Koren-Selfridge, L.; 
Londino, H. N.; Vellucci, J. K.; Simmons, B. J.; Casey, C. P.; Clark, T. B. 
Organometallics 2009, 28, 2085-2090. (c) Sigman, M. S.; Werner, E. W. Acc. Chem. 
Res. 2012, 45, 874-884. 
59. Wang, X.; Guram, A.; Caille, S.; Hu, J.; Preston, J. P.; Ronk, M.; Walker, S. Org. Lett. 
2011, 13, 1881-1883. 
60. Yang, D.; Zhu, Y.; Yang, N.; Jiang, Q.; Liu, R. Adv. Synth. Catal. 2016, 358, 1731-
1735. 
61. Zhang, Y.; Sigman, M. S. Org. Lett. 2006, 8, 5557-5560. 
62. Murphy, S. K.; Bruch, A.; Dong, V. M. Angew. Chem., Int. Ed. 2014, 53, 2455-2459. 
63. Sasano, K.; Takaya, J.; Iwasawa, N. J. Am. Chem. Soc. 2013, 135, 10954-10957. 
64. Chen, J.; Shao, Y.; Zheng, H.; Cheng, J.; Wan, X. J. Org. Chem. 2015, 80, 10734-
10741. 
65. Yu, S.-Y.; Zhang, H.; Gao, Y.; Mo, L.; Wang, S.; Yao, Z.-J. J. Am. Chem. Soc. 2013, 
135, 11402-11407. 
66. Yoshida, M.; Ohno, S.; Namba, K. Angew. Chem., Int. Ed. 2013, 52, 13597-13600. 
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